Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.8291878904903288,-2.5343005504838843,0.0,0.0,0.0,8/22,7.22%,NR2F2;ALDH1A2;PTGDS;RBP4;CYP26B1;RBP1;CRABP2;ABCA4
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6992630072871098,-2.0584984035393363,0.0,0.010093789240609696,0.029,9/16,10.46%,PTPRK;PTPRG;PTPRB;PTPRD;PTPRM;PTPRN2;PTPRZ1;PTPRO;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6992630072871098,-2.0584984035393363,0.0,0.010093789240609696,0.029,9/16,10.46%,PTPRK;PTPRG;PTPRB;PTPRD;PTPRM;PTPRN2;PTPRZ1;PTPRO;PTPRT
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.7744976283415324,-1.9842995147354348,0.0,0.022972072064835862,0.08,4/11,10.93%,ITPR1;RASA3;ITPR3;RYR2
prerank,retinoic acid binding (GO:0001972),-0.7516526020792358,-1.938919886947108,0.0,0.03863484847267849,0.153,2/12,3.86%,NR2F2;CYP26B1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5860013977547841,-1.916982586114965,0.0055248618784530384,0.04089724950936687,0.19,9/26,7.71%,SLC6A13;SLC16A12;SLC16A2;ABCG2;SLC6A12;SLC16A6;SLC6A1;SLC16A11;SLC16A4
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.8726739133139227,1.881898063791614,0.0013351134846461949,0.05347563375881066,0.046,3/14,0.90%,NOX4;DUOX1;NCF4
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.723424424936419,-1.8814619308913614,0.0035087719298245615,0.05131423889807491,0.263,7/11,13.95%,ITPR1;TRPC5;ITPR3;TRPC6;TRPC4;TRPC7;TRPC3
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.7000943047524055,-1.8667820823812278,0.003676470588235294,0.05155663900914867,0.298,8/12,19.04%,CNOT2;PAN3;CNOT7;NOCT;CNOT6L;TOE1;PNLDC1;CNOT1
prerank,amino acid:sodium symporter activity (GO:0005283),-0.704247871899389,-1.8616376724564423,0.0,0.048148534883368094,0.308,4/11,2.97%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.9196852236553348,1.8547174613122426,0.0,0.05298048900178464,0.091,3/10,0.90%,NOX4;DUOX1;NCF4
prerank,semaphorin receptor activity (GO:0017154),-0.7193298357744417,-1.853725007316657,0.01056338028169014,0.04761484027984161,0.331,6/11,8.54%,PLXNA2;NRP2;PLXNA4;PLXND1;NRP1;PLXNB1
prerank,monocarboxylic acid binding (GO:0033293),-0.6401427812555216,-1.8337950510577226,0.008438818565400843,0.053253439786664955,0.391,3/18,6.24%,NR2F2;CYP26B1;NAPEPLD
prerank,store-operated calcium channel activity (GO:0015279),-0.7267038432429237,-1.8234685401138497,0.013468013468013467,0.05360150148461701,0.416,6/10,13.95%,TRPC5;TRPC6;TRPC4;ORAI2;TRPC7;TRPC3
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.4625659460578725,-1.8186816580603025,0.0,0.05140603538984249,0.43,12/55,4.74%,SLC7A2;SLC6A13;SLC16A12;SLC13A3;SLC16A2;SLC6A12;SLC16A6;PDPN;SLC38A11;SLC7A5;SLC16A11;SLC22A4
prerank,acid-thiol ligase activity (GO:0016878),-0.6802246175159903,-1.8132609168076357,0.003875968992248062,0.05019546915465758,0.448,5/13,12.38%,ACSL1;ACSS3;AACS;ACSS1;ACSS2
prerank,CoA-ligase activity (GO:0016405),-0.6718134379617281,-1.7967008185918283,0.0,0.05443684955970195,0.496,5/14,12.38%,ACSL1;ACSS3;AACS;ACSS1;ACSS2
prerank,platelet-derived growth factor binding (GO:0048407),0.8286077535521653,1.7519037119164076,0.005594405594405594,0.2746402918971017,0.49,7/11,12.80%,COL3A1;COL1A2;COL1A1;COL5A1;COL6A1;COL2A1;PDGFRA
prerank,sulfuric ester hydrolase activity (GO:0008484),0.8338656525229375,1.7349197685053523,0.005376344086021506,0.2748053401494437,0.591,5/12,6.47%,ARSA;ARSJ;SULF2;ARSI;SULF1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.7415730826272708,1.7241083356360045,0.004975124378109453,0.26044614219568896,0.653,4/21,2.82%,FGF18;FGF7;NPTN;FGF2
prerank,serine-type peptidase activity (GO:0008236),0.6196666834974899,1.7094642663545137,0.0,0.2701839890838675,0.726,23/96,16.96%,HTRA3;PCSK6;KLK9;PRSS48;DPP4;FAP;HPN;PCSK5;MMP2;GZMK;PRSS12;PCSK4;RHBDF1;TPP1;MASP2;GZMM;PIK3IP1;KLK1;KLK6;CLPP;HGF;PRSS8;HTRA2
prerank,protease binding (GO:0002020),0.6148840312883403,1.701394370716522,0.0,0.26412436039073944,0.762,21/99,6.91%,COL3A1;COMP;COL1A2;TIMP2;COL1A1;CCBE1;DPP4;FAP;ITGB3;ANXA2;CD177;ECM1;SRI;BIN1;CLTC;SYVN1;SPATA2;ADAMTSL4;ATP9A;CARD16;TRIP4
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.661728943890435,-1.6914230683915688,0.018315018315018316,0.12504116498927703,0.818,4/11,15.44%,PPP1R1A;PPP1R8;PPP1R14A;PABIR1
prerank,serine-type endopeptidase activity (GO:0004252),0.6062199164858377,1.6486898993875092,0.0,0.4750913943664707,0.942,16/80,12.36%,PCSK6;KLK9;PRSS48;DPP4;FAP;HPN;PCSK5;MMP2;PRSS12;PCSK4;RHBDF1;MASP2;GZMM;PIK3IP1;KLK1;KLK6
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.6551999970170266,-1.630146030964048,0.06129032258064516,0.18236385550935205,0.925,6/10,15.83%,CASP4;CASP3;CASP7;CFLAR;CASP9;CASP6
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.5576915116815233,-1.6146356260943373,0.024691358024691357,0.18934556368591982,0.943,10/16,32.83%,ETHE1;CDO1;ALOX12;PIR;ADI1;BCO2;HGD;ALOXE3;HAAO;ALOX5
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.609153723956715,-1.6137522033805591,0.04263565891472868,0.1800944501350888,0.944,4/13,2.02%,BMP6;CDH5;BMP5;BMP7
prerank,low-density lipoprotein particle binding (GO:0030169),-0.5669713806331454,-1.6095294589507145,0.016194331983805668,0.1767805363898505,0.949,6/16,10.39%,PLTP;SCARB1;THBS1;STAB1;CDH13;SORL1
prerank,BMP receptor binding (GO:0070700),-0.6091549732228695,-1.5958239541568275,0.04044117647058824,0.18392574581780918,0.959,4/12,2.02%,BMP6;CDH5;BMP5;BMP7
prerank,microtubule plus-end binding (GO:0051010),0.7035414383714931,1.5951351244730627,0.014814814814814815,0.7909112252229034,0.996,13/20,22.09%,DCTN1;CLIP1;DST;MAPRE3;CLIP2;MAPRE1;CLIP4;PAFAH1B1;CLIP3;STIM1;CLASP2;NUMA1;FBXW11
prerank,protein tyrosine kinase activator activity (GO:0030296),0.7009820958310384,1.5847579064756008,0.022613065326633167,0.7942121902697435,0.997,7/19,10.98%,EFNA5;ANGPT4;DGKQ;GAS6;ABI1;NRG3;EGF
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.7315255575253765,1.5708839581553546,0.02925531914893617,0.8350841393042554,1.0,2/13,3.66%,EHHADH;MIF
prerank,filamin binding (GO:0031005),-0.6188695073689282,-1.5577647201674416,0.05844155844155844,0.2229809804971051,0.984,6/11,16.00%,NEBL;SYNPO2;TMEM67;CEACAM1;FBLIM1;MICALL2
prerank,calcium-release channel activity (GO:0015278),-0.5286555709126901,-1.535608280389146,0.0410958904109589,0.24429391261043829,0.99,3/17,5.06%,ITPR1;RASA3;ITPR3
prerank,clathrin adaptor activity (GO:0035615),0.6955380766878614,1.5261419499349853,0.04716981132075472,1.0,1.0,4/15,6.13%,STON2;AP1G2;AP1M1;AP2A2
prerank,protein kinase C binding (GO:0005080),0.5945039836655278,1.5212611473210502,0.021158129175946547,1.0,1.0,15/43,10.15%,AVPR1A;NELL2;IRS1;DACT3;ADAM9;HDAC7;HDAC9;DACT1;DACT2;YWHAG;PRKD2;TIRAP;PARD6A;ITGAV;SQSTM1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.7146077659480237,1.519006113982459,0.03753351206434316,1.0,1.0,4/14,11.16%,CAPN5;CAPN2;CAPN1;CAPN11
prerank,frizzled binding (GO:0005109),0.608911360174477,1.511712755842859,0.03305785123966942,1.0,1.0,6/34,2.77%,MYOC;LRP6;WNT2;WNT10B;CCDC88C;WNT9A
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5931447953990114,-1.5103347632103579,0.0457516339869281,0.2722712632229978,0.996,3/10,2.97%,SLC6A13;SLC6A12;SLC6A1
prerank,phospholipase binding (GO:0043274),0.7117948568572874,1.5079500160535517,0.04900662251655629,1.0,1.0,4/13,6.79%,SYK;FYN;DGKQ;SRC
prerank,C-C chemokine binding (GO:0019957),0.6228161749112126,1.4863691133137968,0.042735042735042736,1.0,1.0,6/22,17.79%,ACKR3;ACKR4;ACKR1;ZFP36;CXCR4;CXCR2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.53776616436952,-1.4847985487532418,0.06763285024154589,0.29968112193672236,0.998,5/15,9.75%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.4770471721006423,-1.4603483326417062,0.05025125628140704,0.328115085261729,1.0,3/19,5.06%,ITPR1;RASA3;ITPR3
prerank,phospholipase inhibitor activity (GO:0004859),0.71950668021904,1.4586376710086475,0.05374823196605375,1.0,1.0,3/10,2.53%,SNCB;ANXA1;ANXA2
prerank,3'-5' DNA helicase activity (GO:0043138),0.6495438971891973,1.4468329734870113,0.05721716514954486,1.0,1.0,6/16,18.50%,NAV2;HELQ;ASCC3;ERCC3;RECQL;BLM
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.5506579959664873,-1.4448196013179844,0.07111111111111111,0.34229934317485217,1.0,5/13,9.75%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1
prerank,growth factor receptor binding (GO:0070851),0.5199353677267127,1.4431759161404731,0.015447991761071062,1.0,1.0,27/95,16.74%,AREG;FGF18;FGF7;TIMM50;GLMN;BTC;ITGB3;FYN;VEGFA;FGF2;ITGA5;PTPRJ;ARF4;SRC;TLR5;SNX1;ATXN2;ESM1;PSEN1;ERN1;EGF;PIBF1;PDGFRA;FER;IL4;IL6;EFEMP1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.6887405459987582,1.4425865560161066,0.06963788300835655,1.0,1.0,3/11,14.46%,AKR1B1;RDH14;RDH13
prerank,dipeptidyl-peptidase activity (GO:0008239),0.7227239338578842,1.4397369124293184,0.07692307692307693,1.0,1.0,3/10,6.24%,DPP4;FAP;PRCP
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.6584795887499588,1.432341317429515,0.0958904109589041,1.0,1.0,1/14,0.75%,DHRS9
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3857636988525435,-1.429323128765996,0.03773584905660377,0.35640274792798105,1.0,15/47,12.92%,SLC7A11;SLC7A2;SLC6A13;SLC16A2;SLC6A1;PDPN;SLC38A11;SLC7A5;SLC22A4;SLC3A2;SLC38A5;SLC25A44;SLC6A6;SLC43A1;SLC7A14
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6615383436255909,1.4287352538412805,0.07049608355091384,1.0,1.0,3/15,4.69%,SLC1A5;SLC1A7;SLC1A6
prerank,bHLH transcription factor binding (GO:0043425),-0.48117767421482155,-1.428294224928297,0.07729468599033816,0.34612935542204876,1.0,8/19,12.94%,FHL2;SMAD3;CREBBP;SP1;TCF12;SIRT1;LMO2;USF1
prerank,receptor antagonist activity (GO:0048019),0.6372955620509455,1.4227076884038756,0.08300907911802853,1.0,1.0,4/17,17.14%,DKK2;IGSF1;DKK3;PXDN
prerank,ubiquitin-specific protease binding (GO:1990381),0.6245660016783052,1.422598713056529,0.08521303258145363,1.0,1.0,9/19,24.22%,CLTC;SYVN1;SPATA2;AMFR;SELENOS;PTEN;DERL1;LCOR;RHBDD2
prerank,acylglycerol lipase activity (GO:0047372),0.6934294959242697,1.4191326164516473,0.08513513513513514,1.0,1.0,1/11,0.65%,MGLL
prerank,carbohydrate:cation symporter activity (GO:0005402),0.6817590981909898,1.4171850272486113,0.07788595271210014,1.0,1.0,5/11,13.12%,SLC5A9;SLC17A5;SLC2A10;SLC23A1;SLC23A2
prerank,chemokine binding (GO:0019956),0.5678132604652792,1.4169808035880014,0.06375442739079103,1.0,1.0,9/30,17.79%,ACKR3;ITGB3;FGF2;ACKR4;ITGAV;ACKR1;ZFP36;CXCR4;CXCR2
prerank,lipoprotein particle binding (GO:0071813),-0.4611174205217516,-1.4132931800486257,0.0891089108910891,0.35895602909795793,1.0,6/20,10.39%,PLTP;SCARB1;THBS1;STAB1;CDH13;SORL1
prerank,ferrous iron binding (GO:0008198),-0.4611871969589141,-1.4085677781516341,0.06382978723404255,0.3559660668345827,1.0,9/21,16.89%,SNCA;FTH1;PHYH;EGLN3;FECH;EGLN1;ISCU;CDO1;FTL
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5566662217722971,-1.4081328000993285,0.12714776632302405,0.3455600044980281,1.0,6/11,15.83%,CASP4;CASP3;CASP7;CFLAR;CASP9;CASP6
prerank,phospholipase activator activity (GO:0016004),0.6911884514277283,1.4010538780114816,0.09228650137741047,1.0,1.0,4/10,9.23%,CCL8;FYN;SRC;STX4
prerank,UDP-glycosyltransferase activity (GO:0008194),0.5180810263900448,1.39325286974411,0.036055143160127257,1.0,1.0,13/70,10.81%,HAS2;HAS1;B4GALT1;B3GALNT1;CSGALNACT2;EXT1;B4GALNT4;POMGNT2;CHSY3;B3GAT3;RFNG;LARGE1;B3GNT8
prerank,tropomyosin binding (GO:0005523),-0.49088288399393615,-1.3887304207188567,0.09345794392523364,0.36935674547221625,1.0,3/16,6.37%,NEBL;CALD1;TMOD3
prerank,metalloendopeptidase activity (GO:0004222),0.5120261576330685,1.387805805235837,0.04653567735263702,1.0,1.0,23/76,18.07%,ADAMTS5;ADAMTS2;MMP2;ADAM9;ADAM19;ADAMTS3;ADAMTSL1;ADAM33;ADAMTSL4;MMP11;ADAMTSL5;ECE1;ADAMTS18;ADAMTSL3;EEF1AKMT4-ECE2;ECE2;PAPLN;THOP1;RCE1;SPG7;IDE;MMP16;ADAMTS6
prerank,anion transmembrane transporter activity (GO:0008509),-0.5183095573253192,-1.3870252322561194,0.10661764705882353,0.36153373308455583,1.0,4/12,4.37%,ABCG2;SLCO2B1;SLC39A8;SLC22A6
prerank,glucuronosyltransferase activity (GO:0015020),0.6109689582329086,1.3854182768333485,0.10635538261997406,1.0,1.0,5/19,21.80%,EXT1;B3GAT3;LARGE1;CHPF;B3GAT2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.49971789420514695,1.3828406075850568,0.047520661157024795,1.0,1.0,25/83,15.81%,UCHL1;DESI2;JOSD2;USP36;COPS5;OTUD3;ZRANB1;USP32;USP10;USP4;USP29;OTUD1;UCHL5;USP39;USP26;USP33;OTUD7B;USP48;USP50;USP5;ZC3H12A;STAMBPL1;USP7;MINDY3;USP22
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.5479356505714597,1.3791763604324248,0.07560137457044673,1.0,1.0,8/35,7.51%,SYK;SRMS;TNK1;FYN;CLK1;CSK;SRC;ABL2
prerank,lipase activator activity (GO:0060229),0.6795502119223172,1.3763663498740257,0.11357340720221606,1.0,1.0,3/10,6.79%,CCL8;FYN;SRC
prerank,cytokine activity (GO:0005125),0.4873202914117589,1.3762201021909628,0.00906344410876133,1.0,1.0,18/131,6.82%,LIF;WNT2;CCL8;WNT10B;TGFB3;IL16;CTF1;WNT9A;VEGFA;FGF2;TGFB2;MIF;BMP15;CLCF1;IL33;CXCL10;TNFRSF11B;INHA
prerank,growth factor activity (GO:0008083),0.5054245794322616,1.3736312585701222,0.036055143160127257,1.0,1.0,17/74,16.46%,LIF;AREG;FGF18;FGF7;BTC;VEGFA;FGF2;CLCF1;INHA;JAG1;NRG3;EGF;GDNF;ARTN;IL4;IL6;HGF
prerank,water transmembrane transporter activity (GO:0005372),-0.5469857728042384,-1.3721942907533717,0.13805970149253732,0.37662264642401033,1.0,2/11,8.69%,PDPN;AQP11
prerank,metallocarboxypeptidase activity (GO:0004181),-0.41245926785605663,-1.3705346360378567,0.06578947368421052,0.36874236383870995,1.0,4/26,5.72%,AEBP1;CPE;CPM;AGBL3
prerank,ATPase binding (GO:0051117),0.5111280250082937,1.3684675789148635,0.049893842887473464,1.0,1.0,25/71,20.24%,AR;ESR1;EGFR;ANK2;ATP6V0A2;TOR1AIP2;SYVN1;ZNHIT6;ABCA1;SRC;PKD2;PSEN1;ATP6V1E1;BBC3;PDE4D;SNU13;PPP3CA;CLPP;ATP6V0A1;SELENOS;ANK1;NUFIP1;PTPN3;DNAJB1;RALA
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.6411876883926931,1.366836954236183,0.11596180081855388,1.0,1.0,3/13,10.21%,GPSM2;GPSM1;GDI1
prerank,C-C chemokine receptor activity (GO:0016493),0.5780035576916676,1.3610512189238089,0.11290322580645161,1.0,1.0,4/21,17.79%,ACKR3;ACKR4;CXCR4;CXCR2
prerank,lipase activity (GO:0016298),0.5337409107161477,1.3590129396209443,0.08928571428571429,1.0,1.0,10/43,19.82%,MGLL;SMPD3;CEL;LCAT;SEC23IP;PNPLA8;DAGLB;LIPC;LIPH;DDHD1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6731209620296534,1.3579663778248907,0.12066574202496533,1.0,1.0,2/10,8.02%,AMDHD1;DPEP1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5687568953191318,1.3524852455605403,0.10891089108910891,1.0,1.0,7/25,10.90%,PARP3;ART4;PARP11;PARP6;SIRT2;PARP14;ZC3HAV1
prerank,cardiolipin binding (GO:1901612),0.6834415468425169,1.3519058056222826,0.13544668587896252,1.0,1.0,1/10,0.59%,UCP1
prerank,solute:sodium symporter activity (GO:0015370),0.5692152638958777,1.3515721626929385,0.08047337278106509,1.0,1.0,3/27,2.17%,SLC5A9;SLC4A10;SLC4A8
prerank,chemoattractant activity (GO:0042056),0.5642141339937438,1.3498070276474108,0.12293144208037825,1.0,1.0,8/26,16.46%,FGF7;VEGFA;FGF2;MIF;CXCL10;GPNMB;GDNF;HGF
prerank,metallopeptidase activity (GO:0008237),0.48051922443250555,1.3445124047680501,0.044579533941236066,1.0,1.0,32/113,18.50%,ADAMTS5;BMP1;ADAMTS2;MMP2;ANPEP;ADAM9;ADAM19;ADAMTS3;COPS5;ADAMTSL1;ADAM33;ADAMTSL4;LNPEP;MMP11;DPEP1;ADAMTSL5;ECE1;ADAMTS18;ADAMTSL3;EEF1AKMT4-ECE2;ECE2;NUDT16;PAPLN;THOP1;ADAM15;RCE1;LAP3;SPG7;IDE;MMP16;ADAMTS6;METAP2
prerank,galactosyltransferase activity (GO:0008378),0.6527199128173072,1.343640276162746,0.12239221140472879,1.0,1.0,2/11,2.23%,B4GALT3;B4GALT1
prerank,cytokine receptor binding (GO:0005126),0.4885777485637437,1.3432716198099925,0.065625,1.0,1.0,11/83,9.08%,TNFSF9;SYK;LIF;TIMM50;VEGFA;TGFB2;MIF;CLCF1;SOCS2;TLR5;CCL25
prerank,pre-mRNA binding (GO:0036002),0.5436455113035409,1.3261761210742875,0.11913357400722022,1.0,1.0,11/28,20.12%,TARBP2;HNRNPA1;SRSF6;RBM4;U2AF1;RBM22;CELF2;DDX5;SLBP;U2AF2;PTBP1
prerank,deubiquitinase activity (GO:0101005),0.47951426647305756,1.3240900633842292,0.07061266874350987,1.0,1.0,25/88,15.81%,UCHL1;DESI2;JOSD2;USP36;COPS5;OTUD3;ZRANB1;USP32;USP10;USP4;USP29;OTUD1;UCHL5;USP39;USP26;USP33;OTUD7B;USP48;USP50;USP5;ZC3H12A;STAMBPL1;USP7;MINDY3;USP22
prerank,omega peptidase activity (GO:0008242),0.47765068339866074,1.3209615516679971,0.06832298136645963,1.0,1.0,26/89,15.81%,UCHL1;DESI2;JOSD2;USP36;COPS5;OTUD3;ZRANB1;USP32;USP10;USP4;USP29;OTUD1;UCHL5;USP39;USP26;USP33;OTUD7B;USP48;USP50;USP5;ZC3H12A;GGT7;STAMBPL1;USP7;MINDY3;USP22
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5481723444205785,1.3207697904528213,0.15393939393939393,1.0,1.0,6/25,11.50%,FMO2;FMO4;FMO1;CYP27B1;MICAL2;POR
prerank,hexosyltransferase activity (GO:0016758),0.47436643879082807,1.3163176309252729,0.06550665301944729,1.0,1.0,20/101,11.25%,HAS2;HAS1;B4GALT3;B4GALT1;B3GALNT1;CSGALNACT2;FUT2;DPY19L2;EXT1;B4GALNT4;POMGNT2;PIGZ;CHSY3;B3GAT3;RFNG;ALG1;LARGE1;FUT9;B3GNT8;GBA2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.5407056404974948,1.3160937320697912,0.12997658079625293,1.0,1.0,4/29,4.69%,SLC1A5;SLC25A21;SLC26A5;SLC1A6
prerank,hormone activity (GO:0005179),0.505149759041033,1.3139847126057722,0.12052117263843648,1.0,1.0,9/54,13.47%,AMH;METRNL;INHA;GRP;ADCYAP1;SPX;CCL25;HCRT;TRH
prerank,calcium-activated potassium channel activity (GO:0015269),0.6323865324337122,1.3132579540094904,0.16178521617852162,1.0,1.0,2/11,6.11%,KCNMA1;KCNU1
prerank,adrenergic receptor binding (GO:0031690),0.5847013072772154,1.3096185852629978,0.1686429512516469,1.0,1.0,6/16,12.04%,GNAS;UCHL1;DLG4;C1QBP;MAGI2;PDE4D
prerank,peptidoglycan binding (GO:0042834),-0.5376618209705041,-1.3095391852599518,0.14790996784565916,0.47338272336063486,1.0,9/10,43.68%,RNASE7;NOD1;NOD2;PGLYRP1;JCHAIN;NLRP3;TLR2;PGLYRP3;HK1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.34573347559887335,-1.3078881114495657,0.06315789473684211,0.4643326241047804,1.0,9/48,8.81%,TRPM3;TRPM6;SLC12A7;NALCN;SLC41A1;SLC12A2;ABCC9;TRPC6;CALHM5
prerank,LRR domain binding (GO:0030275),-0.4832433967239504,-1.3073026209122598,0.15298507462686567,0.4538724541294843,1.0,2/14,0.31%,PAWR;ROBO1
prerank,microtubule binding (GO:0008017),0.45584095672629876,1.3066606582742446,0.02002002002002002,1.0,1.0,73/222,22.09%,MID1;NME8;MAP1B;DNM1;SAXO1;DCTN1;CCDC88C;CEP295NL;FGF13;PSRC1;S100A8;S100A9;HOOK2;CLIP1;MID2;NDEL1;CEP44;REEP3;FHDC1;DST;FSD1;KIFC2;KIF21B;MAPRE3;STARD9;GAS2L1;HDAC6;TOGARAM1;CLIP2;SYBU;DYNC1I1;KIF2A;ALMS1;POLB;CFAP157;MAPRE1;CLIP4;CAMSAP1;MAPT;KIF20B;CCSAP;KIF3A;SBDS;KIF21A;MAP6;KIF3B;TERF1;ABRAXAS1;CRIPT;CHP1;MAP4;CDK5RAP2;MAP7D3;SNPH;CKAP5;RCC2;NAV3;KIF26B;PAFAH1B1;CLIP3;CENPE;EML1;UXT;STIM1;RMDN2;MDM1;CLASP2;NUMA1;TUBGCP5;MAP1A;MAP1S;DCX;FBXW11
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5108663164873666,-1.3062741965029727,0.17421602787456447,0.44453569908192037,1.0,3/10,6.69%,SLC24A3;SLC8A3;SLC3A2
prerank,gap junction channel activity (GO:0005243),-0.41098252403961577,-1.3043770230484375,0.11538461538461539,0.43695325988513184,1.0,10/22,30.30%,GJB6;GJB2;GJA1;GJC1;GJD3;GJA4;PANX2;GJA5;GJD2;GJA3
prerank,O-acyltransferase activity (GO:0008374),0.5428662094048481,1.301407555651067,0.15366705471478465,1.0,1.0,11/30,20.79%,GPAT4;MOGAT1;PLAAT1;LCAT;LPCAT1;PIGW;MBOAT7;MOGAT2;GPAT3;GPAM;SOAT1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5593402279843637,1.3009053163042772,0.1822849807445443,1.0,1.0,3/18,14.32%,DHRS9;HSD3B7;HSD17B8
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5222862031751367,-1.2985393422369709,0.17666666666666667,0.43798592377295814,1.0,3/10,5.63%,PRKAG2;PKIG;PRKAR1B
prerank,myosin II binding (GO:0045159),0.6330969659924597,1.2967476735570052,0.1747159090909091,1.0,1.0,2/10,3.58%,GSN;LLGL1
prerank,1-phosphatidylinositol binding (GO:0005545),0.582445811851578,1.2944719348777358,0.1804812834224599,1.0,1.0,4/15,11.38%,SESTD1;SCIN;FRMPD2;WDFY1
prerank,endopeptidase activity (GO:0004175),0.4514448900365625,1.2937817926477564,0.022022022022022022,1.0,1.0,57/257,18.07%,ADAMTS5;HTRA3;PCSK6;KLK9;PRSS48;DPP4;FAP;HPN;UCHL1;PCSK5;ADAMTS2;MMP2;ADAM9;PRSS12;USP36;ADAM19;ADAMTS3;ADAMTSL1;ADAM33;PCSK4;RHBDF1;ADAMTSL4;USP10;USP29;MMP11;TPP1;PSEN1;ADAMTSL5;ECE1;ADAMTS18;MASP2;ADAMTSL3;USP26;USP33;GZMM;EEF1AKMT4-ECE2;ECE2;USP48;NAPSA;PAPLN;PIK3IP1;THOP1;KLK1;KLK6;USP5;RCE1;USP7;TASP1;PDIA3;CLPP;HGF;SPG7;HTRA2;IDE;MMP16;HTRA4;ADAMTS6
prerank,myosin V binding (GO:0031489),0.5747937582362286,1.293155840878182,0.1806108897742364,1.0,1.0,7/15,26.45%,RAB6A;RAB6B;RAB3D;RAB27B;RAB10;RAB39B;RAB3C
prerank,single-stranded telomeric DNA binding (GO:0043047),0.6301607851709228,1.2922328021917941,0.17852161785216178,1.0,1.0,5/11,21.89%,HNRNPA1;CTC1;TERF1;RAD50;TERF2IP
prerank,transcription coactivator binding (GO:0001223),0.5644726885634058,1.2906041276523381,0.16769420468557336,1.0,1.0,4/20,8.61%,AR;ESR1;SMAD4;CDK9
prerank,ribosome binding (GO:0043022),0.4962198254862436,1.2876696112814887,0.1291390728476821,1.0,1.0,14/46,17.92%,RPSA;IGHMBP2;C1QBP;SRP19;GTPBP6;MRPS27;EIF6;SBDS;ZC3H12A;EIF2S1;SEC61A1;CPEB1;YTHDF1;NAA15
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.39302982253170415,-1.2876549924430807,0.1301775147928994,0.4487081898668468,1.0,5/26,5.42%,PTN;PPP1R1A;LMTK2;BOD1L1;PPP1R8
prerank,wide pore channel activity (GO:0022829),-0.4034163403451397,-1.2793698846329473,0.12244897959183673,0.45422051582743633,1.0,10/23,30.30%,GJB6;GJB2;GJA1;GJC1;GJD3;GJA4;PANX2;GJA5;GJD2;GJA3
prerank,pentosyltransferase activity (GO:0016763),0.505938606399214,1.278261191633488,0.16474654377880185,1.0,1.0,9/36,10.90%,PARP3;UMPS;ART4;PARP11;PARP6;SIRT2;LARGE1;PARP14;ZC3HAV1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.5621814631652562,1.2769381006669789,0.1620603015075377,1.0,1.0,3/18,2.53%,ANXA1;PKP3;ANXA2
prerank,general transcription initiation factor binding (GO:0140296),0.5246027421368948,1.2746576983188136,0.17191283292978207,1.0,1.0,6/25,15.46%,AR;ESR1;BRF2;DR1;GTF2A2;YEATS2
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6267408387140455,1.2719563250085208,0.20027624309392264,1.0,1.0,5/10,21.92%,GNAS;DLG4;SQSTM1;NSF;SHISA6
prerank,neuropeptide hormone activity (GO:0005184),0.5458441429449499,1.2712570078204832,0.17258261933904528,1.0,1.0,4/22,11.86%,GRP;ADCYAP1;SPX;HCRT
prerank,kinase inhibitor activity (GO:0019210),0.5156963152138486,1.26909357046003,0.1718931475029036,1.0,1.0,14/33,24.92%,LRP6;TAOK3;PPP1R1B;GSKIP;NPM1;SMCR8;CDKN1A;NCK1;QARS1;GMFB;DUS2;YWHAB;HEXIM1;DNAJC3
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.5383354773749678,1.2657346165388672,0.18009478672985782,1.0,1.0,4/24,5.58%,CAMKK1;EEF2K;CAMK2D;PHKA2
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6219883734962804,1.2627478805339167,0.19830028328611898,1.0,1.0,2/10,7.65%,EHHADH;AUH
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4790181103869765,-1.2617800504867538,0.19117647058823528,0.4795129992119526,1.0,3/12,11.53%,SLC3A2;SLC38A5;SLC6A6
prerank,calcium ion binding (GO:0005509),0.4373299860225803,1.260867713458609,0.011022044088176353,1.0,1.0,40/323,8.16%,ASPN;COMP;FBN1;GSN;CDH26;THBS3;LOXL2;CDHR5;SNCB;LRP1;ANXA1;SCIN;SYT2;CLEC3B;SPARC;ARSA;ANXA2;EFHD1;PLSCR4;S100A10;SLIT3;SLIT2;SRI;S100A8;S100A9;SLIT1;SMOC2;THBS4;SYT12;SYT11;CALU;DSC3;DSC2;COLEC11;SYT13;RCN3;RET;PKD2;S100A6;CAPN1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4629391198964715,1.2597048096842367,0.11217948717948718,1.0,1.0,17/72,11.43%,GSN;SESTD1;SCIN;ANXA2;AMER3;SVIL;KCNJ2;CGAS;PFN2;OSBPL2;FZD7;TIRAP;PLEKHA4;TWF1;SNX21;AVIL;SLC9A1
prerank,chemokine receptor activity (GO:0004950),0.5233223028679742,1.2590751535618885,0.189718482252142,1.0,1.0,4/24,17.79%,ACKR3;ACKR4;CXCR4;CXCR2
prerank,carboxypeptidase activity (GO:0004180),-0.35751648663594515,-1.2572611598891135,0.12962962962962962,0.4788950635887768,1.0,5/35,5.72%,AEBP1;CPE;CPM;MINDY2;AGBL3
prerank,G protein-coupled receptor binding (GO:0001664),0.4457516714341197,1.2569455118467725,0.07817258883248732,1.0,1.0,18/132,10.38%,MYOC;LRP6;WNT2;WNT10B;GNAS;GNAI3;CCDC88C;WNT9A;S1PR2;USP4;C1QBP;BICD1;STUB1;FZD7;CCL25;GNAZ;USP33;CALCA
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.30695716874302187,-1.2568063214744667,0.12307692307692308,0.4696389084899084,1.0,22/71,13.81%,PTPRK;PTPN14;EYA1;PTPRG;PTPRB;PTPRD;PTPN9;PTPRM;PTPRN2;PALD1;PTPRZ1;PTPRO;PTPN1;CDC25A;PTPRT;PTPN4;PTPN2;HACD2;PTPN21;PTP4A2;PTPRN;UBASH3B
prerank,receptor ligand activity (GO:0048018),0.4372236329020974,1.255796178296979,0.036036036036036036,1.0,1.0,32/245,9.80%,LIF;SEMA3C;AREG;FGF18;AMH;WNT2;FGF7;WNT10B;DPP4;TGFB3;IL16;CTF1;BTC;WNT9A;VEGFA;FGF2;TGFB2;MIF;BMP15;METRNL;CLCF1;IL33;CXCL10;TNFRSF11B;INHA;GAS6;SEMA3A;JAG1;CCL25;TNFSF13B;NRG3;BMP8A
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.5396005409904364,1.2557667196680942,0.20496894409937888,1.0,1.0,9/21,28.29%,REV3L;POLE3;POLB;POLI;POLD1;REV1;POLH;POLE2;CHRAC1
prerank,nuclear import signal receptor activity (GO:0061608),0.5743674061134367,1.2541405395129486,0.19893190921228304,1.0,1.0,9/15,26.17%,KPNA2;IPO9;TNPO2;IPO5;KPNA1;RANBP6;TNPO1;KPNA6;KPNB1
prerank,ribonuclease P activity (GO:0004526),0.6029540085401771,1.2499728921322448,0.21208053691275167,1.0,1.0,3/11,5.84%,RPP25;RPP21;PRORP
prerank,dynactin binding (GO:0034452),0.5948066367034752,1.2464569861529016,0.20467032967032966,1.0,1.0,5/12,18.89%,BICD1;MAPT;BBS4;SNX6;PAFAH1B1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.5866689436270114,1.2437061259880453,0.2111111111111111,1.0,1.0,6/13,12.80%,ITGB3;VEGFA;ITGA5;PTPRJ;ERN1;PDGFRA
prerank,O-methyltransferase activity (GO:0008171),0.6074481069863589,1.240011369138465,0.22826086956521738,1.0,1.0,7/10,30.23%,MEPCE;COQ3;COMT;CMTR2;ASMT;FTSJ3;LRTOMT
prerank,chemokine receptor binding (GO:0042379),0.49208236418674456,1.2386758490578038,0.1853997682502897,1.0,1.0,5/35,13.15%,CCL8;ITCH;CXCL10;CCL25;CCL13
prerank,heme binding (GO:0020037),0.45897971510492136,1.2384425375870598,0.15451577801958652,1.0,1.0,5/65,6.79%,NOX4;CYP2S1;NR1D1;DGCR8;SRC
prerank,cell-cell adhesion mediator activity (GO:0098632),0.48139815013360515,1.2372014624691254,0.17333333333333334,1.0,1.0,11/42,13.22%,ANXA1;PKP3;NPTN;ANXA2;JAM3;SIRPA;CD47;DSCAM;PDLIM1;PALLD;IGSF9
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.4418125375704623,1.2363672275263395,0.13250517598343686,1.0,1.0,21/91,11.43%,GSN;SESTD1;SCIN;ANXA2;AMER3;SVIL;KCNJ2;CGAS;PFN2;OSBPL2;FZD7;TIRAP;CLVS2;WIPI2;PLEKHA4;TWF1;WDR45B;SNX21;AVIL;MAPT;SLC9A1
prerank,gated channel activity (GO:0022836),0.5683922408281024,1.2361027331002759,0.2163265306122449,1.0,1.0,3/14,6.82%,PIEZO2;TMEM63A;TMEM266
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5006642157728569,1.2347562345557337,0.19883720930232557,1.0,1.0,12/33,22.87%,AR;SCAF8;RTRAF;NCOA3;AGO2;ELP4;URI1;LLPH;UVSSA;ERCC5;PAF1;TBP
prerank,androgen receptor binding (GO:0050681),0.516008857163809,1.232711520831885,0.20559610705596107,1.0,1.0,15/25,28.82%,FOXP1;PRMT2;SMARCA4;RNF14;TRIM68;DDX5;NSD1;TMF1;RNF6;KDM4C;CALR;KDM3A;PRPF6;WIPI1;ZBTB7A
prerank,glucose transmembrane transporter activity (GO:0005355),0.5473776690206343,1.231450322191763,0.22802547770700637,1.0,1.0,4/17,14.21%,SLC5A9;MFSD4A;SLC2A10;SLC2A3
prerank,ligand-gated ion channel activity (GO:0015276),0.49755122475283053,1.2250739869318912,0.21064814814814814,1.0,1.0,12/30,25.07%,GRIN3A;GRIN2D;GRIA2;CNGB1;GRID1;GRIN2A;CHRNA5;GRIA3;GRIK5;GRIK2;ANXA6;GRIK4
prerank,tubulin binding (GO:0015631),0.4246488102635764,1.220898793921136,0.05120481927710843,1.0,1.0,103/295,25.86%,MID1;NME8;RAB11FIP5;MAP1B;DNM1;SAXO1;DCTN1;CCDC88C;CEP295NL;FYN;FGF13;PSRC1;S100A8;S100A9;HOOK2;ATF5;CLIP1;MID2;GPAA1;DLEC1;NDEL1;CEP44;REEP3;FHDC1;DST;FSD1;KIFC2;KIF21B;MAPRE3;STARD9;GAS2L1;HDAC6;TOGARAM1;CLIP2;SYBU;DYNC1I1;NCALD;KIF2A;ALMS1;POLB;CFAP157;CAMSAP1;MAPT;TBCEL;TPPP3;SETD2;KIF20B;CCSAP;KIF3A;SBDS;KIF21A;MAP6;KIF3B;TERF1;ABRAXAS1;CRIPT;INO80;BCAS3;BBS4;BLOC1S2;CHP1;MAP4;CDK5RAP2;MAP7D3;SNPH;CKAP5;RCC2;NAV3;KIF26B;PAFAH1B1;CLIP3;CENPE;ALDOA;EML1;UXT;RMDN2;MDM1;STMN4;TTLL11;CLASP2;NUMA1;TUBGCP5;MAP1A;MAP1S;DCX;DNAL1;TPR;CCDC88A;RMDN1;TRIM36;NLRP5;KATNA1;EMD;ARL8A;RMDN3;MTCL1;VBP1;KIF13B;AGBL1;PHF6;TPGS1;CCDC88B;MAST2
prerank,ligand-gated channel activity (GO:0022834),0.5012993561491405,1.2208727465967077,0.21386603995299647,1.0,1.0,12/29,25.07%,GRIN3A;GRIN2D;GRIA2;CNGB1;GRID1;GRIN2A;CHRNA5;GRIA3;GRIK5;GRIK2;ANXA6;GRIK4
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.44026802246922203,-1.2182273413463274,0.24390243902439024,0.5378205849042964,1.0,2/14,0.47%,SLC7A11;SLC1A3
prerank,protein tyrosine kinase activity (GO:0004713),0.436111203678365,1.218036660605965,0.1574642126789366,1.0,1.0,28/108,14.48%,SYK;DDR2;EPHB2;AXL;SRMS;EGFR;TNK1;FGFR1;EPHA3;FYN;MST1R;CLK1;CSK;SRC;RET;ABL2;EPHB3;TWF1;MUSK;DYRK2;CAMKK2;EPHA10;PDGFRA;SCYL1;FLT3;HIPK4;DDR1;FER
prerank,translation initiation factor activity (GO:0003743),0.4832136089968878,1.2164957557125458,0.21939953810623555,1.0,1.0,19/36,27.39%,EIF3B;COPS5;EIF4A1;EIF3K;AGO2;EIF1;EIF3A;EIF2S1;EIF3E;EIF3D;EIF2S2;EIF2B1;EIF2A;EIF4G3;EIF3L;EIF4G1;EIF2B2;EIF4E2;EIF3M
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.47670004127288323,1.2161478559761525,0.2016036655211913,1.0,1.0,11/38,15.10%,SESTD1;NCF4;PLEKHF1;ATG2B;WIPI2;PLEKHA4;WDR45B;SNX21;ATG2A;DENND1A;PLA2G4E
prerank,phospholipase activity (GO:0004620),0.4536136551382821,1.2145483407266764,0.16350210970464135,1.0,1.0,15/67,20.05%,MGLL;SMPD3;PLCE1;PLCB4;PLAAT1;SEC23IP;PNPLA8;PLA2G4E;PDIA3;SMPD1;LIPC;LIPH;GPLD1;DDHD1;GDPD3
prerank,chloride transmembrane transporter activity (GO:0015108),0.542367252414379,1.2142817108326314,0.2389937106918239,1.0,1.0,5/16,17.33%,SLC26A5;SLC4A8;SLC26A6;SLC12A5;SLC26A1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.38548929647231645,-1.210566948436764,0.20444444444444446,0.5437647151005721,1.0,11/22,30.01%,DUSP10;PPM1F;DUSP7;MTMR3;DUSP6;DUSP19;DUSP15;MTMR2;DUSP4;CDKN3;DUSP18
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.45009924434365417,-1.2060040339174891,0.23703703703703705,0.542433272556406,1.0,5/12,19.57%,H3-3A;POU2F1;STAT1;GTF2B;TAF1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.6055548122806483,1.2015221711793616,0.24195804195804196,1.0,1.0,4/10,26.09%,DESI2;STAMBPL1;CYLD;OTUD4
prerank,exopeptidase activity (GO:0008238),0.462807795320929,1.2007399420028275,0.2230769230769231,1.0,1.0,22/50,26.88%,DPP4;FAP;ANPEP;PRCP;LNPEP;DPEP1;CNDP2;XPNPEP3;NUDT16;NPEPPS;RCE1;LAP3;METAP2;DPP9;METAP1;METAP1D;JMJD7;DPEP2;ZMPSTE24;CTSA;DPP7;DPP10
prerank,alkali metal ion binding (GO:0031420),-0.4463531892113154,-1.2001695158991752,0.22267206477732793,0.5434062073732697,1.0,2/13,3.26%,ATP1A2;PDXK
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.44009892281714014,1.191154221193884,0.19831223628691982,1.0,1.0,12/73,14.41%,AVPR1A;VIPR2;F2R;GLP2R;S1PR2;CRHR1;LTB4R2;INPP5K;GPR37L1;TSHR;GPR37;LHCGR
prerank,anion:anion antiporter activity (GO:0015301),0.5310787319219834,1.190598769261741,0.2731893265565438,1.0,1.0,5/17,11.54%,SLC26A5;SLC26A11;SLC4A3;SLC25A4;SLC26A6
prerank,ribosomal large subunit binding (GO:0043023),0.5771826038633767,1.189513058103385,0.263448275862069,1.0,1.0,6/11,13.96%,DHX33;CPSF6;NPM1;EIF6;LTN1;RBM3
prerank,calcium-dependent phospholipid binding (GO:0005544),0.45615100857001223,1.1890067903678874,0.2105843439911797,1.0,1.0,7/49,5.36%,ANXA1;SYT2;ANXA2;CPNE8;SYT12;SYT11;SYT13
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5364112998505407,1.187777646861992,0.25318066157760816,1.0,1.0,8/17,25.07%,GRIN3A;GRIN2D;GRIA2;GRIN2A;GRIA3;GRIK5;GRIK2;GRIK4
prerank,peptidase inhibitor activity (GO:0030414),0.47559564127728193,1.1862948021921513,0.25057736720554274,1.0,1.0,7/33,12.48%,TIMP2;GPC3;UCHL5;CAST;CSTB;SLPI;RECK
prerank,cAMP binding (GO:0030552),-0.47610336752473864,-1.1851333815411402,0.28205128205128205,0.5654262283231191,1.0,2/11,0.58%,RAPGEF4;RAPGEF2
prerank,glutamate receptor binding (GO:0035254),0.5326327105482654,1.1851138270617707,0.26813471502590674,1.0,1.0,5/17,16.14%,GNAS;DLG4;SQSTM1;SYNDIG1;NSF
prerank,R-SMAD binding (GO:0070412),0.5139693193568423,1.1843851047693594,0.26658163265306123,1.0,1.0,8/18,22.47%,LDLRAD4;PMEPA1;SMAD4;SMAD6;DDX5;PPM1A;SMURF1;JUN
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.5350614421700511,1.1829353826365594,0.2702702702702703,1.0,1.0,5/15,17.33%,SLC26A5;SLC4A8;SLC4A3;SLC26A6;SLC26A1
prerank,cAMP response element binding (GO:0035497),0.5931038118756067,1.1801643488290794,0.28062678062678065,1.0,1.0,5/10,22.47%,CREB5;CREB3L1;ATF7;E4F1;JUN
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.477179020210349,1.1784285601379552,0.27251732101616627,1.0,1.0,12/31,22.82%,UBE2B;UBE2J2;UBE2W;UBE2N;UBE2G2;UBE2A;CDC34;UBE2G1;UBE2R2;UBE2D3;UBE2Q2;UBE2Z
prerank,DNA polymerase activity (GO:0034061),0.5028640373708326,1.1783088632434753,0.2729528535980149,1.0,1.0,9/22,28.29%,REV3L;POLE3;POLB;POLI;POLD1;REV1;POLH;POLE2;CHRAC1
prerank,mechanosensitive ion channel activity (GO:0008381),0.5579311197641417,1.1773713982724512,0.2886740331491713,1.0,1.0,2/12,5.15%,PIEZO2;TMEM63A
prerank,myosin binding (GO:0017022),0.44150068024726713,1.1769768170542414,0.24835886214442013,1.0,1.0,17/55,21.01%,MYOC;GSN;RAB6A;LLGL1;RAB6B;TRAK2;RAB3D;MOBP;RHOA;RAB27B;TRIOBP;GIPC1;CXCR4;ARFGEF1;RALA;RAB10;PYCARD
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.4621594870688847,-1.1764802761833777,0.24621212121212122,0.574104785565452,1.0,3/11,4.39%,SGMS1;SAMD8;PIGN
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.4696377123434512,1.175499457854844,0.2725199543899658,1.0,1.0,15/34,26.54%,UBE2B;UBE2J2;UBE2W;UBE2N;UBE2G2;UBE2A;CDC34;UFC1;UBE2G1;UBE2R2;UBE2D3;UBE2Q2;UBE2Z;UBE2K;UBE2F
prerank,insulin-like growth factor I binding (GO:0031994),0.5575593315893951,1.1754460846269452,0.29658792650918636,1.0,1.0,4/13,4.33%,IGFBP5;ITGB3;IGFBP6;IGFBP4
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.5708428273516983,1.1743021160064162,0.28846153846153844,1.0,1.0,4/10,24.09%,KAT2B;CDKN1A;CDKN2C;HEXIM1
prerank,cytokine receptor activity (GO:0004896),0.42612964163933725,1.1726382604640782,0.2265135699373695,1.0,1.0,11/83,15.83%,IL4R;GHR;IL1RL1;CD44;IL10RA;IL17RA;ACKR4;CSF2RA;FLT3;CNTFR;FZD4
prerank,protein tyrosine kinase binding (GO:1990782),0.43251800953895675,1.1717379776051293,0.22163308589607636,1.0,1.0,10/71,10.15%,NOX4;ANGPT4;PIK3R2;ACVR1;BANK1;GAS6;FLT3LG;NRG3;SIRPA;SQSTM1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5158455398033097,1.1707412808032547,0.28019925280199254,1.0,1.0,7/20,14.99%,GPAT4;MOGAT1;AGPAT3;LPCAT1;MOGAT2;AGPAT5;GPAT3
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.5137813102533808,1.1697620996406313,0.2738537794299876,1.0,1.0,4/18,6.89%,AKR1B1;ALDH18A1;ALDH3A2;FAR1
prerank,CoA hydrolase activity (GO:0016289),0.5389581107051775,1.1689723822484086,0.2935196950444727,1.0,1.0,4/16,14.47%,ACOT6;NUDT7;ACOT9;ACOT1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.5560996329321374,1.1673663449654212,0.2921646746347942,1.0,1.0,5/13,14.99%,GPAT4;AGPAT3;LPCAT1;AGPAT5;GPAT3
prerank,syntaxin-1 binding (GO:0017075),-0.37734268623796996,-1.166471468229107,0.2391304347826087,0.5854011024333677,1.0,5/22,9.05%,UNC13B;UNC13C;SYNPR;STXBP5;DAPK1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.5422598064008255,1.1657058298725111,0.2874015748031496,1.0,1.0,3/14,5.84%,RPP25;RPP21;PRORP
prerank,snoRNA binding (GO:0030515),0.47357702801598917,1.164584513723758,0.28402366863905326,1.0,1.0,16/30,29.26%,NUDT1;NUDT7;NUDT16L1;GAR1;DDX21;NUDT16;XRCC5;SNU13;NUDT5;NUFIP1;TBL3;NHP2;PRKDC;NOP56;TSR1;NOP58
prerank,insulin-like growth factor binding (GO:0005520),0.5313468667388164,1.1619223861571226,0.29545454545454547,1.0,1.0,4/15,4.33%,IGFBP5;ITGB3;IGFBP6;IGFBP4
prerank,poly-purine tract binding (GO:0070717),-0.3484409168265275,-1.1598386227954853,0.2222222222222222,0.5888824225678337,1.0,11/27,19.41%,RBPMS;ATXN1;RBMS2;ZC3H14;PPIE;KHDRBS1;TIA1;PABPC4L;EIF4A3;HNRNPDL;PNPT1
prerank,nucleotide diphosphatase activity (GO:0004551),-0.42843217419002105,-1.1591287392532839,0.27530364372469635,0.5799142965003735,1.0,6/14,15.74%,ENPP1;NUDT4;ENPP4;NUDT3;NUDT12;NUDT13
prerank,CXCR chemokine receptor binding (GO:0045236),0.5577777091848444,1.1584830630239058,0.30013831258644535,1.0,1.0,2/11,6.05%,ITCH;CXCL10
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.45520613555768324,1.1568027742515243,0.29358830146231724,1.0,1.0,7/38,11.82%,SERPINB8;ANXA2;SERPINE3;SERPINF1;SERPINH1;SERPING1;SLPI
prerank,BMP binding (GO:0036122),-0.44606751932227506,-1.1563539343129292,0.3007246376811594,0.5752177534576125,1.0,3/11,8.04%,ENG;GREM2;BMPR2
prerank,peptidase activator activity (GO:0016504),0.4952294575039129,1.154746964662843,0.28869778869778867,1.0,1.0,4/22,8.69%,PCOLCE2;PCOLCE;CLPX;ADRM1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.44705517886810264,-1.1545008934528098,0.2768166089965398,0.5693869304032632,1.0,2/11,8.74%,SLC22A4;SLC25A20
prerank,chemorepellent activity (GO:0045499),0.48265539169342947,1.1525874836073495,0.2911084043848965,1.0,1.0,5/25,12.60%,SEMA3C;DPP4;SEMA3A;NRG3;SEMA3D
prerank,triglyceride lipase activity (GO:0004806),0.5051046003268247,1.1523774877014485,0.31572327044025156,1.0,1.0,5/20,18.79%,CEL;LCAT;DAGLB;LIPC;LIPH
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5256971743962919,1.1515331021957544,0.3073878627968338,1.0,1.0,2/16,4.69%,SLC1A5;SLC1A6
prerank,death domain binding (GO:0070513),-0.43807417462829673,-1.15147160234227,0.2896551724137931,0.5659660189224853,1.0,4/11,11.85%,BCL2L1;BCL2;DAPL1;RIPK1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.45621774004317317,-1.1512531723221384,0.27169811320754716,0.5571249568269625,1.0,2/11,3.54%,SASH1;DAB2IP
prerank,sodium channel regulator activity (GO:0017080),0.45389278395432625,1.1511258756763254,0.2862029646522235,1.0,1.0,11/37,19.61%,FGF13;SGK3;SGK2;ATP2B4;CAMK2D;FXYD5;SCN4B;PRSS8;FGF14;GPLD1;PTPN3
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5475678248629657,1.148677701924892,0.31657608695652173,1.0,1.0,5/12,18.34%,TENT5B;TENT4A;PAPOLB;TENT2;TENT4B
prerank,ion gated channel activity (GO:0022839),0.4873679042585709,1.1486567168660196,0.2954822954822955,1.0,1.0,3/24,5.15%,KCNT2;ANO3;TMEM63A
prerank,RNA polymerase core enzyme binding (GO:0043175),0.4634794749282261,1.1483529315880623,0.2948717948717949,1.0,1.0,12/33,21.48%,SCAF8;MAF1;RTRAF;NCOA3;SPTY2D1;AGO2;ELP4;URI1;UVSSA;ERCC5;RRN3;PAF1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.49332745808435785,1.1483468958992886,0.3194103194103194,1.0,1.0,5/21,9.38%,CDKL2;CDK14;CDK4;CDK9;CDK20
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.49332745808435785,1.1483468958992886,0.3194103194103194,1.0,1.0,5/21,9.38%,CDKL2;CDK14;CDK4;CDK9;CDK20
prerank,protein phosphorylated amino acid binding (GO:0045309),0.45240838996476496,1.146820324086277,0.28361581920903955,1.0,1.0,14/42,23.55%,SYK;IRS1;PIK3R2;ABL2;YWHAE;PIN1;PTPN5;PTPN3;RASA1;YES1;SH3BP2;VAV2;YWHAB;NCK2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.47135019000071404,1.146624381276926,0.2857142857142857,1.0,1.0,10/28,23.88%,RPP25;RPP21;PRORP;AGO2;NUDT16L1;NUDT16;POP4;AGO3;RPP30;EDC3
prerank,RNA polymerase binding (GO:0070063),0.5071501164986032,1.14538041786609,0.305019305019305,1.0,1.0,5/18,12.93%,BIN1;SCAF8;TCERG1;ANP32B;ZFP36
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.498567743046769,1.1449592942758136,0.30456226880394577,1.0,1.0,10/21,21.20%,ACBD3;WASF1;GSKIP;AKAP14;AKAP8;AKAP9;AKAP1;ARFGEF1;PRRC1;AKAP8L
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.42845421824369173,1.1442770592878535,0.28216216216216217,1.0,1.0,16/60,14.09%,DDR2;EPHB2;AXL;EGFR;FGFR1;EPHA3;MST1R;TGFBR2;ACVR1;RET;EPHB3;MUSK;EPHA10;PDGFRA;FLT3;DDR1
prerank,epidermal growth factor receptor binding (GO:0005154),0.4799462041111076,1.1434735888878529,0.3006060606060606,1.0,1.0,8/25,16.74%,AREG;BTC;ARF4;SNX1;ATXN2;EGF;FER;EFEMP1
prerank,ribonuclease activity (GO:0004540),0.4358486829815933,1.1425818476130476,0.2841880341880342,1.0,1.0,13/56,14.95%,DIS3L2;RNASE4;ANG;NYNRIN;AGO2;EXOSC7;SAMHD1;ERN1;RNASE6;RCL1;EXOSC1;ZC3H12A;SMG6
prerank,regulatory RNA binding (GO:0061980),0.4523455120367366,1.1416932180855741,0.3,1.0,1.0,11/38,19.51%,TARBP2;HNRNPA1;RBM4;TRIM71;RC3H1;AGO2;DDX21;PUM1;ZC3H12A;AGO4;AGO3
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.47614719394954386,1.1397813918277826,0.3118279569892473,1.0,1.0,8/26,22.10%,B3GALNT1;CSGALNACT2;B4GALNT4;CHSY3;B3GNT8;B3GALNT2;CHPF;CHPF2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5313138519593624,1.1395871125673451,0.32531824611032534,1.0,1.0,5/11,31.77%,PRMT2;FBXO11;CARM1;PRMT8;PRMT7
prerank,"DNA binding, bending (GO:0008301)",-0.39980972485336574,-1.1372284532634038,0.2851851851851852,0.5782731285352348,1.0,3/14,3.60%,LEF1;HMGB1;FOXC1
prerank,transcription coregulator binding (GO:0001221),0.43549586567527543,1.1334359158952394,0.292972972972973,1.0,1.0,20/50,25.12%,AR;ESR1;SMAD4;NR1D1;HDAC6;PHF1;CDK9;HDAC3;EHMT2;PER1;CTCF;RORA;CIT;RPL23;CTBP1;EZH2;RELA;PER3;LCOR;CHD6
prerank,hormone receptor binding (GO:0051427),0.5292227184379715,1.1331154112850088,0.3455978975032852,1.0,1.0,5/14,28.19%,SOCS2;ADCYAP1;NCOA6;JAK2;NPPC
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.49431261358315276,1.132796218772051,0.3359273670557717,1.0,1.0,8/20,19.13%,MAGI3;DLG2;AK2;MPP1;CMPK2;AK8;AK9;CARD11
prerank,double-stranded DNA binding (GO:0003690),0.38820620187604754,1.1325638274263892,0.095,1.0,1.0,85/531,15.57%,LMX1A;LHX8;ESR1;PAX9;NFIX;SP9;IRF4;EGFR;CREB5;PAX1;WT1;MEOX2;TBX15;SCRT2;HSF2;HOXA2;ELF4;SIX4;NEUROD2;KLF3;PBX1;KLF12;FOXP1;BHLHE40;GLIS2;TLX3;TEF;LMX1B;RAD51B;MEF2D;SOX10;IRX5;CREB3L1;ZBTB12;RFX1;KLF2;JUND;NR1D2;NFATC4;MAFF;MEIS2;NFATC1;HOXA5;NR1D1;NFIB;MND1;CGAS;TARDBP;DPF1;SMAD5;GLI2;MTF1;HOXA4;TBX6;ETV3;SOX8;NR6A1;MYBL2;FOXC2;ONECUT1;POLG2;MBNL2;BCL6;CPSF4;GLI3;ATF7;CEBPB;MAPT;BACH2;XRCC5;KDM5B;TERF1;DDX11;SIX1;RFX5;KLF4;HOXC4;HOXA7;HOXA9;POU3F2;SNAI2;NR2C2;E2F3;HMGB3;UBP1
prerank,insulin-like growth factor receptor binding (GO:0005159),0.546916881775587,1.132358976806553,0.32332878581173263,1.0,1.0,4/12,7.01%,GNAS;IRS1;SOCS2;YWHAG
prerank,nucleotidyltransferase activity (GO:0016779),0.49850938341376894,1.1322832422190996,0.31666666666666665,1.0,1.0,9/19,23.72%,PAPSS2;TENT4A;CGAS;YRDC;NUDT5;TENT2;TENT4B;CRPPA;REV1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4287136177041594,1.1319400278440623,0.29180327868852457,1.0,1.0,14/53,20.37%,NOX4;ETFA;AIFM2;ACADVL;MICAL2;POR;NQO2;PPOX;ACOX1;AOX1;ETFDH;MICAL1;KDM1B;QSOX1
prerank,GDP binding (GO:0019003),0.4215052400527481,1.1315918789301076,0.2904255319148936,1.0,1.0,26/63,28.01%,GNAI3;RAP1B;RIT2;DYNC1LI1;RAB2A;NRAS;KRAS;RRAGD;NME2;RAB27B;ARF6;GEM;RAB35;RAB5B;RAB5C;RRAS2;RALA;RAB10;RAB12;RAB18;RAB29;RAB8B;RAP1A;DIRAS2;RHEBL1;RAP2B
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5527450370584196,1.1314302964094052,0.34610123119015046,1.0,1.0,2/12,6.52%,IRS1;SH2B1
prerank,FAD binding (GO:0071949),-0.34957653343376255,-1.1310599683512093,0.2887700534759358,0.5831268498334874,1.0,5/24,7.63%,MICAL3;DDO;PRODH;CRY1;AGPS
prerank,lipid phosphatase activity (GO:0042577),0.5175556033219364,1.1299662853401937,0.31758530183727035,1.0,1.0,6/14,18.06%,PLPP3;PLPP1;PLPP7;INPP5K;PLPPR3;PLPP2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5716189434393293,1.1294872671246583,0.35694050991501414,1.0,1.0,4/10,11.99%,DSC2;SIRPA;CD47;JUP
prerank,manganese ion binding (GO:0030145),0.44122394507217066,1.1283625551275691,0.3045912653975364,1.0,1.0,18/48,27.14%,B4GALT1;MGAT1;ABL2;XPNPEP3;LARGE1;DYRK2;GALNT1;MGAT5;NUDT16;MPPE1;MGAT2;NEK4;XYLT2;MGAT5B;ADCY2;GALNT4;XXYLT1;ADPRM
prerank,transcription corepressor binding (GO:0001222),0.46670800155929204,1.128244078756398,0.33373063170441003,1.0,1.0,12/27,24.07%,ESR1;NR1D1;HDAC6;PHF1;HDAC3;EHMT2;PER1;RORA;CTBP1;EZH2;PER3;LCOR
prerank,phosphatidate phosphatase activity (GO:0008195),0.5310591647142894,1.1269017527124165,0.3472222222222222,1.0,1.0,6/13,20.27%,PLPP3;PLPP5;PLPP1;PLPPR3;PLPP2;LPIN3
prerank,chemokine activity (GO:0008009),0.4563800031858769,1.1267042707907653,0.31338028169014087,1.0,1.0,4/31,13.15%,CCL8;CXCL10;CCL25;CCL13
prerank,ribonuclease P RNA binding (GO:0033204),0.5591502740599729,1.1265531242327795,0.3337874659400545,1.0,1.0,5/10,26.72%,RPP25;RPP21;POP4;RPP30;RPP14
prerank,snRNA binding (GO:0017069),0.4380274280356545,1.1263117429591423,0.3272933182332956,1.0,1.0,15/42,24.09%,MEPCE;LSM4;PRPF4;CDK9;RBM22;SNRPB2;DDX21;SNU13;SNRPA;SNRPD3;LSM7;LARP7;COIL;SNRPA1;HEXIM1
prerank,carboxy-lyase activity (GO:0016831),0.4709747265583775,1.1257065725409299,0.31456548347613217,1.0,1.0,9/23,25.58%,UMPS;GGCX;ODC1;BCKDHA;UXS1;AZIN2;UROD;AMD1;MVD
prerank,AMP binding (GO:0016208),-0.43696869632405533,-1.1255887037835148,0.2872727272727273,0.5865999816152025,1.0,5/11,13.08%,PRKAG2;PFKM;PRKAG3;ACSS2;PFKL
prerank,metal ion binding (GO:0046872),0.38706766541986737,1.1222942302540162,0.113,1.0,1.0,98/477,20.52%,ASPN;COMP;FBN1;GSN;CDH26;THBS3;GCLC;LOXL2;CDHR5;SNCB;LRP1;ANXA1;SCIN;POSTN;DIS3L2;MAPK12;SYT2;CLEC3B;SPARC;ARSA;ANXA2;IRAK3;EFHD1;PLSCR4;S100A10;SLIT3;SLIT2;SRI;S100A8;S100A9;SLIT1;SMOC2;THBS4;SYT12;SYT11;CALU;FOXK2;DSC3;DSC2;MVK;COLEC11;SYT13;RCN3;RET;IDH1;ABL2;EYA2;UBA2;PKD2;S100A6;CAPN1;IQGAP1;NDUFAB1;CALML4;CDH22;ERN1;DYRK2;MAP3K6;CAMKK2;NUDT16;CALM2;CERK;FAN1;GLCE;ATP2A2;S100G;CASQ1;STK3;PPP3CA;DNASE1L2;TUBB4A;PLA2G4E;GEM;CHP1;NUDT5;ANXA4;PADI2;SYT1;CANT1;NME1;ADPRH;TPM4;ANXA8;ANXA8L1;STK38;NCS1;EFCAB9;RP2;EML1;STIM1;PPP3CB;IDH3G;TNNC2;ANXA7;XYLT2;OXSR1;STK26;PITPNM1
prerank,endopeptidase inhibitor activity (GO:0004866),0.40791833547129797,1.121946720007521,0.27615062761506276,1.0,1.0,14/82,12.48%,TIMP2;SERPINB8;ANXA2;BIN1;SERPINE3;CARD16;UCHL5;CAST;SERPINF1;SERPINH1;CSTB;SERPING1;SLPI;RECK
prerank,double-stranded RNA binding (GO:0003725),0.41732787914111613,1.1208325028616815,0.30662393162393164,1.0,1.0,11/70,9.62%,MBNL1;TARBP2;ADARB1;RFTN1;CLTC;EIF4A1;DGCR8;RC3H1;DHX33;AGO2;SIDT2
prerank,telomeric DNA binding (GO:0042162),0.4570778596926059,1.1187581691494337,0.334916864608076,1.0,1.0,15/32,28.59%,CTC1;ACD;HNRNPD;XRCC5;TERF1;SMG7;SMG6;RAD50;BLM;TINF2;TERF2IP;SMG5;UPF1;STN1;XRCC6
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.4507211802104938,1.1187323659175517,0.3278879813302217,1.0,1.0,14/34,27.88%,CKS1B;ETAA1;STRADA;IQGAP1;CALM2;DBF4;STK3;MAP2K2;CAB39;ALS2;PARP16;CKS2;FAM20A;INCENP
prerank,MHC class II protein complex binding (GO:0023026),0.5438382027577666,1.1148343368565632,0.35172413793103446,1.0,1.0,4/11,15.84%,YWHAE;CD81;HSP90AA1;PKM
prerank,sequence-specific DNA binding (GO:0043565),0.3828584125364661,1.1144739625022047,0.127,1.0,1.0,95/590,15.57%,LMX1A;LHX8;ESR1;PAX9;NFIX;FOXP2;SP9;IRF4;CREB5;PAX1;WT1;MEOX2;TBX15;SCRT2;HSF2;HOXA2;ELF4;SIX4;NEUROD2;KLF3;CTC1;PBX1;KLF12;FOXP1;BHLHE40;GLIS2;TLX3;SMAD4;NFE2L2;TEF;ATF5;LMX1B;MEF2D;CXXC1;SOX10;IRX5;CREB3L1;FOXK2;ZBTB12;RFX1;KLF2;JUND;TCF7L2;NR1D2;NFATC4;MAFF;MEIS2;NFATC1;HOXA5;FOXO1;NR1D1;NFIB;DPF1;SMAD5;GLI2;MTF1;HOXA4;TBX6;FOXL1;ACD;ETV3;SOX8;WDR77;NR6A1;MYBL2;FOXC2;HNRNPD;ONECUT1;MBNL2;BCL6;CPSF4;GLI3;ATF7;CSRNP3;CEBPB;MAPT;BACH2;XRCC5;KDM5B;TERF1;SIX1;RFX5;SMG7;HDAC4;KLF4;HOXC4;PLAGL2;HOXA7;HOXA9;POU3F2;SMG6;SNAI2;NR2C2;E2F3;UBP1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.4055135498416266,1.1143233114424305,0.3111111111111111,1.0,1.0,16/78,15.23%,CAPN5;UCHL1;CAPN2;USP36;GPAA1;USP10;USP29;CAPN1;USP26;USP33;CAPN11;USP48;USP5;PIGK;USP7;PDIA3
prerank,transferrin receptor binding (GO:1990459),0.543001498992542,1.1118562283428384,0.3622589531680441,1.0,1.0,3/10,8.29%,SNX1;CHUK;CD81
prerank,RNA binding (GO:0003723),0.37864829059179933,1.1105329030307254,0.044,1.0,1.0,473/1321,27.95%,COL14A1;DCN;RPSA;AHNAK;DDX18;C1D;LRP1;SRSF2;AFF2;ZC3H8;DNM1;MBNL1;FNDC3B;PKP3;RPP25;TARBP2;EIF3B;ADARB1;MTHFSD;HNRNPA1;ALDH18A1;MRPS11;ANXA2;ANG;SRSF6;DIMT1;RFTN1;NXF1;RRBP1;HDLBP;NYNRIN;DDX19B;CLTC;ABT1;RBMS3;ZFP36L1;USP36;DHX16;URB1;DDX49;TNS1;DAZL;TRMT6;RBM4;KRI1;NUDT1;EIF4A1;CLUH;GTPBP4;RPP21;ZCRB1;ERI3;GNL3L;SUGP2;DDX42;SAMD4B;USP10;NUDT7;SCAF8;KPNA2;KCTD12;DDX51;TRMT2A;RTRAF;RCAN3;CFAP65;RBBP6;FSCN1;UBAP2L;DGCR8;TARDBP;IGHMBP2;C1QBP;SYNE1;MEPCE;SRP19;YWHAG;RC3H1;DNAJC2;MYO5A;FNDC3A;NOC2L;UCHL5;LSM4;SPATS2;FCF1;TDRD3;DHX33;U2AF1;ATXN2;SRSF3;CAST;POLR1G;UBE2N;NSRP1;ZFP36L2;USO1;YWHAE;DYNC1LI1;CHCHD1;PRPF3;LARP4;GPATCH1;MRPL13;NUP98;CPSF6;NOP9;AGO2;ESF1;DUSP11;DALRD3;SELENOH;HNRNPD;RBM22;TDRD7;KHDC4;NUDT16L1;EXOSC7;SIDT2;GAR1;LGALS1;ARF1;SRP9;MRPS27;SAMHD1;EIF1;SMC1A;MBNL2;MEX3A;SON;HELZ2;CHD2;SERPINH1;ASCC3;CSTB;TCERG1;HNRNPH1;RRP36;DHX8;NPM1;CPSF4;MAPRE1;ZC3HAV1;GSPT2;RPL10A;YRDC;DDX56;DDX21;SEC23IP;WDR46;DAP3;MRPL10;GFM1;CELF2;PUM1;HNRNPUL2;RBFOX2;SARS2;PEG10;MAPT;UBTF;GTPBP10;NUDT16;SLPI;PRPF40A;PSTK;SRSF11;DNA2;UNK;IGF2BP1;EIF3A;FLNB;XRCC5;DDX17;LARP1;ZCCHC24;POLR2D;SBDS;MPHOSPH10;ZFP36;RPP25L;RPS27L;POLR2G;RPS5;RPGR;DDX11;SNU13;ELP1;NOLC1;ATXN2L;SMG7;EXOSC1;ZC3H12A;DCAF13;EIF2S1;AKAP8;RBM3;DDX4;HNRNPA3;LLPH;POLDIP3;TRMT10B;NUFIP2;SEC63;AQR;MRM3;THOC2;RRP7A;PNISR;MRPL3;CISD2;PTCD2;DDX50;HSP90AA1;GSPT1;GTF2F1;DYNC1H1;EIF3E;SMG6;ZCCHC8;DIAPH1;TRMT1;FYTTD1;BTF3;SF3B4;PDIA3;BAG4;ZC3H11A;RSL1D1;DDX20;MRPL21;MDH2;SNTB2;RPL6;GRWD1;HMGB3;MAP4;DDX52;MANF;POP4;PKM;NOP53;SF3A1;SPTBN1;PPIL4;PRPF38B;PSIP1;CCDC124;NUDT5;PPP1CC;PHF5A;SAP18;RBM33;FXR2;CPSF2;RTCA;EIF3D;CHD3;SNRPA;DDX5;SNRPG;SNRPD3;AGO4;PNN;DDX31;YTHDF2;NUFIP1;NME1;ILF2;SNIP1;PPIA;ABCF1;YTHDF1;ARCN1;LUC7L3;PWP2;RCC1L;RCC2;SRRM1;RBM6;ARL6IP4;IPO5;DDX39A;EBNA1BP2;RBM39;NAA15;AKAP1;FKBP4;PUF60;EPRS1;SLBP;RPF2;TENT4B;EIF2S2;ZBED4;METAP2;AIMP1;STRAP;SRFBP1;NCBP3;UBFD1;HNRNPUL1;SUPV3L1;DDX24;ALDOA;TCF20;LSM7;NOC3L;DUS2;RPL22L1;TYW5;MEX3C;AGO3;PTCD1;LUC7L2;U2AF2;TBL3;XPOT;KMT2C;SRRM3;MCAT;RPL23;RPL17;NOL10;PDCD11;NOVA1;PTBP1;ANXA7;MAK16;ELAVL2;FLNA;RBM28;REPIN1;SF3B2;SF3B1;RPS25;ZCCHC17;GTF2E2;GANAB;KRR1;MTIF2;TEP1;SRPK1;AKAP8L;RBM45;NEMF;RC3H2;THRAP3;PRR3;KIN;NOP2;YTHDF3;RPP30;EIF2A;IMMT;GPKOW;PLEC;PTBP2;DUSP14;LARP7;JUN;RSL24D1;BAZ2A;PRPF38A;RNMT;EIF4G3;TPR;ZC3H4;NOC4L;RBM5;CSTF2T;TRAP1;SNRPA1;PURG;DIDO1;RTF1;MRPL54;EDC3;AGFG1;BRIX1;TNRC6A;RRP1B;SCAF4;HEXIM1;PSMD4;CCT4;CPSF7;EIF3L;DAZAP1;NOA1;EIF4H;G3BP1;CALR;RALY;MKRN2;RTN4;API5;RPL22;SEC61B;MTCL1;MARK2;LARP6;RAMAC;PABPN1;KHNYN;TNPO1;WDR33;CELF3;EWSR1;HSP90B1;PPIG;PARP12;EXOSC10;PHF6;S100A16;UBAP2;DHX32;APEH;ALYREF;R3HDM1;RBMX;ERAL1;UPF3B;FBRSL1;DCP1A;NOP16;DCP1B;ZNF638;H1-0;EIF4G1;CEBPZ;OTUD4;KPNB1;DHX29;MRPL14;FTSJ3;LRRC59;SAFB;CSNK1E;CRNKL1;BZW1;RSRC2;TASOR;EIF4E2;RPP14;PRPF6;NHP2;DDX1;GDI2;YARS1;CCDC9;PRKDC;CMSS1;SMG5;ZFR;MRPL12;CELF1;NOP56;UPF1;LSM5;THOC5;TBL2;HTATSF1;CCT6A;AGO1;CCDC86;AATF;TSR1;CPSF3;CDC40;RPL34;DUT;ZRANB2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.5420034914403971,1.1053400959941673,0.38589211618257263,1.0,1.0,5/11,16.16%,NUDT1;NUDT7;NUDT16L1;NUDT16;NUDT5
prerank,histone deacetylase activity (GO:0004407),0.4843318324176323,1.1047333161294792,0.34318766066838047,1.0,1.0,7/19,20.14%,HDAC9;HDAC6;SIRT2;HDAC3;HDAC4;SUDS3;MIER1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.33346814493233135,-1.1044925497824072,0.32051282051282054,0.6248632017124635,1.0,7/27,5.73%,SLC22A8;SLC26A7;ANO1;ANKH;SLC39A8;SLC22A6;SLC5A5
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.4617831716017231,-1.103165870271538,0.33214285714285713,0.6180611892465,1.0,2/10,2.53%,KDM7A;KDM4A
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3762553399867364,1.1013524752569457,0.142,1.0,1.0,96/597,15.57%,LMX1A;AR;LHX8;ESR1;PAX9;NFIX;SP9;BNC2;IRF4;CREB5;PAX1;WT1;MEOX2;TBX15;SCRT2;HSF2;HOXA2;ELF4;SIX4;NEUROD2;RUNX1;KLF3;PBX1;KLF12;FOXP1;BHLHE40;GLIS2;TLX3;SMAD4;NFE2L2;TEF;ATF5;LMX1B;MEF2D;SOX10;IRX5;CREB3L1;FOXK2;ZBTB12;RFX1;KLF2;ZW10;JUND;TCF7L2;NR1D2;NFATC4;MAFF;MEIS2;NFATC1;HOXA5;NR1D1;NFIB;CREBZF;DPF1;SMAD5;GLI2;MTF1;HOXA4;DHX33;TBX6;ETV3;SOX8;NR6A1;SOX5;MYBL2;FOXC2;ONECUT1;SMAD6;BRD7;MBNL2;RNF10;BCL6;MCM3;MZF1;CPSF4;GLI3;ATF7;CEBPB;BACH2;XRCC5;KDM5B;NCOR1;DDX11;SIX1;RFX5;HDAC4;KLF4;HOXC4;HOXA7;HOXA9;POU3F2;SNAI2;NR2C2;E2F3;GRWD1;UBP1
prerank,leucine zipper domain binding (GO:0043522),-0.450740595386087,-1.0990167527208565,0.3108108108108108,0.6179519027413388,1.0,1/10,0.29%,PAWR
prerank,chloride channel regulator activity (GO:0017081),0.506887333496358,1.0970249475493514,0.3711615487316422,1.0,1.0,7/14,28.20%,SGK3;STX1A;CHRNA7;WNK2;STX7;CFTR;STX8
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.32343257008520065,-1.0952050122926296,0.271523178807947,0.6178926330763552,1.0,8/32,10.88%,KDM7A;KDM4A;TET1;PHYH;EGLN3;BBOX1;TMLHE;EGLN1
prerank,Toll-like receptor binding (GO:0035325),0.5254252514457339,1.094112511783832,0.361794500723589,1.0,1.0,3/11,8.27%,S100A8;S100A9;TIRAP
prerank,potassium ion leak channel activity (GO:0022841),0.5060234986779947,1.092920813696363,0.38511749347258484,1.0,1.0,3/15,9.47%,KCNK5;KCNK13;KCNK9
prerank,WW domain binding (GO:0050699),0.45331135877428397,1.08917044292115,0.37922705314009664,1.0,1.0,8/26,22.01%,SCNN1B;PMEPA1;TCEAL6;KIF20B;NDFIP1;WBP1;TCEAL9;TRAF4
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.43382574975042915,1.0890634081211543,0.3613348676639816,1.0,1.0,19/37,34.16%,MARS2;TARS1;SARS2;VARS1;GARS1;HARS1;VARS2;EPRS1;QARS1;EARS2;NARS1;YARS1;SARS1;DARS1;AARS1;LARS2;WARS2;IARS2;LARS1
prerank,phosphotyrosine residue binding (GO:0001784),0.4372014503797254,1.0890335844352623,0.3524027459954233,1.0,1.0,11/37,23.55%,SYK;IRS1;PIK3R2;ABL2;PTPN5;PTPN3;RASA1;YES1;SH3BP2;VAV2;NCK2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.35034997913615457,-1.0885612269793306,0.32653061224489793,0.6241309285262391,1.0,3/21,1.62%,PDE1A;PDE7B;PDE3A
prerank,DNA polymerase binding (GO:0070182),0.4813552156926753,1.0884556522160054,0.38076923076923075,1.0,1.0,6/18,14.95%,FANCD2;ACD;POLG2;HSP90AA1;SMARCA4;SMG6
prerank,transforming growth factor beta binding (GO:0050431),0.4575272804409958,1.0878231939212029,0.3743718592964824,1.0,1.0,6/23,11.97%,TGFB3;TGFBR2;ACVR1;ITGAV;TSKU;VASN
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3409181406703593,-1.0869315496696148,0.29508196721311475,0.6191563613048053,1.0,3/23,1.62%,PDE1A;PDE7B;PDE3A
prerank,protein kinase inhibitor activity (GO:0004860),0.4302077497352456,1.086127378593101,0.35553047404063204,1.0,1.0,16/42,24.92%,CAMK2N1;TAOK3;PPP1R1B;GSKIP;NPM1;SMCR8;CDKN1A;NCK1;QARS1;GMFB;IBTK;DUS2;CIT;YWHAB;HEXIM1;DNAJC3
prerank,beta-tubulin binding (GO:0048487),-0.31759906447572495,-1.0857677418396774,0.33974358974358976,0.6131305701824341,1.0,13/31,18.56%,EML4;GJB6;IFT74;PDCD5;GABARAPL1;GABARAP;SMC3;HTT;TRPV4;PEX14;VAPB;TAOK1;RACGAP1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.44937814012461186,1.0847057257681076,0.38814993954050786,1.0,1.0,8/28,23.51%,TNFSF9;TMBIM1;EDA;MADD;TRAF3;TRAF4;TRAF5;TRAP1
prerank,protein heterodimerization activity (GO:0046982),-0.23990156289325104,-1.083825292766084,0.3,0.6087452028858427,1.0,29/178,9.14%,TCF4;ATP1A2;BMP6;TPM1;TENM4;BCL2L1;MEF2C;EPAS1;BCL2;ARNT2;ADRA1B;YWHAH;RALGAPA1;ZHX3;ITGA3;KCNB1;KCNB2;AHR;ABCG1;IRAK2;AGTR1;PSMF1;IKBKG;MICU2;ZHX1;ADRA2A;MIGA2;SMC3;ERBB2
prerank,antiporter activity (GO:0015297),0.46948078892224854,1.0837215213044533,0.3772609819121447,1.0,1.0,5/20,16.85%,SLC35E3;ATP1A3;SLC25A16;SLC35D1;SLC35E1
prerank,TBP-class protein binding (GO:0017025),0.461665920455483,1.0827030545419272,0.36835443037974686,1.0,1.0,5/21,15.46%,ESR1;BRF2;DR1;GTF2A2;YEATS2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5281227701194117,1.0817728955986543,0.38516405135520687,1.0,1.0,3/11,19.31%,CNGB1;HCN4;HCN1
prerank,N-acetyltransferase activity (GO:0008080),0.4757603631671993,1.0814652434177776,0.39227895392278955,1.0,1.0,6/19,18.12%,GNPNAT1;ATAT1;KAT2B;NAT8;SAT1;NAA50
prerank,ligand-gated cation channel activity (GO:0099094),0.3985209028173819,1.0787224611652382,0.3683105981112277,1.0,1.0,17/75,23.38%,SCNN1B;P2RX3;GRIN3A;KCNJ2;GRIN2D;GRIA2;KCNJ3;ASIC2;GRIN2A;CHRNA7;CHRNA5;KCNH2;GRIA3;ASIC1;GRIK5;GRIK2;KCNJ11
prerank,MAP kinase activity (GO:0004707),0.49776503264249394,1.0773924115943838,0.3941798941798942,1.0,1.0,4/14,9.55%,MAPK12;MAPK7;MAPK14;MAPK11
prerank,calcium activated cation channel activity (GO:0005227),0.4790854767978774,1.0769660746767478,0.4066924066924067,1.0,1.0,2/17,5.15%,KCNMA1;TMEM63A
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.519543695231244,1.0761811988617942,0.3776824034334764,1.0,1.0,4/12,15.19%,AIFM2;DHRS4;NQO2;CRYZ
prerank,signal sequence binding (GO:0005048),0.4368450078213268,1.0756279519211012,0.37397420867526376,1.0,1.0,18/35,26.17%,KDELR3;KPNA2;KDELR1;CABP1;KDELR2;TNPO2;SEC61A1;TIMM22;PEX5L;PEX5;IPO5;KPNA1;BRAP;RANBP6;AP2M1;TNPO1;KPNA6;KPNB1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.36893130659246837,1.0748350223170808,0.184,1.0,1.0,123/731,16.32%,EBF2;PRRX1;AR;HOXA3;ESR1;PAX9;EBF1;NFIX;FOXP2;SP9;IRF4;CREB5;PAX1;WT1;ZFHX4;MEOX2;TBX15;SCRT2;ZNF367;HSF2;HOXA2;ELF4;SIX4;HIVEP2;SKIL;NEUROD2;RUNX1;KLF3;PBX1;KLF12;FOXP1;BHLHE40;GLIS2;TLX3;SMAD4;NFE2L2;TEF;MEF2D;SKI;SOX10;IRX5;CREB3L1;FOXK2;ZBTB12;RFX1;KLF2;JUND;TCF7L2;NR1D2;NFATC4;MAFF;MEIS2;NFATC1;HOXA5;FOXO1;NR1D1;NFIB;EBF3;ZBTB7C;MUC1;NFIA;ZFHX3;SMAD5;GLI2;MLXIPL;MYT1;MTF1;HDAC6;HOXA4;TBX6;STAT5A;FOXL1;SOX8;ZNF260;ZBTB1;NR6A1;VDR;SATB2;SOX5;MYBL2;FOXC2;ONECUT1;BCL6;MITF;CHD2;MYPOP;MZF1;PRDM15;GLI3;ATF7;CEBPB;BACH2;ATF1;ZNF112;ZNF691;PROX2;IKZF5;TWIST1;SIX1;RFX5;NACC2;HDAC4;PLAGL1;ZNF569;KLF4;HOXC4;MLXIP;HOXA7;ZNF692;HOXA9;NFE2L3;POU3F2;SNAI2;NR2C2;E2F3;ZEB1;ZBTB5;UBP1;ZBTB25;HIVEP3;STAT5B;ZFP28;PER1
prerank,vinculin binding (GO:0017166),0.5292085974949975,1.0714421317870353,0.4050632911392405,1.0,1.0,2/11,4.06%,CORO2B;SORBS3
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.43674249448419283,1.0706124082054402,0.40898617511520735,1.0,1.0,11/31,23.10%,KCNK5;SLC12A8;SLC12A4;PKD2;KCNK9;KCNA2;SLC12A5;HCN1;KCNF1;SLC12A6;ABCC8
prerank,mRNA 3'-UTR binding (GO:0003730),0.39410028815202935,1.068433111437052,0.38381742738589214,1.0,1.0,21/79,16.92%,RBMS3;ZFP36L1;DAZL;RBM4;TARDBP;RC3H1;CARHSP1;AUH;ZFP36L2;LARP4;CELF2;PUM1;IGF2BP1;LARP1;ZFP36;ZC3H12A;CRYZ;RSL1D1;CPEB1;FXR2;DDX5
prerank,palmitoyltransferase activity (GO:0016409),0.443413109800834,1.06840460489223,0.38698224852071006,1.0,1.0,11/28,23.66%,ZDHHC16;ZDHHC7;HHAT;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;ZDHHC18;ZDHHC8;ZDHHC5
prerank,cholesterol binding (GO:0015485),0.4090791431854371,1.0665480031854282,0.3991228070175439,1.0,1.0,9/47,11.50%,OSBP2;GRAMD1A;OSBPL3;ABCA1;OSBPL2;CD81;SCP2;OSBPL6;VDAC2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3657525912519017,1.065727606065887,0.225,1.0,1.0,121/732,16.32%,EBF2;PRRX1;AR;HOXA3;ESR1;PAX9;EBF1;NFIX;FOXP2;SP9;IRF4;CREB5;PAX1;WT1;ZFHX4;MEOX2;TBX15;SCRT2;ZNF367;HSF2;HOXA2;ELF4;SIX4;HIVEP2;SKIL;NEUROD2;RUNX1;KLF3;PBX1;KLF12;FOXP1;BHLHE40;GLIS2;TLX3;SMAD4;NFE2L2;TEF;MEF2D;SKI;SOX10;IRX5;FOXK2;ZBTB12;RFX1;KLF2;JUND;TCF7L2;NR1D2;NFATC4;MAFF;MEIS2;NFATC1;HOXA5;FOXO1;NR1D1;NFIB;EBF3;ZBTB7C;MUC1;NFIA;ZFHX3;SMAD5;GLI2;MLXIPL;MYT1;MTF1;HDAC6;HOXA4;TBX6;STAT5A;FOXL1;SOX8;ZNF260;ZBTB1;NR6A1;VDR;SATB2;SOX5;MYBL2;FOXC2;ONECUT1;BCL6;MITF;CHD2;MYPOP;MZF1;PRDM15;GLI3;ATF7;CEBPB;BACH2;ATF1;ZNF112;ZNF691;PROX2;IKZF5;SIX1;RFX5;NACC2;HDAC4;PLAGL1;ZNF569;KLF4;HOXC4;MLXIP;HOXA7;ZNF692;HOXA9;NFE2L3;POU3F2;SNAI2;NR2C2;E2F3;ZEB1;ZBTB5;UBP1;ZBTB25;HIVEP3;STAT5B;ZFP28;PER1
prerank,sulfotransferase activity (GO:0008146),0.4259832643208095,1.065562524994933,0.37777777777777777,1.0,1.0,6/33,9.30%,CHST1;CHST10;GAL3ST3;CHST12;CHST14;HS2ST1
prerank,I-SMAD binding (GO:0070411),0.5039580359525276,1.0648274407275926,0.40425531914893614,1.0,1.0,6/13,21.72%,SMAD4;AXIN1;SMAD5;SMAD6;TGFBR1;SMURF1
prerank,sulfate transmembrane transporter activity (GO:0015116),0.4902572127719899,1.0637596714207125,0.39365918097754293,1.0,1.0,4/14,17.33%,SLC26A5;SLC26A11;SLC26A6;SLC26A1
prerank,SUMO transferase activity (GO:0019789),0.486411325464038,1.0635511371315058,0.42091836734693877,1.0,1.0,8/16,28.15%,RNF212B;CBX4;PIAS3;HDAC4;NSMCE2;MDM2;MUL1;TOPORS
prerank,active ion transmembrane transporter activity (GO:0022853),-0.28835696712432224,-1.063548192317722,0.3333333333333333,0.6458429831207926,1.0,7/37,6.75%,SLC22A8;SLCO2B1;SLCO1C1;SLC22A6;SLC22A4;COX4I1;ATP13A3
prerank,miRNA binding (GO:0035198),0.43729214037684405,1.0633785865165615,0.39814814814814814,1.0,1.0,10/30,19.51%,HNRNPA1;RBM4;TRIM71;RC3H1;AGO2;DDX21;PUM1;ZC3H12A;AGO4;AGO3
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.521793505014885,1.0621140519318446,0.42799461641991926,1.0,1.0,1/10,0.44%,SLCO2A1
prerank,damaged DNA binding (GO:0003684),0.40878153448508864,1.0610554696041372,0.40607424071991,1.0,1.0,16/44,26.13%,MPG;ERCC3;ERCC4;RAD1;DDB1;SMC6;FANCG;NBN;ERCC5;POLD1;DCLRE1A;OGG1;SDE2;ERCC1;XRCC1;CRY2
prerank,disordered domain specific binding (GO:0097718),0.45311659669884163,1.0609511767260453,0.41676942046855736,1.0,1.0,9/23,24.50%,FYN;CLTC;NCOA3;CALM2;HSP90AA1;FKBP8;NUMA1;DFFB;MDM2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.4960024415246312,1.0595758066033014,0.41906005221932113,1.0,1.0,5/14,21.90%,DESI2;OTUD7B;USP7;MINDY3;USP13
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3625457448197904,1.0593607403137166,0.231,1.0,1.0,131/831,16.32%,LMX1A;EBF2;PRRX1;AR;LHX8;HOXA3;ESR1;PAX9;EBF1;TRPS1;NFIX;FOXP2;SP9;IRF4;CREB5;PAX1;WT1;ZFHX4;MEOX2;TBX15;SCRT2;ZNF367;HSF2;HOXA2;ELF4;SIX4;HIVEP2;SKIL;NEUROD2;RUNX1;KLF3;PBX1;KLF12;FOXP1;BHLHE40;GLIS2;TLX3;ZNF25;SMAD4;NFE2L2;TEF;ATF5;LMX1B;MEF2D;SKI;SOX10;IRX5;FOXK2;ZBTB12;RFX1;KLF2;JUND;TCF7L2;NR1D2;NFATC4;MAFF;MEIS2;RBAK;NFATC1;HOXA5;FOXO1;NR1D1;NFIB;EBF3;ZBTB7C;MUC1;NFIA;ZFHX3;SMAD5;GLI2;MLXIPL;MYT1;MTF1;HDAC6;HOXA4;TBX6;STAT5A;FOXL1;SOX8;ZNF260;ZBTB1;NR6A1;VDR;SATB2;SOX5;MYBL2;FOXC2;ONECUT1;BCL6;MITF;CHD2;MYPOP;ZNF3;MZF1;PRDM15;GLI3;ATF7;CEBPB;BACH2;ATF1;ZNF112;ZNF691;PEG3;PROX2;IKZF5;TWIST1;SIX1;RFX5;NACC2;HDAC4;PLAGL1;ZNF569;KLF4;HOXC4;MLXIP;HOXA7;ZNF692;HOXA9;NFE2L3;POU3F2;SNAI2;NR2C2;E2F3;ZEB1;ZBTB5;UBP1;ZBTB25;HIVEP3;STAT5B;ZFP28;PER1
prerank,lysophospholipase activity (GO:0004622),0.46276536174579835,1.0588498924795335,0.3902439024390244,1.0,1.0,1/20,0.65%,MGLL
prerank,actinin binding (GO:0042805),-0.3460361190095499,-1.0583527429337436,0.3316062176165803,0.6484961589062662,1.0,4/21,4.55%,PDLIM5;SYNPO2;PROM1;CACNA1D
prerank,solute:proton symporter activity (GO:0015295),0.4658535808716871,1.0578678360141525,0.37516170763260026,1.0,1.0,5/16,15.31%,SLC11A2;SLC17A5;SLC2A10;SLC15A4;SLC25A3
prerank,nuclear localization sequence binding (GO:0008139),0.4659677472395068,1.0568247986372767,0.41516709511568123,1.0,1.0,10/18,26.17%,KPNA2;CABP1;TNPO2;IPO5;KPNA1;BRAP;RANBP6;TNPO1;KPNA6;KPNB1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.36715883710402974,1.0557996403601793,0.376,1.0,1.0,46/254,15.57%,PRRX1;AR;ESR1;IRF4;WT1;MEOX2;HSF2;ELF4;RUNX1;GLIS2;SMAD4;ATF5;SOX10;CREB3L1;FOXK2;MAFF;MEIS2;NFATC1;SMARCD2;HOXA5;FOXO1;NFIB;NFIA;MDM4;MTF1;SMARCD1;SATB2;MYBL2;FOXC2;ONECUT1;MITF;MZF1;PRDM15;ATF1;ZNF112;SIX1;RFX5;PLAGL1;KLF4;HOXC4;MLXIP;PLAGL2;HOXA7;NR2C2;E2F3;UBP1
prerank,death receptor activity (GO:0005035),-0.4063172198401099,-1.0552605829309347,0.37809187279151946,0.646943218690783,1.0,5/11,22.71%,TNFRSF19;TNFRSF11A;FAS;TNFRSF10B;TNFRSF25
prerank,cGMP binding (GO:0030553),0.5181768740116791,1.0544881577171386,0.4316644113667118,1.0,1.0,4/11,11.80%,PDE11A;PDE10A;CNGB1;PDE5A
prerank,aminopeptidase activity (GO:0004177),0.4416676265937096,1.0538057382540973,0.4201474201474201,1.0,1.0,11/26,24.50%,ANPEP;LNPEP;XPNPEP3;NPEPPS;LAP3;MMP16;METAP2;METAP1;METAP1D;JMJD7;MMP15
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5225431560277152,1.0534790526722555,0.43072702331961593,1.0,1.0,5/10,21.48%,DNAJB2;FAN1;PML;IDE;FAAP20
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.49094284270624955,1.053402627044111,0.4166666666666667,1.0,1.0,4/12,18.52%,CISD1;CISD2;AOX1;FDX1
prerank,transition metal ion binding (GO:0046914),0.3648589082059416,1.053089435812548,0.33,1.0,1.0,100/397,21.40%,TIMP2;LOXL2;SNCB;WT1;SEC24D;B4GALT1;ANPEP;ANG;S100A8;S100A9;CLIP1;CRIP1;SKI;ADAMTS3;ADAM33;MSRB1;MGAT1;TK1;RASSF1;RBAK;SEC24A;ABCE1;SLC11A2;MDM4;GLI2;RC3H1;MYT1;MELTF;LNPEP;ZFPM2;RNF2;ABL2;MYCBP2;TIMM9;SEC23A;DPEP1;SIAH1;SIRT2;ECE1;GDA;XPNPEP3;KDM5C;SAMHD1;USP33;LARGE1;ZNF3;TARS1;DYRK2;GALNT1;WDFY1;MGAT5;NQO2;NUDT16;RNF7;MPPE1;NPEPPS;ACO2;CZIB;KDM5B;MGAT2;IKZF5;ZCCHC4;PEX12;HDAC4;KLF4;CHORDC1;ZEB1;AOX1;SOD3;GRIN2A;PHF5A;SLC30A5;CHD3;NEK4;IDE;SEC24B;FBXL5;ZDHHC20;TIMM8B;TYR;KMT2A;MMP16;ARIH2;EPRS1;CTCF;BLM;FDX1;SMPD1;SCD5;TYW5;ARIH1;FBXL19;KDM1B;XYLT2;MBD1;MGAT5B;NSD1;CCS;TAB2;KDM2B
prerank,RNA stem-loop binding (GO:0035613),0.5063224271494957,1.0516623242980525,0.43169398907103823,1.0,1.0,8/12,34.53%,RC3H1;ZC3H12A;EPRS1;RC3H2;LARP6;MYH10;CPEB3;DDX3X
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.36953032364939464,1.048096536014278,0.39354187689202824,1.0,1.0,32/173,16.70%,TRPS1;FOXP2;SCRT2;SKIL;KLF12;FOXP1;BHLHE40;ZNF25;SKI;CREB3L1;FOXK2;ZBTB12;NFATC4;NR1D1;ZFHX3;ZBTB1;BCL6;MITF;MYPOP;ZNF3;MZF1;CEBPB;PEG3;IKZF5;NACC2;PLAGL1;ZNF692;SNAI2;ZEB1;ZBTB5;ZBTB25;E4F1
prerank,RNA polymerase II complex binding (GO:0000993),0.42610633404045495,1.0451822990655257,0.4217289719626168,1.0,1.0,16/32,32.05%,SCAF8;RTRAF;NCOA3;AGO2;ELP4;URI1;UVSSA;ERCC5;PCIF1;PAF1;ELOF1;AGO1;WDR43;SCAF1;RPRD1A;WAC
prerank,E-box binding (GO:0070888),0.4180309320448657,1.0440921998610462,0.4272300469483568,1.0,1.0,9/34,17.09%,SCRT2;NEUROD2;BHLHE40;MITF;TWIST1;SNAI2;ZEB1;PER1;TFAP4
prerank,Hsp70 protein binding (GO:0030544),0.4256027192599372,1.0433879786421307,0.44632086851628466,1.0,1.0,12/31,28.00%,DNAJC2;STUB1;DNAJC8;ERN1;PPEF2;DNAJB2;GPR37;DNAJB1;MVD;TSC1;DNAJA1;HDAC8
prerank,ubiquitin-dependent protein binding (GO:0140036),0.5171914902021508,1.0421227521591578,0.4361111111111111,1.0,1.0,5/10,21.48%,DNAJC2;DNAJB2;FAN1;IDE;FAAP20
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4070399394009684,1.0405238797231549,0.43097643097643096,1.0,1.0,8/42,15.45%,CCNL2;CKS1B;KAT2B;CCNC;CDKN1A;CCND1;CCNH;CCNQ
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3596193919403421,1.0315582104535435,0.4262788365095286,1.0,1.0,82/248,27.69%,GNG8;GNAS;DNM1;GNAI3;RAB32;RAB6A;KLC1;RAB23;GTPBP4;RAB6B;RAB19;RAP1B;VPS4B;ABCG4;RIT2;CLPX;DYNC1I1;TOR1A;KIF2A;RHOJ;GNAZ;RHOQ;RAB2A;GSPT2;GFM1;NRAS;KRAS;GTPBP10;KIF20B;DNA2;NKIRAS1;RAB43;RHOA;PIN1;GNB1;RRAGD;DDX4;RAB27B;RND3;HSP90AA1;GSPT1;GEM;RAB33B;RAC3;RAB35;CHD3;RAB5B;DYNC2H1;RAB1B;ATP2B1;RAB5C;RAB24;RRAS2;ATAD1;RALA;ABCB10;GNAO1;GNB5;GPN1;SEPTIN9;RABL3;ARL8A;RAC1;RAB18;AGAP3;RHOT2;GNA14;ATL1;RAB1A;RAB29;RHOBTB2;GNA13;DHX29;RAB3C;RND2;CFTR;RAB8B;RAP1A;DIRAS2;RHEBL1;RAP1GAP;TSR1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4834280511020348,1.0306375038476698,0.4424083769633508,1.0,1.0,5/15,14.99%,GPAT4;AGPAT3;LPCAT1;AGPAT5;GPAT3
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.4150053814273665,-1.0304802613059156,0.40344827586206894,0.6952741253611141,1.0,5/10,25.24%,CACNB2;CACNA1D;CACNB3;CACNA1B;CACNB4
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.46827370461930135,1.0302897856074997,0.42328042328042326,1.0,1.0,6/16,24.79%,MTMR11;INPP5F;MTMR6;MTMR1;PTEN;MTM1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.2895315890553989,-1.030113956831839,0.38028169014084506,0.6870875310349142,1.0,8/34,9.82%,MYO1B;ADAP2;ARAP2;IQGAP2;ARAP3;FCHSD2;HIP1R;ZFYVE1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4498995379646008,1.0299329696860264,0.45057766367137353,1.0,1.0,4/18,10.07%,TGFB3;TGFB2;TGFBR2;SMAD6
prerank,methyltransferase activity (GO:0008168),0.39526224717399405,1.0296472615804473,0.4560622914349277,1.0,1.0,20/46,32.11%,NTMT1;MEPCE;FTSJ1;COMTD1;COQ3;GAMT;COMT;TRMT11;COQ5;N6AMT1;ASMT;FTSJ3;EEF1AKMT3;NNMT;SUV39H1;PRMT8;LRTOMT;AS3MT;PRMT7;DNMT3B
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3751556225153027,1.0296377630041247,0.4418604651162791,1.0,1.0,16/75,23.12%,EHHADH;DHRS9;UGDH;DHRS4;HSD3B7;HIBADH;PTGR1;KCNAB3;HSD17B8;MDH2;BDH2;GLYR1;LDHA;HSD17B4;HSD17B11;LDHAL6B
prerank,GTPase activity (GO:0003924),0.36131959474766384,1.028250167436676,0.4353059177532598,1.0,1.0,65/192,28.32%,GNG8;GNAS;DNM1;GNAI3;RAB32;RAB6A;RAB23;GTPBP4;RAB6B;RAB19;RAP1B;RIT2;RHOJ;GNAZ;RHOQ;RAB2A;GSPT2;GFM1;NRAS;KRAS;GTPBP10;NKIRAS1;RAB43;RHOA;GNB1;RRAGD;RAB27B;RND3;GSPT1;GEM;RAB33B;RAC3;RAB35;RAB5B;RAB1B;RAB5C;RAB24;RRAS2;RALA;GNAO1;GNB5;GPN1;SEPTIN9;RABL3;ARL8A;RAC1;RAB18;AGAP3;RHOT2;GNA14;ATL1;RAB1A;RAB29;RHOBTB2;GNA13;RAB3C;RND2;RAB8B;RAP1A;DIRAS2;RHEBL1;RAP1GAP;TSR1;RAP2B;HBS1L
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.4610881622697494,1.026499324548268,0.46532156368221944,1.0,1.0,4/18,16.55%,PIK3R2;SOCS2;WDR91;SOCS6
prerank,cholesterol transfer activity (GO:0120020),0.46860458585428255,1.0246563035503633,0.4671916010498688,1.0,1.0,3/16,6.94%,GRAMD1A;ABCA1;OSBPL2
prerank,glycerophospholipid flippase activity (GO:0140333),0.4990782013524906,1.0239077544048092,0.4686192468619247,1.0,1.0,2/11,7.59%,ATP8B1;ATP11A
prerank,deoxyribonuclease activity (GO:0004536),0.48261164948153806,1.022277411513503,0.469281045751634,1.0,1.0,7/14,25.15%,ERCC4;DNASE1L2;NME1;ERCC5;MAP1S;DFFB;DNASE1L1
prerank,CCR chemokine receptor binding (GO:0048020),0.41519120570729884,1.0222408165584853,0.45486935866983375,1.0,1.0,5/28,20.55%,CCL8;CCL25;CCL13;MSMP;CNIH4
prerank,histone deacetylase binding (GO:0042826),0.3681355355662225,1.0217564146512257,0.4491080797481637,1.0,1.0,40/88,30.44%,HDAC9;MEF2D;DACT1;KPNA2;HDAC6;YWHAE;SATB2;SIRT2;KAT2B;HDAC3;GLI3;NCOR2;NCOR1;CCND1;NACC2;AKAP8;HDAC4;HSP90AA1;GMNN;TFAP4;NIPBL;TOP2B;SUDS3;KCTD21;MIER1;AKAP8L;YWHAB;RELA;LCOR;PHF6;SMG5;HES1;HIC1;TP53;MEF2B;BRMS1L;BRMS1;THAP7;TRAF6;RAD9A
prerank,semaphorin receptor binding (GO:0030215),0.4351796149288615,1.0206964783336219,0.4617283950617284,1.0,1.0,4/23,12.60%,SEMA3C;RIT2;SEMA3A;SEMA3D
prerank,mannose binding (GO:0005537),0.4866530599514095,1.020333856074031,0.47462277091906724,1.0,1.0,3/12,18.80%,COLEC11;LMAN1;MBL2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.3458704856820223,-1.0203219923955287,0.39732142857142855,0.6996718171105114,1.0,8/18,20.52%,TNFAIP8;SNCA;XIAP;PRDX3;RPS6KA1;MT3;SERPINB9;BIRC2
prerank,methyl-CpG binding (GO:0008327),-0.3157099050447318,-1.0145614832336391,0.46551724137931033,0.7042760718292249,1.0,5/22,13.27%,CXXC4;TET1;ZBTB38;CXXC5;LRWD1
prerank,ribosomal small subunit binding (GO:0043024),0.44917790629152055,1.0127245301338939,0.4796854521625164,1.0,1.0,9/17,26.22%,ABCE1;EIF1;NPM1;LARP1;NME1;MTIF2;EIF4H;ERAL1;DHX29
prerank,sialyltransferase activity (GO:0008373),-0.3419506882712598,-1.0121792506827607,0.4413145539906103,0.7010050713640017,1.0,6/20,9.63%,ST3GAL6;ST8SIA4;ST6GALNAC3;ST6GALNAC5;ST6GAL1;ST8SIA2
prerank,zinc ion binding (GO:0008270),0.3515856383190156,1.0104068742862395,0.489,1.0,1.0,71/293,21.68%,TIMP2;WT1;SEC24D;ANPEP;S100A8;S100A9;CLIP1;CRIP1;SKI;ADAMTS3;ADAM33;MSRB1;TK1;RASSF1;RBAK;SEC24A;MDM4;GLI2;RC3H1;MYT1;LNPEP;ZFPM2;RNF2;MYCBP2;TIMM9;SEC23A;DPEP1;SIAH1;SIRT2;ECE1;GDA;KDM5C;SAMHD1;USP33;ZNF3;TARS1;WDFY1;NQO2;NPEPPS;CZIB;KDM5B;IKZF5;ZCCHC4;PEX12;HDAC4;KLF4;CHORDC1;ZEB1;GRIN2A;PHF5A;SLC30A5;CHD3;IDE;SEC24B;ZDHHC20;TIMM8B;KMT2A;MMP16;ARIH2;EPRS1;CTCF;BLM;SMPD1;ARIH1;FBXL19;KDM1B;MBD1;NSD1;TAB2;KDM2B;CBLB
prerank,phosphatidylglycerol binding (GO:1901611),0.48383352840439203,1.0094167704245909,0.470189701897019,1.0,1.0,1/13,0.59%,UCP1
prerank,phosphatase binding (GO:0019902),0.3650694027874715,1.008959145527386,0.47584789311408016,1.0,1.0,26/105,17.75%,EGFR;EIF2AK3;DLG4;PIK3R2;MAPK14;RCAN3;CARHSP1;IQGAP1;FBXL2;SIRPA;ANAPC5;MAGI2;JUP;STX17;SHOC2;KIF3A;SFI1;PPP1R3C;CDC27;GTF2F1;TRPC4AP;CNST;ANK1;TRAF3;SH2D4A;ANAPC4
prerank,mannosyltransferase activity (GO:0000030),-0.31911620920831185,-1.0087386288227358,0.4031413612565445,0.7005437794681082,1.0,7/21,13.80%,TMTC1;TMTC4;TMTC2;ALG12;PIGB;DPY19L4;POMT2
prerank,titin binding (GO:0031432),0.4689385623288802,1.0077215687179029,0.4585635359116022,1.0,1.0,3/13,12.36%,ANKRD23;CAMK2D;CALM2
prerank,fibroblast growth factor binding (GO:0017134),0.42760449270329803,1.007454790710223,0.46609124537607893,1.0,1.0,4/21,9.97%,FGFR1;ITGB3;GLG1;ITGAV
prerank,MAP kinase phosphatase activity (GO:0033549),-0.395718928973132,-1.0068227940634364,0.43462897526501765,0.6958526812501543,1.0,3/12,16.64%,DUSP10;DUSP7;DUSP6
prerank,adenyl nucleotide binding (GO:0030554),0.4862853663288859,1.006610759466268,0.46986301369863015,1.0,1.0,5/11,24.92%,GRPEL2;BAG4;BAG3;BAG5;HSPH1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.4862853663288859,1.006610759466268,0.46986301369863015,1.0,1.0,5/11,24.92%,GRPEL2;BAG4;BAG3;BAG5;HSPH1
prerank,cell adhesion mediator activity (GO:0098631),0.4287387487553348,1.0062521664510964,0.47619047619047616,1.0,1.0,7/24,13.22%,NPTN;JAM3;SIRPA;CD47;DSCAM;PALLD;IGSF9
prerank,phosphatidylinositol binding (GO:0035091),0.36374191924048566,1.005842532804576,0.47357512953367875,1.0,1.0,17/91,14.35%,SESTD1;SCIN;GAP43;GPAA1;FRMPD2;AIDA;PARD3B;PLEKHF1;SNX1;DPEP1;WDFY1;MAPT;MPPE1;PASK;PIGK;DENND1A;BCAS3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.40797667972450674,1.0057571215551726,0.46996466431095407,1.0,1.0,8/30,20.02%,SLC39A14;SLC39A13;SLC11A2;SLC39A7;SLC25A28;SLC30A5;TMEM165;SLC39A3
prerank,telomerase RNA binding (GO:0070034),0.426853245038704,1.0047088808104099,0.4770755885997522,1.0,1.0,10/22,29.02%,GAR1;SMG7;SMG6;SNRPD3;TENT4B;TEP1;EXOSC10;NHP2;SMG5;HNRNPC
prerank,motor activity (GO:0003774),0.37520551760554044,1.002574646047218,0.48527808069792805,1.0,1.0,16/60,19.28%,KLC1;KIFC2;KIF21B;STARD9;DNAH8;DYNC1I1;KIF2A;KIF20B;KIF3A;KIF21A;PIN1;KIF3B;DYNC2H1;KIF26B;CENPE;KIFC3
prerank,SH3 domain binding (GO:0017124),-0.2549169153662514,-1.0021907119798963,0.4473684210526316,0.6982032767821232,1.0,15/62,13.03%,AFAP1L1;CD2AP;AFAP1;SHANK3;DAB2IP;AFAP1L2;PLSCR1;LANCL1;ZNF106;EVL;SGIP1;ABL1;KHDRBS1;CASP9;ABI3
prerank,methylation-dependent protein binding (GO:0140034),0.3808152638917949,1.0009134868586027,0.4860813704496788,1.0,1.0,26/57,30.39%,MORC4;CXXC1;SPIN4;TDRD3;PHF1;MSL3;ING4;ZCWPW2;MPHOSPH8;WDR5;CDYL;CHD8;CHD1;GLYR1;SGF29;SPIN1;JMJD7;TRIM24;PYGO1;MSH6;ING1;CBX2;ATRX;MBTD1;THAP7;CBX5
prerank,sterol binding (GO:0032934),0.38030017828739016,1.0006798880373484,0.48695652173913045,1.0,1.0,10/56,11.50%,OSBP2;GRAMD1A;OSBPL3;ABCA1;OSBPL2;INSIG2;CD81;SCP2;OSBPL6;VDAC2
prerank,phosphate ion binding (GO:0042301),0.500795176983923,0.9999885028713966,0.5014245014245015,1.0,1.0,5/10,25.00%,CHST14;ADSS2;RELA;MTHFD2;RPH3A
prerank,potassium:proton antiporter activity (GO:0015386),0.4934955014366723,0.999686345055654,0.514324693042292,1.0,1.0,4/10,16.13%,SLC9A9;SLC9A1;SLC9A6;SLC9A7
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.46675652863308387,0.999275378385891,0.48947368421052634,1.0,1.0,7/13,29.09%,FTSJ1;TRMT10B;TRMT1;TRMT11;METTL1;WDR4;THUMPD3
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.48359087424499814,0.9988836890999393,0.4986301369863014,1.0,1.0,3/12,4.55%,ITGB3;VEGFA;ITGA5
prerank,SH2 domain binding (GO:0042169),0.4120594230894201,0.9983359835299812,0.49065420560747663,1.0,1.0,5/31,12.37%,LAX1;IRS1;SRC;SQSTM1;RUFY1
prerank,metalloaminopeptidase activity (GO:0070006),0.4516210807722734,0.9981213121124706,0.47429305912596403,1.0,1.0,5/16,17.95%,ANPEP;LNPEP;XPNPEP3;NPEPPS;MMP16
prerank,poly(A) binding (GO:0008143),-0.32743424530335463,-0.9979044651000863,0.39487179487179486,0.6996165934269372,1.0,9/21,19.11%,RBPMS;RBMS2;ZC3H14;PPIE;KHDRBS1;TIA1;PABPC4L;EIF4A3;HNRNPDL
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4560704787896884,0.9968472430632722,0.4927916120576671,1.0,1.0,7/15,22.50%,PIK3C2B;PI4K2B;PIK3CA;PI4KB;PI4KA;PIK3CG;PI4K2A
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.4180979069617978,0.9955201392809951,0.4944649446494465,1.0,1.0,6/23,15.10%,SESTD1;CLVS2;WIPI2;PLEKHA4;WDR45B;PLA2G4E
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.4614990370372117,0.995094847722053,0.5006784260515604,1.0,1.0,5/14,18.15%,NME2;CMPK2;AK8;NME1;AK9
prerank,endonuclease activity (GO:0004519),0.3830618618176794,0.9946381204047614,0.5048648648648648,1.0,1.0,17/49,27.77%,ANG;NYNRIN;N4BP2;AGO2;ERN1;ERCC4;RCL1;ZC3H12A;SMG6;ERCC5;AGO3;YBEY;OGG1;RNASEK;KHNYN;AGO1;CPSF3
prerank,P-type ion transporter activity (GO:0015662),0.4687874914932391,0.9936973370511031,0.49531459170013387,1.0,1.0,4/12,17.59%,ATP2B4;ATP6V1E1;ATP2A2;ATP2B1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3726433577027849,0.9933559458550408,0.4989177489177489,1.0,1.0,14/60,14.09%,DDR2;EPHB2;AXL;EGFR;FGFR1;EPHA3;MST1R;RET;EPHB3;MUSK;EPHA10;PDGFRA;FLT3;DDR1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3715641851538628,0.9930574360090167,0.5168421052631579,1.0,1.0,21/69,23.66%,CERS6;ZDHHC16;MOGAT1;PLAAT1;ZDHHC7;SCP2;KAT2B;HHAT;MBOAT7;MOGAT2;ZDHHC2;PLA2G4E;ZDHHC21;ZDHHC20;NAA15;MCAT;SOAT1;ZDHHC18;KAT6B;ZDHHC8;ZDHHC5
prerank,methylated histone binding (GO:0035064),0.37318395045349123,0.9909118297104166,0.5058324496288441,1.0,1.0,27/62,30.39%,MORC4;DPF2;CXXC1;SPIN4;TDRD3;PHF1;MSL3;ING4;ZCWPW2;MPHOSPH8;WDR5;CDYL;CHD8;CHD1;GLYR1;SGF29;SPIN1;JMJD7;TRIM24;PYGO1;MSH6;ING1;CBX2;ATRX;MBTD1;THAP7;CBX5
prerank,MHC protein binding (GO:0042287),0.4299810798536166,0.9896855803680382,0.48711656441717793,1.0,1.0,7/20,28.67%,KIR3DL2;CD81;COL2A1;ABCB9;DERL1;ATP5F1B;ATP5F1A
prerank,protein homodimerization activity (GO:0042803),0.33872913963166845,0.9888628003157118,0.537,1.0,1.0,145/589,21.99%,MID1;GHR;LRP6;MGLL;CADM3;FOXP2;SRM;ST3GAL2;DPP4;FAP;FGFR1;STK25;TARBP2;ANG;IRAK3;VEGFA;TGFB2;S100A10;SLIT2;SLC51A;BHLHE40;NECTIN3;SLC39A13;EXT1;SMAD4;MID2;ACVR1;AXIN1;TENM3;VPS4B;CAMK2D;ALDH3A2;PRMT2;ABCG4;DGCR8;SYNE1;TMEM266;IDH1;MLXIPL;STUB1;SNX1;MYO9B;PKD2;TIMM9;S100A6;SLK;CHUK;ZBTB1;NR6A1;HPS4;INPP5F;DPY30;ECE1;PON3;NUDT16L1;XPNPEP3;ODC1;ERN1;MZF1;NPM1;ZHX2;GSTM2;SPPL2B;AKT1;CEBPB;NQO2;KIF20B;CRYM;NUDT16;IRAK1;JUP;GLA;BAK1;FLRT3;GLCE;ALDH1A3;PDGFRA;ADCY8;GDNF;MGAT2;GTF2A2;ZDHHC2;TERF1;NACC2;CR2;NFS1;SYNDIG1;CISD2;HSP90AA1;PANK1;MTMR1;ACOX1;AOX1;FZD4;HARS1;NUDT5;TRIM68;PADI2;PHETA2;FXR2;PRPS1L1;PRPS1;PML;TFAP4;IDE;CHRNA7;CANT1;SRGAP2;ABCB9;SNX6;QTRT1;TYR;KMT2A;TPM4;ERCC5;EPRS1;GLDC;BLM;AIMP1;SUPV3L1;KCNH2;PRDM9;MKLN1;PANK3;TYW5;MCL1;ABCD3;GALM;PIP4K2B;STK26;ACP3;FLNA;NECTIN1;HSD17B4;BMPR1A;PYCARD;ABCB10;ATIC;CRPPA;TPST2;UXS1;CSF1;SRR;PDCD6IP;SLC8B1
prerank,sterol transfer activity (GO:0120015),0.44663059035738906,0.9887281678691658,0.5052083333333334,0.9997460815242647,1.0,3/17,6.94%,GRAMD1A;ABCA1;OSBPL2
prerank,voltage-gated cation channel activity (GO:0022843),0.3558272036777956,0.9882833425225431,0.5067357512953368,0.9977114733573658,1.0,21/97,19.83%,KCNMA1;KCNV1;CACNA2D2;GRIN3A;KCND1;GRIN2D;PKD2;ITGAV;HCN4;KCNA2;KCNA6;CACNG2;CACHD1;CATSPER3;CACNB1;KCNC2;GRIN2A;NCS1;KCNH2;HCN1;KCNF1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4237414304283803,0.9875945080989107,0.4943820224719101,0.996162000121393,1.0,5/21,27.41%,P2RX3;CHRNA7;CHRNA5;GRIK2;P2RX4
prerank,acetylation-dependent protein binding (GO:0140033),0.43083275306733193,0.985392321024238,0.5062814070351759,0.9957670529266496,1.0,10/20,24.04%,DPF2;BRD9;ATAD2B;BRD7;SMARCA4;KMT2A;CARM1;BRD2;BAZ2A;TRIM24
prerank,lysine-acetylated histone binding (GO:0070577),0.43083275306733193,0.985392321024238,0.5062814070351759,0.9957670529266496,1.0,10/20,24.04%,DPF2;BRD9;ATAD2B;BRD7;SMARCA4;KMT2A;CARM1;BRD2;BAZ2A;TRIM24
prerank,amyloid-beta binding (GO:0001540),0.35955565716890464,0.9850862513186084,0.5185577942735949,0.9930924788357677,1.0,19/79,20.53%,EPHB2;LRP1;APBA3;TGFB2;APBA1;ATP1A3;ITGA2;TM2D1;TLR4;GRIA2;HSPG2;FZD4;GRIN2A;IAPP;CHRNA7;PFDN6;GRIA3;ITGAM;BACE1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.40065825087594614,0.9849025009975504,0.4976190476190476,0.9901017005235221,1.0,6/29,11.13%,MAPK7;MAPK14;PTPRJ;NFATC1;ATF7;TNIP1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.42551181291783624,0.9848273601029787,0.5171149144254279,0.9869034725864761,1.0,6/22,15.71%,RBMS3;ZFP36L1;ZFP36L2;ZFP36;ZC3H12A;CPEB1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.38641936822625733,0.9840025843937854,0.5155555555555555,0.9859519103244035,1.0,11/46,15.80%,B3GALNT1;EXT1;MGAT1;POMGNT2;RFNG;LARGE1;B3GNT8;MGAT5;MGAT2;MGAT4B;OGT
prerank,glycine binding (GO:0016594),0.4820272512023506,0.9828646655387793,0.5358126721763086,0.9856321114910809,1.0,5/11,30.46%,GRIN3A;GLDC;SRR;GLRA3;GLRA2
prerank,endoribonuclease activity (GO:0004521),0.39987318702855446,0.9823372139373381,0.5081018518518519,0.9837717922503803,1.0,12/32,27.77%,NYNRIN;AGO2;ERN1;RCL1;ZC3H12A;SMG6;AGO3;YBEY;RNASEK;KHNYN;AGO1;CPSF3
prerank,translation elongation factor activity (GO:0003746),0.45057704530535203,0.9821013787215784,0.5178807947019868,0.981054644719313,1.0,4/14,20.45%,GTPBP2;GFM1;EEF1B2;EIF5A2
prerank,leak channel activity (GO:0022840),0.4326024578748725,0.9819058986801041,0.5105067985166872,0.9782387612492943,1.0,3/18,9.47%,KCNK5;KCNK13;KCNK9
prerank,phosphatase inhibitor activity (GO:0019212),-0.31489690379815277,-0.9805762636852434,0.4540540540540541,0.7311657504229332,1.0,3/20,4.14%,PTN;LMTK2;BOD1L1
prerank,U6 snRNA binding (GO:0017070),0.45418167066147863,0.9803607336004623,0.5144429160935351,0.9792229453748144,1.0,5/14,22.42%,LSM4;PRPF4;RBM22;LSM7;LARP7
prerank,guanyl ribonucleotide binding (GO:0032561),0.34426561276908213,0.9799118298928051,0.5518630412890232,0.9771565470737481,1.0,66/196,28.01%,GNAI3;RAB32;RAB6A;GTPBP4;RAP1B;PDE11A;ARF4;SCG5;PDE10A;RIT2;DYNC1LI1;RHOJ;CNGB1;ARF1;RHOQ;RAB2A;TUBB6;NRAS;KRAS;GTPBP10;PDE5A;NUDT16;TUBD1;RRAD;RHOA;RRAGD;NME2;RAB27B;RND3;TUBB4A;ARF6;TUBA4A;GEM;GLUD1;RAC3;RAB35;RAB5B;NME1;RAB1B;RAB5C;RRAS2;PIP4K2B;RALA;RAB10;ADSS2;TUBG2;RABL3;RAB12;NOA1;ARL8A;RAC1;RAB18;ANXA6;RHOT2;ATL1;RAB29;RHOBTB2;EIF2B2;RND2;TUBB2A;RAB8B;RAP1A;DIRAS2;RHEBL1;TSR1;RAP2B
prerank,receptor tyrosine kinase binding (GO:0030971),0.37213541162448904,0.9794211336244443,0.5449561403508771,0.975289443118465,1.0,16/56,23.28%,IRS1;ANGPT4;PIK3R2;SH2B1;GAS6;FLT3LG;NRG3;SQSTM1;CBL;NCK1;DOCK4;GAB2;PITPNM1;RNF41;CBLB;MAP3K7
prerank,potassium channel activity (GO:0005267),0.3539375295347754,0.9754855178444751,0.527806925498426,0.9829184591024551,1.0,11/89,11.18%,KCNK5;KCNT2;KCNMA1;KCNV1;KCND1;PKD2;KCNK13;KCNK9;HCN4;KCNA2;KCNA6
prerank,copper ion binding (GO:0005507),0.37916170962250656,0.9718686582519894,0.5291428571428571,0.9897762743039028,1.0,3/42,2.55%,LOXL2;SNCB;ANG
prerank,endopeptidase regulator activity (GO:0061135),-0.2630527691722099,-0.9715861572955361,0.5161290322580645,0.7443565575532617,1.0,13/40,18.38%,TFPI;ITIH2;SERPIND1;USP14;RENBP;PSMF1;PSME2;CST3;PSME1;A2M;PROS1;SPINT2;APH1A
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.2876035289861641,-0.9707097271313918,0.4853801169590643,0.7378867524293181,1.0,9/29,17.86%,PRKAG2;PKIG;PRKAR1B;RPTOR;PRKAR2B;HSPB1;SPRED2;INKA2;CIB1
prerank,mRNA binding (GO:0003729),0.33766513497680256,0.9700073468505233,0.56312625250501,0.9915158990793852,1.0,84/249,26.02%,ADARB1;MRPS11;SRSF6;HDLBP;NYNRIN;RBMS3;ZFP36L1;DAZL;RBM4;EIF4A1;CLUH;SAMD4B;SCAF8;TARDBP;C1QBP;RC3H1;CARHSP1;DHX33;AUH;NSRP1;LARP4;MRPL13;NUP98;CPSF6;AGO2;TDRD7;CELF2;PUM1;RBFOX2;NUDT16;SLPI;UNK;IGF2BP1;EIF3A;LARP1;ZFP36;RPS5;ZC3H12A;AQR;THOC2;FYTTD1;CRYZ;ZC3H11A;RSL1D1;CPEB1;PKM;FXR2;EIF3D;DDX5;YTHDF2;SNIP1;YTHDF1;LUC7L3;SLBP;EIF2S2;NCBP3;LUC7L2;SRRM3;NOVA1;PTBP1;ELAVL2;SF3B1;RC3H2;YTHDF3;EIF2A;PTBP2;EIF4G3;TPR;RBM5;CSTF2T;EDC3;DAZAP1;G3BP1;CALR;LARP6;KHNYN;RBM24;CELF3;RBMX;RNF20;UPF3B;DCP1A;DCP1B;EIF4G1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.40316691421674383,-0.9700059727408019,0.47315436241610737,0.722635413646988,1.0,3/10,16.64%,DUSP10;DUSP7;DUSP6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.40316691421674383,-0.9700059727408019,0.47315436241610737,0.722635413646988,1.0,3/10,16.64%,DUSP10;DUSP7;DUSP6
prerank,protein phosphatase 1 binding (GO:0008157),-0.3163083827935646,-0.9696481863150772,0.49760765550239233,0.715301986541835,1.0,6/21,13.12%,PPP1R16B;PPP1R3B;SH3RF2;KCNQ1;PHACTR4;PPP1R16A
prerank,neurexin family protein binding (GO:0042043),0.48577711422905245,0.9690907756033889,0.5213068181818182,0.9908353171835564,1.0,2/10,9.01%,CEL;SYTL5
prerank,G protein-coupled receptor activity (GO:0004930),0.3346136606456684,0.967728839041186,0.585,0.9913156364103598,1.0,21/239,12.06%,ADGRD1;AVPR1A;VIPR2;LPAR3;PROKR2;MTNR1B;GPR12;F2R;LPAR1;GLP2R;S1PR2;ADGRG2;CRHR1;LTB4R2;GPR20;TM2D1;GPR141;GPR161;GPR45;GPR37L1;TSHR
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.36284552589109903,0.967479045934817,0.5451541850220264,0.9887245319347605,1.0,20/60,21.14%,TIMM50;CDC14B;ILKAP;PPP5C;CTDSP2;PPM1G;PHLPP2;PGAM5;PPEF2;PPP1R3C;PPP3CA;CTDP1;MTMR6;PPP1CC;PDP2;PPP3CB;PPP1R3D;PPM1A;PTEN;PPP6C
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3607034714345173,-0.9666323631815316,0.4959677419354839,0.714048573348648,1.0,4/12,8.32%,DCPS;CYFIP2;EIF4E;GEMIN5
prerank,iron ion binding (GO:0005506),-0.2686610587867094,-0.9663957145134197,0.5333333333333333,0.7067411901185666,1.0,13/48,12.91%,KDM7A;SNCA;FTH1;TET1;PHYH;EGLN3;FECH;PHF2;NFU1;EGLN1;ETHE1;SCD;ISCU
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.44782052266244265,0.964492898753772,0.510148849797023,0.9937005112671176,1.0,1/14,0.31%,TIMP2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.3710363100696785,-0.9639731230029602,0.4765625,0.7044276940237341,1.0,4/12,9.53%,PDE7B;PDE3A;PDE8B;PDE2A
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.44903450969257724,0.9634728874073432,0.5107816711590296,0.993189417221863,1.0,5/14,24.79%,MTMR11;MTMR6;MTMR1;PTEN;MTM1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3342773745905418,0.961872834502799,0.647,0.994054543340864,1.0,116/346,26.14%,SH3RF3;TSPAN17;MIB2;UBE2B;SMURF2;UBE2J2;FBXW8;NEURL4;SYVN1;ITCH;TRIM71;RFWD3;RNF121;RMND5B;RBBP6;MSL2;COP1;RNF111;PELI3;RC3H1;STUB1;RNF2;MYCBP2;UBE2W;ANKRD39;FBXO2;UBE2N;MYLIP;FANCL;SIAH1;MAGEL2;FBXO17;CUL3;DTL;UBE2G2;ASB12;HECW2;RNF10;TRIM11;CDC23;IRF2BPL;RNF141;RNF7;UBE2A;CDC34;LTN1;RSPRY1;BSPRY;TRAF3IP2;FBXL3;CBL;PEX12;UBR4;AMFR;RNF128;UHRF2;RNF216;RNF14;RBCK1;TRIM68;RNF187;RNF138;TRAF3;HACE1;PML;FBXL5;UBE2G1;FBXO11;ANAPC4;ARIH2;UBE2R2;VPS11;BRAP;RNF19A;MEX3C;RING1;LRSAM1;TRIM35;UBE3C;ARIH1;UBE2D3;CUL5;KCTD10;RNF41;FBXW2;RC3H2;CBLB;SMURF1;DTX2;KLHL9;FBXW11;UBE2Q2;FBXO24;SEL1L;UBE3A;UBR2;RNF6;UBE2Z;RNF114;TRIM36;RNF157;TRAF5;RNF123;RNF13;TRIM24;TRIM44;MDM2;MKRN2;RNF166;FBXO22;ZNRF2;UBA7;RNF20;UBE2K;RNF167;RNF126
prerank,RNA methyltransferase activity (GO:0008173),0.4216669251563756,0.9597763680264634,0.5343320848938826,0.9965100705141046,1.0,4/19,12.47%,TYW3;MEPCE;FTSJ1;TGS1
prerank,single-stranded RNA binding (GO:0003727),0.37396405325141147,0.9594611313538283,0.5553072625698324,0.9941931714267965,1.0,22/43,34.53%,HNRNPA1;AGO2;POLR2D;POLR2G;DDX11;AQR;AGO4;AGO3;U2AF2;PTBP1;EIF4H;EXOSC10;ZFR;AGO1;CNBP;SNRPC;SRA1;FXR1;STRBP;JMJD6;HNRNPU;DDX3X
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.4384753469181508,0.9594098950256119,0.5388739946380697,0.9911396982972325,1.0,2/15,5.85%,SESTD1;PLEKHF1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.42953921413060203,0.9589792208576078,0.5238095238095238,0.9858854149991404,1.0,4/17,11.71%,EPHB2;EPHA3;EPHB3;EPHA10
prerank,ephrin receptor activity (GO:0005003),0.42953921413060203,0.9589792208576078,0.5238095238095238,0.9858854149991404,1.0,4/17,11.71%,EPHB2;EPHA3;EPHB3;EPHA10
prerank,SUMO binding (GO:0032183),0.44810814390753834,0.9578035010890515,0.5176151761517616,0.9858048271444633,1.0,3/13,7.63%,CBX4;RNF111;UBA2
prerank,protein serine/threonine kinase activity (GO:0004674),0.3314405287813094,0.9532082286921182,0.63,0.9951214981253762,1.0,57/334,14.41%,SYK;PRKCA;EGFR;MAPK12;EIF2AK3;RPS6KA2;CAMKK1;CDKL2;DYRK4;MAPK7;IRAK3;SGK3;SGK2;CDK14;TGFBR2;TAOK3;MAPK14;TRIO;ACVR1;CDK4;RIOK1;MTOR;CLK1;CAMK2D;PRKAB2;MAST4;PRKD2;SLK;CHUK;TESK2;CDK9;AKT3;CDK20;MAPK11;NRBP2;BMP2K;SQSTM1;ERN1;DYRK2;IRAK4;CSNK1G1;AMHR2;CSNK1G3;MAP3K6;AKT1;STK16;IRAK1;STK39;PASK;PRKD3;ULK2;TAOK2;HIPK4;ULK1;MAP3K14;STK24;STK3
prerank,DNA-binding transcription factor binding (GO:0140297),0.33322959017026077,0.9523467855905495,0.6253776435045317,0.9940062335573207,1.0,31/189,15.37%,PRRX1;AR;TLE6;DGKQ;BHLHE40;NFE2L2;CRTC2;HDAC7;HDAC9;MEF2D;SKI;DACT1;TCF7L2;NFATC1;PIAS3;NOC2L;ZFPM2;TBX6;BEX1;TLE2;TCERG1;NPM1;NCOR1;TWIST1;HDAC4;NBN;BBS4;KLF4;DMAP1;TTC8;DDX20
prerank,MAP kinase kinase activity (GO:0004708),0.43338172574440287,0.9523381644901965,0.5531088082901554,0.990889310855513,1.0,4/15,18.00%,MAPK14;MAP2K3;MAP2K2;MAP2K4
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.4113932195872487,0.9521558445460158,0.5397022332506204,0.9882217397208211,1.0,5/21,25.55%,CHRNA7;CHRFAM7A;GRM1;CHRNA5;GRM5
prerank,protein phosphatase binding (GO:0019903),0.3444105562430795,0.9512214576865431,0.5813715455475946,0.9875204286397158,1.0,27/117,17.75%,EGFR;EIF2AK3;DLG4;PIK3R2;MAPK14;GRIN3A;ATP2B4;FOXO1;IQGAP1;FBXL2;SIRPA;MAPT;SLC9A1;ANAPC5;JUP;STX17;SHOC2;KIF3A;ADCY8;PPP1R3C;CDC27;SMG7;GTF2F1;ANK1;TRAF3;PPP1R9B;ANAPC4
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.38180873674122495,-0.9510952353076418,0.5379746835443038,0.7260005629444534,1.0,2/10,7.51%,MECOM;PRDM16
prerank,N-methyltransferase activity (GO:0008170),0.41238579588919244,0.94910997967003,0.5514993481095176,0.9898160318781433,1.0,7/20,22.69%,DIMT1;FDXACB1;ZCCHC4;TRMT1;TRMT11;N6AMT1;RNMT
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.39210957104745775,0.9490594356575712,0.5464414957780458,0.9868805735130229,1.0,9/29,20.82%,HEXD;PARG;GBA2;GLA;GAA;PGGHG;IDUA;OVGP1;GANAB
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.42915202984422607,0.9472665606879116,0.5414438502673797,0.9886011011849234,1.0,6/15,19.93%,CXXC1;WDR5;KMT2A;PRDM9;KMT2C;SETD1B
prerank,histone methyltransferase activity (GO:0042054),0.3809704355343738,0.9456313445632618,0.5460910151691949,0.9896579362195578,1.0,15/32,29.04%,PRMT2;NTMT1;SETD7;SETD2;EHMT2;PRDM9;KMT2C;N6AMT1;CARM1;EZH2;SETDB1;KMT5A;MEN1;SUV39H1;PRMT8
prerank,protein kinase binding (GO:0019901),0.32592289514482675,0.9436097888952385,0.708,0.9915304323937318,1.0,93/479,18.62%,NOX4;GHR;AVPR1A;ESR1;LAX1;NELL2;IRS1;DNM1;DCTN1;PRAM1;CKS1B;MAPK7;DACT3;IRAK3;ANK2;CAMK2N1;TNNI3;CLTC;ADAM9;LLGL1;HDAC7;HDAC9;SKI;PKD1;ACVR1;AXIN1;DACT1;DACT2;MAP2K3;TCF7L2;PTPRJ;FAM83G;PRKAB2;RBBP6;CSK;AP2A2;MAPRE3;TRIP4;YWHAG;BANK1;BICD1;STX1B;SLC12A4;PRKD2;TIRAP;PARD6A;GSKIP;SRCIN1;IQGAP1;KAT2B;ITGAV;SIRPA;SQSTM1;IRAK4;NPM1;MAPRE1;ATF7;TNIP1;FBXO5;MAPT;IRAK1;PPEF2;CALM2;SMCR8;ZFP36;TAOK2;CDKN1A;RHOA;PIN1;CCND1;PDE3B;RND3;HSP90AA1;TUBA4A;VDAC1;CDK5RAP2;NSF;TRIM68;KIZ;NBR1;PPP1CC;RAC3;RNF138;CAVIN3;UFL1;RCC2;ILK;SNAP91;QARS1;DOK7;IBTK;TOP2B;STK38
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.45088456790563536,0.9416806405186777,0.5289256198347108,0.9933853114252089,1.0,2/12,10.81%,B3GALNT1;B3GNT8
prerank,tau protein binding (GO:0048156),0.371338942926026,0.9406259932938685,0.5689851767388826,0.9928776326593266,1.0,9/40,14.68%,DCTN1;FYN;BIN1;STUB1;HDAC6;PPP5C;TAOK2;PIN1;HSP90AA1
prerank,aspartic-type peptidase activity (GO:0070001),0.462361855590919,0.9400946443041475,0.5578800557880056,0.9911889513171058,1.0,4/10,20.53%,PSEN1;NAPSA;CTSD;BACE1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.40890482283338764,0.9392507157959396,0.5815147625160462,0.9903619742603945,1.0,4/20,14.83%,DESI2;COPS5;USP50;USP7
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.39748197699439736,0.9379170801567239,0.5710900473933649,0.9906296438851433,1.0,8/27,16.13%,SLC4A8;SLC9A9;SLC9A1;SLC23A1;SLC8A2;CNNM4;SLC9A6;SLC9A7
prerank,outward rectifier potassium channel activity (GO:0015271),0.44955048567897704,0.9377880094542935,0.5450762829403606,0.9879638341326846,1.0,3/11,7.64%,KCNT2;KCND1;PKD2
prerank,actin binding (GO:0003779),0.32870352171056627,0.9372017935291013,0.6562814070351759,0.9864988892354212,1.0,47/170,21.97%,DBN1;GSN;KCNMA1;CORO2B;SCIN;MAP1B;ANG;TNNI3;COBL;ABLIM1;MSRB1;FHDC1;FSCN1;PDLIM7;SYNE1;PFN2;ABL2;MYO9B;FXYD5;NCALD;TWF1;SSH1;MICAL2;AVIL;MAPT;PDLIM1;FLNB;ADCY8;MOBP;GIPC1;ARPC1A;CAP1;CORO7;CXCR4;EPS8L2;COTL1;MICAL1;PDLIM2;ALDOA;TNNC2;GC;ABITRAM;FMN2;MAP1A;MAP1S;SSH3;SPTBN4
prerank,lipoprotein particle receptor binding (GO:0070325),0.37967203755172535,0.9360614665132577,0.5666266506602641,0.9863581839932524,1.0,3/27,11.21%,LRP1;CLTC;HSPG2
prerank,nuclear receptor coactivator activity (GO:0030374),0.354545363704727,0.9354142943969945,0.5730088495575221,0.9848711732274161,1.0,11/52,12.94%,ZMIZ1;FGF2;SFR1;NCOA3;WDR77;ATXN7L3;MED24;HELZ2;SLC30A9;DCAF6;MED13
prerank,tau-protein kinase activity (GO:0050321),-0.3010627638622317,-0.934953047013058,0.5789473684210527,0.7537683375394112,1.0,7/20,18.72%,MARK1;DYRK1A;MARK3;TTBK1;CDK5;TAOK1;ROCK1
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.2676379566789514,-0.9337029107277577,0.5588235294117647,0.7483729524777414,1.0,6/32,10.32%,KCNB1;KCNB2;KCNS3;KCNQ5;KCNQ1;KCNA1
prerank,NADPH binding (GO:0070402),-0.3454705273516572,-0.9336742002449089,0.5209125475285171,0.7406752932419804,1.0,8/13,24.55%,HMGCR;QDPR;CBR4;NDOR1;LBR;DECR1;CBR3;GRHPR
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.33710935237481027,-0.931563829010109,0.5361216730038023,0.7378836231285093,1.0,5/14,14.33%,MAL;BCL2L13;CASP8AP2;ATP2A3;NOD1
prerank,sodium:proton antiporter activity (GO:0015385),0.45125928824049266,0.9300679688423031,0.5891891891891892,0.9945738504227237,1.0,4/11,16.13%,SLC9A9;SLC9A1;SLC9A6;SLC9A7
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3254993186143783,0.9292406451727291,0.6622983870967742,0.993550079228167,1.0,31/181,14.90%,PRRX1;AR;BHLHE40;NFE2L2;MAPK14;DACT1;TCF7L2;NFATC1;TACC2;PIAS3;NCOA3;TRIP4;MDFIC;ZFPM2;TBX6;BEX1;HDAC3;TCERG1;NPM1;JUP;NCOR2;COMMD6;NCOR1;HDAC4;BCAS3;BBS4;CTDP1;KLF4;DMAP1;TTC8;SMARCA4
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3312919087933305,-0.9268228445882755,0.5595238095238095,0.7400821676954703,1.0,11/15,42.72%,COX4I1;NDUFA4;COX5A;NDUFA4L2;COX4I2;COX6A1;COX6B1;COX7A1;COX5B;COX8A;COX6A2
prerank,pyrophosphatase activity (GO:0016462),0.35196782387999115,0.9264277994366585,0.6076502732240437,0.9974190090951801,1.0,20/50,29.15%,ENTPD2;NUDT1;NUDT7;PLPP5;PLPP1;NUDT16L1;NUDT16;ATCAY;NUDT6;NUDT5;PRUNE2;ENTPD6;CILP;LHPP;PPA1;DHX29;ADPRM;ITPA;PPA2;BNIP2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.3508853889783998,-0.9260009843173763,0.5074626865671642,0.734336351409581,1.0,3/12,7.40%,KDM7A;KDM4A;PHF2
prerank,kinase binding (GO:0019900),0.3193153665385651,0.9252839116869533,0.761,0.9971069374128825,1.0,112/434,24.18%,GHR;GSN;ESR1;LAX1;EGFR;DNM1;DCTN1;PRAM1;CKS1B;IRAK3;ANK2;DGKQ;PDE8A;TNS2;CAMK2N1;TNNI3;STX1A;CLTC;LLGL1;DLG4;HDAC7;ATF5;CD160;ATP1A4;SKI;PKD1;AXIN1;MIDN;MAP2K3;TCF7L2;PTPRJ;FAM83G;TTC28;PRKAB2;RBBP6;DLG2;AP2A2;MAPRE3;CARD16;SRC;TRIP4;BICD1;STX1B;STUB1;SLC12A4;STRADA;GSKIP;SRCIN1;IQGAP1;KAT2B;SQSTM1;IRAK4;NPM1;MAPRE1;FBXO5;MAPT;IRAK1;PIK3IP1;CALM2;SMCR8;ZFP36;CDKN1A;RHOA;CCND1;RND3;TUBA4A;VDAC1;CHP1;CDK5RAP2;NSF;TRIM68;KIZ;PPP1CC;PER1;RAC3;RNF138;TAX1BP1;UFL1;RCC2;ILK;SNAP91;QARS1;DOK7;IBTK;ATG13;CIT;TOLLIP;IL31RA;OXSR1;FLNA;TIAM1;LYST;NISCH;MOB1B;BTG1;CAB39;CDKN2C;ATF4;DCX;SIKE1;STK11IP;DCTN2;CYLD;CDC25B;TNIP2;TRAP1;NR3C1;RELA;VRK2;BAG5;DVL1;LATS1
prerank,voltage-gated anion channel activity (GO:0008308),-0.3278288695198779,-0.9248963721840852,0.5666666666666667,0.7293006369529073,1.0,6/15,17.03%,VDAC3;ANO1;CLCN2;GPR89B;GPR89A;CLCN1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.44179322418335665,0.9235363768368816,0.5572625698324022,0.9983055853847309,1.0,4/12,18.36%,ENTPD2;NUDT5;CANT1;ENTPD6
prerank,single-stranded DNA binding (GO:0003697),0.33017819416725475,0.9199753529047732,0.6303219106957425,1.0,1.0,19/93,18.50%,POLR2H;HNRNPA1;CTC1;RAD51B;RAD23B;IGHMBP2;HMCES;SAMHD1;MCM3;MAPT;ERCC4;POLR2D;POLR2G;DDX11;SMC6;FAM111A;RNF138;ERCC5;BLM
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.3935674006335209,0.9194876278887434,0.5825977301387137,1.0,1.0,5/20,20.02%,SLC39A14;SLC39A13;SLC39A7;SLC30A5;SLC39A3
prerank,ATP hydrolysis activity (GO:0140603),0.3541759247794198,0.9175733828951964,0.5954802259887005,1.0,1.0,12/41,21.05%,VPS4B;ABCG4;CLPX;TOR1A;KIF20B;DNA2;DDX4;HSP90AA1;CHD3;ATP2B1;ATAD1;ABCB10
prerank,syntaxin binding (GO:0019905),0.3447532005158466,0.9170084456297642,0.6164529914529915,1.0,1.0,25/61,26.96%,SYT2;SYT12;SCFD2;ABCA1;VPS52;VAMP1;SCFD1;SNAP23;NAPA;SNAP25;SNAP47;NSF;NAPG;SYT1;SNPH;VPS11;VAMP2;STX16;NAPB;STXBP5L;BAIAP3;STX7;SYT6;STXBP4;VAMP3
prerank,ubiquitin binding (GO:0043130),0.33639849173339154,0.915756903714141,0.6273885350318471,1.0,1.0,21/73,22.16%,UCHL1;CKS1B;RAD23B;MVB12A;UBE2N;ADRM1;SIRT2;USP33;SQSTM1;DNAJB2;USP5;ILRUN;RBCK1;NBR1;CXCR4;AUP1;UBAP1;TOLLIP;VPS36;USP13;UBXN11
prerank,calcium channel regulator activity (GO:0005246),0.35834404339503045,0.9128088226587405,0.6077097505668935,1.0,1.0,9/37,15.16%,SGK3;TNNI3;SRI;STIMATE;YWHAE;MCUB;CALM2;RRAD;GEM
prerank,hexosaminidase activity (GO:0015929),-0.34882387860073905,-0.912501327357264,0.5104166666666666,0.7485256353007408,1.0,2/12,3.25%,CEMIP;CEMIP2
prerank,voltage-gated potassium channel activity (GO:0005249),0.33056652956467897,0.9115888131979318,0.6342494714587738,1.0,1.0,14/80,19.83%,KCNT2;KCNMA1;KCNV1;KCNJ2;KCND1;PKD2;HCN4;KCNA2;KCNA6;KCNJ3;KCNC2;KCNH2;HCN1;KCNF1
prerank,GTP binding (GO:0005525),0.3210033913036861,0.9111975535504074,0.6925403225806451,1.0,1.0,55/172,28.01%,RAB32;RAB6A;GTPBP4;RAP1B;ARF4;SCG5;RIT2;DYNC1LI1;RHOJ;ARF1;RHOQ;RAB2A;TUBB6;NRAS;KRAS;GTPBP10;NUDT16;TUBD1;RRAD;RHOA;RRAGD;RAB27B;RND3;TUBB4A;ARF6;TUBA4A;GEM;GLUD1;RAC3;RAB35;NME1;RAB1B;RRAS2;PIP4K2B;RALA;RAB10;ADSS2;TUBG2;RABL3;NOA1;ARL8A;RAC1;ANXA6;RHOT2;ATL1;RAB29;RHOBTB2;EIF2B2;RND2;TUBB2A;RAP1A;DIRAS2;RHEBL1;TSR1;RAP2B
prerank,nuclease activity (GO:0004518),0.34924838824220766,0.9101758842630521,0.6050328227571116,1.0,1.0,16/52,25.15%,DIS3L2;RNASE4;ANG;N4BP2;SAMHD1;DNA2;RNASE6;ZC3H12A;DNASE1L2;NME1;ERCC5;OGG1;MAP1S;DFFB;RNASE1;DNASE1L1
prerank,cation:chloride symporter activity (GO:0015377),-0.3665894543653664,-0.9080339020841108,0.5767790262172284,0.751106907071779,1.0,3/10,2.97%,SLC12A7;SLC12A2;SLC6A1
prerank,rRNA binding (GO:0019843),0.3556454251791168,0.9075834383824161,0.625560538116592,1.0,1.0,10/42,19.77%,MRPS11;ANG;MRPS27;DDX21;SBDS;RPS5;NOP53;RCC1L;RPF2;RPL23
prerank,Hsp90 protein binding (GO:0051879),0.3597680748397893,0.905166875084883,0.6132858837485172,1.0,1.0,16/33,30.39%,STUB1;HDAC6;PPP5C;ERN1;MAPT;PPEF2;CHORDC1;AHSA1;USP19;NR3C1;TSC2;UNC45A;TSC1;HDAC8;HSF1;TELO2
prerank,GTPase inhibitor activity (GO:0005095),-0.3459349424686581,-0.9041716911979935,0.5682656826568265,0.7516713395054369,1.0,6/13,10.30%,TNK2;IQGAP2;CPEB2;CDC42SE1;ARL2;RHOH
prerank,small GTPase binding (GO:0031267),0.3175827949341543,0.9036072995067099,0.7181544633901705,1.0,1.0,40/169,17.76%,SGSM2;AKAP13;RABGGTA;PLCE1;RABGAP1L;CDC42EP2;DOCK7;WASF1;ABCA1;BICD1;MYO5A;FMNL1;MYO9B;MYCBP2;PARD6A;HPS4;OCRL;IQGAP1;GGA1;USP33;DMXL2;KIF3A;ATP6AP1;KIF3B;HPS6;TMEM127;ULK1;GGA2;TRIOBP;CCDC186;GOLGA4;EVI5;SGSM1;ANKRD27;EVI5L;PEX5L;HACE1;SRGAP2;PEX5;RCC2
prerank,N-acyltransferase activity (GO:0016410),0.36825069128453214,0.9035529246522441,0.6189931350114416,1.0,1.0,7/32,18.12%,CERS6;PLAAT1;GNPNAT1;NAT8;PLA2G4E;SAT1;NAA50
prerank,GTPase binding (GO:0051020),0.3169697123258275,0.9031682619853006,0.728184553660983,1.0,1.0,65/194,25.52%,SGSM2;AKAP13;RABGGTA;PLCE1;RABGAP1L;CDC42EP2;RADIL;DOCK7;WASF1;ABCA1;BICD1;MYO5A;FMNL1;MYO9B;MYCBP2;PARD6A;HPS4;OCRL;IQGAP1;GGA1;USP33;DMXL2;KIF3A;ATP6AP1;KIF3B;HPS6;TMEM127;GNB1;RRAGD;ULK1;HSP90AA1;GGA2;TRIOBP;CCDC186;GOLGA4;SPTBN1;EVI5;SGSM1;ANKRD27;EVI5L;PEX5L;HACE1;SRGAP2;PEX5;RCC2;EPRS1;AIMP1;EXOC4;RASA1;DOCK4;FLNA;RNF41;ATG16L1;SIKE1;LZTR1;ANKFY1;ATG14;PDE6D;ALS2;RAB11FIP3;TSC2;RABGGTB;MAPKAP1;CYFIP1;RAB29
prerank,ubiquitin protein ligase binding (GO:0031625),0.31310578112820053,0.9007937683007687,0.7502507522567703,1.0,1.0,76/254,28.45%,MID1;EGFR;GLMN;UCHL1;UBE2B;UBE2J2;SKI;AXIN1;SYT11;FOXO1;SCAMP3;SMAD5;STUB1;HDAC6;UBE2W;UBE2N;YWHAE;FANCL;CUL3;SMAD6;SQSTM1;UBE2A;UBA52;XRCC5;CDKN1A;GPR37;TNFRSF1B;FHIT;SMC6;HSP90AA1;TRIOBP;USP7;BAG4;FZD4;DIO2;ACTG1;PER1;TRAF3;CXCR4;BLZF1;PML;UBE2G1;AUP1;NEDD8;KCNH2;PRKAR2A;RPL23;ARIH1;RALA;CUL5;ARRB1;JKAMP;USP13;TRAF4;JUN;DERL1;TRAF5;RELA;BAG5;ACVR1B;MDM2;CALR;RTN4;FBXW7;RNF20;UBE2K;EIF4E2;MUL1;RNF31;SMG5;CASP8;BCL10;DNAJA1;CUL1;LAPTM5;NPLOC4
prerank,protein kinase regulator activity (GO:0019887),0.32689494981108336,0.9004762190392657,0.6796315250767656,1.0,1.0,23/95,19.31%,CCNL2;FGF13;TAOK3;PPP1R1B;CXCL10;GPRC5D;STRADA;GSKIP;ELP4;NPM1;CCNC;KIDINS220;SMCR8;CDKN1A;CCND1;CCNH;CCNQ;NCK1;MADD;QARS1;GMFB;DUS2;PRKAR2A
prerank,microtubule motor activity (GO:0003777),0.34437630861480073,0.9002276786855751,0.6328125,1.0,1.0,13/51,19.28%,KIFC2;KIF21B;STARD9;DNAH8;DYNC1I1;KIF2A;KIF20B;KIF3A;KIF21A;KIF3B;KIF26B;CENPE;KIFC3
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.31240729690322394,0.8990684008408205,0.7622868605817452,1.0,1.0,67/269,24.64%,MID1;EGFR;GLMN;UCHL1;UBE2B;UBE2J2;SKI;AXIN1;SYT11;ITCH;FOXO1;SCAMP3;SMAD5;TRIP4;STUB1;HDAC6;UBE2W;UBE2N;YWHAE;FANCL;CUL3;SMAD6;SQSTM1;UBE2A;UBA52;XRCC5;CDKN1A;GPR37;TNFRSF1B;FHIT;SMC6;HSP90AA1;TRIOBP;USP7;BAG4;FZD4;DIO2;ACTG1;PER1;TRAF3;CXCR4;BLZF1;PML;UBE2G1;AUP1;NEDD8;KCNH2;PRKAR2A;RPL23;ARIH1;RALA;CUL5;ARRB1;JKAMP;USP13;TRAF4;JUN;DERL1;STAT2;TRAF5;RELA;BAG5;STAM;ACVR1B;MDM2;CALR;RTN4
prerank,nuclear receptor binding (GO:0016922),0.3184909679828253,0.8981292078863098,0.6887755102040817,1.0,1.0,41/111,27.20%,ESR1;FOXP1;TCF7L2;TACC2;PRMT2;NCOA3;TRIP4;GAS2L1;MED24;JUP;NCOR2;MED13;NCOR1;DCAF13;BCAS3;SMARCA4;RNF14;TRIM68;STAT5B;PADI2;DDX5;NRIP1;JMJD1C;THRAP3;NSD1;TMF1;BAZ2A;RNF6;NCOA2;KDM4C;ASXL1;LCOR;LATS1;NCOA6;CALR;KDM3A;BRD8;PRPF6;MMS19;GRIP1;ARID1A
prerank,sodium channel activity (GO:0005272),0.35904725401799886,0.8974421581549206,0.6232718894009217,1.0,1.0,13/37,28.37%,SCNN1B;PKD2;HCN4;ASIC2;SCN4B;HCN1;ASIC1;SCN9A;GRIK5;GRIK2;GRIK4;SCN2A;CACNA1H
prerank,solute:anion antiporter activity (GO:0140323),0.4156439394313642,0.8970493503530851,0.6091644204851752,0.9984380244267285,1.0,4/14,11.54%,SLC26A5;SLC26A11;SLC4A3;SLC26A6
prerank,thioesterase binding (GO:0031996),0.4374927592554268,0.8959502641889653,0.6239436619718309,0.9980660375415636,1.0,6/11,30.35%,ARF6;TRAF3;TRAF4;TRAF5;RAC1;TRAF6
prerank,phosphoric diester hydrolase activity (GO:0008081),0.35767379269005223,0.8955780554911887,0.6301050175029171,0.9961983329253682,1.0,9/35,20.05%,SMPD3;PLCE1;PLCB4;PDE11A;MPPE1;PDIA3;SMPD1;GPLD1;GDPD3
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.37275265314650224,0.8943526726299234,0.608440797186401,0.9960616435400323,1.0,6/28,18.00%,RPS6KA2;MAPK14;MAP2K3;AKT1;MAP2K2;MAP2K4
prerank,alpha-tubulin binding (GO:0043014),0.36463504476982067,0.8942984789414633,0.6314553990610329,0.9934240668114042,1.0,7/31,14.38%,FYN;DLEC1;HDAC6;TBCEL;SETD2;INO80;BBS4
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.3435536342753933,0.8940949363013088,0.6513661202185792,0.9910567163678808,1.0,6/53,5.44%,SLC1A5;SLC1A7;SLC7A6;SLC1A6;SLC47A1;SLC43A2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.31679987211961214,0.8940471406239553,0.6834016393442623,0.9884418779998042,1.0,25/100,20.32%,SESTD1;NCF4;GAP43;MYO10;PLEKHF1;ATG2B;ARHGAP9;CLVS2;IQGAP1;WIPI2;PLEKHA4;WDR45B;PLEKHB2;AKT1;SNX21;MAPT;ATG2A;DENND1A;PLA2G4E;OGT;ARAP1;ANXA8;BBS5;CLVS1;GAB2
prerank,fatty acid synthase activity (GO:0004312),-0.3626441102880279,-0.8920787922781704,0.5901060070671378,0.7698455409280395,1.0,5/10,18.60%,ELOVL7;CBR4;ELOVL1;ELOVL4;OXSM
prerank,UDP-galactosyltransferase activity (GO:0035250),0.44394997461793084,0.890298754043955,0.6265734265734266,0.9934254308465474,1.0,1/10,2.23%,B4GALT1
prerank,tRNA binding (GO:0000049),0.3453949830844934,0.8897961967118992,0.6522222222222223,0.9916953473948861,1.0,14/43,21.95%,IGHMBP2;DALRD3;MRPS27;YRDC;SARS2;PSTK;ELP1;TRMT10B;AIMP1;TYW5;PTCD1;XPOT;NEMF;EIF2A
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4140006290589802,0.8866211680367683,0.6306892067620286,0.9957199603546498,1.0,2/15,5.56%,PIK3R2;SOCS2
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.30966059666022544,0.8858047104658593,0.7837837837837838,0.9947498424324139,1.0,73/232,24.63%,SH3RF3;SMURF2;NEURL4;SYVN1;ITCH;TRIM71;RFWD3;CBX4;RNF121;PIAS3;RBBP6;MSL2;COP1;RNF111;PELI3;RC3H1;STUB1;RNF2;MYCBP2;FBXO2;MYLIP;FANCL;SIAH1;FBXO17;CUL3;ASB12;HECW2;RNF10;TRIM11;IRF2BPL;RNF7;LTN1;BSPRY;TRAF3IP2;CBL;UBR4;AMFR;RNF128;UHRF2;RNF216;RNF14;TRIM68;RNF187;RNF138;HACE1;UFL1;ARIH2;VPS11;BRAP;RNF19A;MEX3C;RING1;LRSAM1;TRIM35;UBE3C;ARIH1;UBE2D3;RNF41;RC3H2;CBLB;SMURF1;DTX2;UBE3A;UBR2;RNF6;RNF114;RNF157;NSMCE2;RNF13;TRIM24;TRIM44;MDM2;MKRN2
prerank,hyaluronic acid binding (GO:0005540),0.43452534449812275,0.8803390575945752,0.6352112676056338,1.0,1.0,2/10,6.78%,CD44;C1QBP
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.4213175454324404,0.8779415578953643,0.6428571428571429,1.0,1.0,4/12,16.13%,SLC9A9;SLC9A1;SLC9A6;SLC9A7
prerank,poly(U) RNA binding (GO:0008266),0.37478348365894765,0.8770092132840277,0.6500638569604087,1.0,1.0,3/20,10.68%,DIS3L2;RBMS3;HNRNPH1
prerank,phosphatidic acid binding (GO:0070300),0.38748827109005346,0.8758554605873498,0.6481958762886598,1.0,1.0,2/19,1.04%,SESTD1;SMPD3
prerank,ephrin receptor binding (GO:0046875),0.38220059306404003,0.8754215564040045,0.6604938271604939,1.0,1.0,4/21,6.79%,EFNA5;FYN;ANKS1B;SRC
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.3535272704792822,0.8749587912935091,0.6602052451539339,1.0,1.0,16/35,29.75%,FOXP1;AGO2;NPM1;UBTF;DR1;SMARCA4;RRN3;BAZ2A;TBP;NR3C1;RELA;KLF10;SNAPC3;AGO1;TP53;FOS
prerank,protein phosphatase 2A binding (GO:0051721),-0.2779565348190376,-0.8749043893983316,0.6623376623376623,0.7975485746873469,1.0,5/23,4.14%,CTTNBP2NL;STRN3;DAB2IP;STRN;BOD1L1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3931224951075117,0.8748452656346055,0.6475300400534045,0.9982091964157581,1.0,8/17,30.95%,NME2;CMPK2;AK8;NME1;AK9;NME6;AK3;AK5
prerank,hydro-lyase activity (GO:0016836),0.33726471837692623,0.8746342939604387,0.683066361556064,0.9960316171759691,1.0,6/41,15.61%,EHHADH;CYP2S1;AUH;ACO2;CDYL;HACD3
prerank,phosphatase activity (GO:0016791),0.3221806535864537,0.8744658775105518,0.7014925373134329,0.993750287724173,1.0,23/73,23.62%,PLPP3;ACP2;PTPRJ;PLPP5;NT5M;PLPP1;BPNT2;PPP5C;OCRL;DUSP11;NUDT16L1;INPP5K;NUDT16;PGAM5;PLPPR3;PHOSPHO2;PPP1CC;PLPP2;LPIN3;ACP3;CILP;LHPP;ACP6
prerank,CARD domain binding (GO:0050700),-0.32298349959347245,-0.8735385729234537,0.6293436293436293,0.792654695870104,1.0,9/14,27.33%,CASP4;MAVS;NOD1;CARD19;IRGM;NOD2;RIPK2;CARD14;CASP1
prerank,intracellular chloride channel activity (GO:0061778),0.39768644281856735,0.8724075282218623,0.6355382619974059,0.9926453606854784,1.0,3/16,17.70%,ANO3;TTYH3;ANO5
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.39768644281856735,0.8724075282218623,0.6355382619974059,0.9926453606854784,1.0,3/16,17.70%,ANO3;TTYH3;ANO5
prerank,PDZ domain binding (GO:0030165),0.32265407558433995,0.8693860017220905,0.6976241900647948,0.9962026601005228,1.0,22/61,21.85%,CCDC88C;DLG4;ATP2B4;GNG12;FZD7;PSEN1;SLC26A6;TBC1D10A;KIDINS220;PLEKHA1;CRIPT;ACOX1;MAP2K2;FZD4;NSF;SDC2;ATP2B1;SNTG2;CIT;DOCK4;PTEN;SRR
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.3493978432595485,-0.8693263366956381,0.6141479099678456,0.7934733251995493,1.0,3/10,13.98%,LACC1;ADARB2;APOBEC1
prerank,potassium ion antiporter activity (GO:0022821),-0.30988810487822205,-0.8691276626883383,0.5911111111111111,0.7865130851861668,1.0,2/15,2.40%,SLC24A3;SLC9A2
prerank,transcription cis-regulatory region binding (GO:0000976),0.2988043525301195,0.8689401465850825,0.868,0.9944451006777705,1.0,61/406,17.09%,LMX1A;AR;LHX8;TRPS1;BNC2;WT1;SCRT2;HSF2;RUNX1;PBX1;FOXP1;GLIS2;ZNF25;SMAD4;NFE2L2;ATF5;LMX1B;MEF2D;SOX10;CREB3L1;FOXK2;JUND;TCF7L2;RBAK;NR1D1;CREBZF;MTF1;SATB2;SOX5;FOXC2;AGO2;SMAD6;BRD7;RNF10;ZNF3;MZF1;NPM1;GLI3;CEBPB;XRCC5;ATF1;DR1;NCOR1;PEG3;IKZF5;TWIST1;SIX1;RFX5;HDAC4;PLAGL1;KLF4;MLXIP;SNAI2;NR2C2;E2F3;ZBTB5;CDK5RAP2;PER1;E4F1;CHD3;TFAP4
prerank,ion channel activity (GO:0005216),0.3171207999245138,0.8681510898937632,0.7315296566077003,0.9932810674926712,1.0,22/80,25.07%,PIEZO2;TRPV3;TMEM63A;GRIN3A;GRIN2D;PKD2;GRIA2;CNGB1;MCUB;TMEM120A;CALHM2;TMC3;GRID1;GRIN2A;CHRNA7;CHRNA5;GRIA3;GRIK5;GRIK2;TRPC1;ANXA6;GRIK4
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.4246353650381464,0.8649555340677139,0.6419400855920114,0.9966516084040453,1.0,4/10,21.30%,SETD2;SETD5;PRDM9;NSD1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.4142816471232127,0.864363768205144,0.6480218281036835,0.9951972345528579,1.0,4/12,20.53%,PSEN1;SPPL2B;NAPSA;BACE1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.2990013770773107,0.8624340325098107,0.7901606425702812,0.9964518855876788,1.0,36/188,19.09%,AR;BNC2;WT1;RUNX1;PBX1;GLIS2;SMAD4;NFE2L2;ATF5;SOX10;CREB3L1;FOXK2;JUND;TCF7L2;NR1D1;CREBZF;SOX5;FOXC2;SMAD6;BRD7;RNF10;MZF1;CEBPB;XRCC5;NCOR1;SIX1;HDAC4;KLF4;CDK5RAP2;PER1;CHD3;TFAP4;CTCF;ZBED4;KCNH2;PRDM9
prerank,cysteine-type peptidase activity (GO:0008234),0.3138977565356301,0.8617566524788116,0.7078059071729957,0.9950823105890507,1.0,13/73,15.23%,UCHL1;CAPN2;USP36;USP10;USP29;USP26;USP33;OTUD7B;USP48;USP50;USP5;USP7;PDIA3
prerank,ATPase regulator activity (GO:0060590),0.34116715633102657,0.8596639422901117,0.658454647256439,0.9963409997165272,1.0,14/38,28.98%,TOR1AIP2;DNAJA2;GRPEL2;DNAJB2;BAG4;AHSA1;DNAJB1;BAG3;BAG5;HSPH1;TSC1;DNAJA1;FNIP1;DNAJC1
prerank,Tat protein binding (GO:0030957),0.42879343376615725,0.8550907465866541,0.6680384087791496,1.0,1.0,4/10,14.90%,MDFIC;NPM1;CTDP1;SMARCA4
prerank,MAP kinase kinase kinase activity (GO:0004709),0.4184318034295263,0.8534050732231286,0.6582984658298466,1.0,1.0,3/11,13.08%,EGFR;MAP3K6;TAOK2
prerank,mRNA methyltransferase activity (GO:0008174),0.4060917211276219,0.8533116049622572,0.6734972677595629,1.0,1.0,4/12,22.69%,TRMT61A;CMTR2;PCIF1;RNMT
prerank,acyl-CoA hydrolase activity (GO:0047617),0.38886526940554367,0.8510510114082075,0.672090112640801,1.0,1.0,3/17,14.47%,ACOT6;ACOT9;ACOT1
prerank,ubiquitin protein ligase activity (GO:0061630),0.2971753625539766,0.8492983600994505,0.8517034068136272,1.0,1.0,76/228,26.73%,SH3RF3;SMURF2;NEURL4;SYVN1;ITCH;TRIM71;RFWD3;RNF121;RBBP6;MSL2;COP1;RNF111;PELI3;RC3H1;STUB1;RNF2;MYCBP2;FBXO2;MYLIP;FANCL;SIAH1;FBXO17;CUL3;ASB12;HECW2;RNF10;TRIM11;IRF2BPL;RNF7;LTN1;BSPRY;TRAF3IP2;CBL;UBR4;AMFR;RNF128;UHRF2;RNF216;RNF14;TRIM68;RNF187;RNF138;HACE1;ARIH2;VPS11;BRAP;RNF19A;MEX3C;RING1;LRSAM1;TRIM35;UBE3C;ARIH1;UBE2D3;RNF41;RC3H2;CBLB;SMURF1;DTX2;UBE3A;UBR2;RNF6;RNF114;RNF157;RNF13;TRIM24;TRIM44;MDM2;MKRN2;RNF166;ZNRF2;UBE2K;RNF167;RNF126;MUL1;PRPF19
prerank,muscle alpha-actinin binding (GO:0051371),0.3884984269468057,0.8464713488851338,0.6729222520107239,1.0,1.0,5/15,19.12%,PDLIM7;PKD2;PDLIM1;PALLD;PDLIM2
prerank,metal ion:proton antiporter activity (GO:0051139),0.3986152341817952,0.8449383895712208,0.6600265604249668,1.0,1.0,4/13,16.13%,SLC9A9;SLC9A1;SLC9A6;SLC9A7
prerank,NADP binding (GO:0050661),-0.24131401783295078,-0.8446379796281375,0.7445255474452555,0.8266401461829654,1.0,16/32,22.78%,GMDS;DPYD;NOS3;HMGCR;QDPR;CBR4;NOS1;SPR;NDOR1;CRYZL1;DHCR7;LBR;DECR1;CBR3;TM7SF2;HSD11B1
prerank,transmitter-gated ion channel activity (GO:0022824),0.345958323285061,0.8434621180808727,0.6929411764705883,1.0,1.0,13/29,30.46%,GRIN2D;GRIA2;GABRG3;GRID1;GABRG2;GRIK5;GRIK2;GRIK4;GABRA3;GLRA3;GRID2;GABRA1;GLRA2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.25999505426357084,-0.8434242825142729,0.7120418848167539,0.8211756355837835,1.0,8/27,14.41%,SIAH2;PPARA;UBE3D;RNF144B;DCUN1D4;RNF180;DCUN1D3;SIAH3
prerank,protein kinase activator activity (GO:0030295),0.31726757461417987,0.8431648760956392,0.7245444801714899,1.0,1.0,13/60,16.41%,FGF13;ETAA1;GPRC5D;GAS6;STRADA;ABI1;IQGAP1;CALM2;CDKN1A;DBF4;STK3;MAP2K2;MADD
prerank,thyroid hormone receptor binding (GO:0046966),0.3484138062024523,0.8407174300992217,0.6930455635491607,1.0,1.0,11/28,26.23%,PRMT2;NCOA3;GAS2L1;MED24;MED13;NCOR1;JMJD1C;THRAP3;NSD1;NCOA6;BRD8
prerank,metal ion transmembrane transporter activity (GO:0046873),0.3471616870746796,0.8382446015072115,0.7062350119904077,1.0,1.0,9/27,17.59%,SLC4A8;ATP2B4;SLC11A2;SLC23A1;SLC8A2;CNNM4;TUSC3;TMEM165;ATP2B1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4187299286250763,0.8362402580943982,0.6704225352112676,1.0,1.0,4/10,22.93%,NAA15;NAA50;NAA20;NAA30
prerank,steroid hydroxylase activity (GO:0008395),0.3763821647447861,0.835387017526483,0.6952506596306068,1.0,1.0,1/16,1.46%,CYP2S1
prerank,carboxylic acid binding (GO:0031406),0.3303838519460204,0.8342332249017982,0.7222222222222222,1.0,1.0,10/38,22.74%,GCLC;GRIN3A;SESN3;GLUD1;EPDR1;GLDC;CASTOR2;SRR;SESN2;UBR2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.40539169100427824,0.8332711015481882,0.6657496561210454,1.0,1.0,4/11,22.93%,NAA15;NAA50;NAA20;NAA30
prerank,chloride channel inhibitor activity (GO:0019869),0.41235998204954377,0.8322884641253112,0.6792452830188679,1.0,1.0,7/10,34.50%,STX1A;WNK2;STX7;CFTR;STX8;VAMP8;WNK3
prerank,actin monomer binding (GO:0003785),0.352766958341629,0.8321275287471872,0.7019464720194647,1.0,1.0,4/22,10.48%,COBL;PFN2;ABL2;TWF1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.31251941590097915,0.8306818325178238,0.7579408543263965,1.0,1.0,14/54,20.14%,HDAC9;HDAC6;SIRT2;HDAC3;NIT2;GLS2;GLS;HDAC4;NGLY1;NTAN1;ASRGL1;NIT1;SUDS3;MIER1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.30669796640943425,0.8282424378004045,0.7644584647739222,1.0,1.0,19/74,19.35%,PAPSS2;DGKQ;PIK3C2B;MVK;GK5;CHKB;GALK1;PIK3CA;AGK;PGM2L1;PI4KB;PI4KA;PANK1;PKM;TRPT1;IPPK;DCAKD;GNE;PANK3
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.38487230460672917,0.8231098025308243,0.6921052631578948,1.0,1.0,3/13,14.59%,DNA2;FAN1;DNASE1L2
prerank,MAP-kinase scaffold activity (GO:0005078),0.3970001333491471,0.822363078018186,0.6956521739130435,1.0,1.0,3/11,15.56%,AKAP13;IQGAP1;MAP2K2
prerank,phosphatase activator activity (GO:0019211),0.37737429649855797,0.8205346834956363,0.6968876860622463,1.0,1.0,4/14,17.38%,B3GAT3;CALM2;GTF2F1;PPP2R5B
prerank,magnesium ion binding (GO:0000287),0.29206431913775305,0.8200286935681672,0.84375,1.0,1.0,44/135,29.00%,GCLC;DIS3L2;MAPK12;IRAK3;FOXK2;MVK;IDH1;ABL2;EYA2;UBA2;ERN1;DYRK2;MAP3K6;NUDT16;CERK;FAN1;STK3;GEM;NUDT5;NME1;ADPRH;STK38;RP2;IDH3G;XYLT2;OXSR1;STK26;SRPK1;SRR;PI4K2A;ADCY2;MTHFD2;LATS1;MARK2;XXYLT1;PPA1;MAST2;PLSCR3;MSH6;PSPH;DUT;PPA2;PGP;HMGCL
prerank,gamma-tubulin binding (GO:0043015),0.3506492664615382,0.8198433637483822,0.7348484848484849,1.0,1.0,7/21,29.77%,RAB11FIP5;BLOC1S2;CDK5RAP2;TUBGCP5;RAD51D;ARHGEF7;TUBGCP3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3524566039645398,0.8194346875992278,0.7391841779975278,1.0,1.0,11/24,30.17%,ZDHHC7;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;ZDHHC18;ZDHHC8;YKT6;ZDHHC15;GOLGA7B
prerank,peptide hormone receptor binding (GO:0051428),0.3952726990348763,0.8191230044689279,0.7018030513176144,1.0,1.0,1/11,7.52%,ADCYAP1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.33213585065332357,0.8187487685665084,0.7305458768873403,1.0,1.0,2/32,5.44%,SLC1A5;SLC43A2
prerank,ATPase activator activity (GO:0001671),0.3580843263103315,0.818729153664595,0.7239263803680982,0.9985331981558047,1.0,5/20,20.00%,TOR1AIP2;DNAJA2;DNAJB2;AHSA1;DNAJB1
prerank,calcium channel inhibitor activity (GO:0019855),-0.3217745435853611,-0.8185955066363797,0.6917808219178082,0.8587810937227398,1.0,1/11,0.07%,ITPR1
prerank,3'-5' exonuclease activity (GO:0008408),0.319867392769927,0.8175986791557603,0.7464324917672887,0.9978793588647841,1.0,6/45,12.70%,REV3L;DIS3L2;ERI3;EXOSC7;RAD1;REXO2
prerank,DNA binding (GO:0003677),0.27953160358367285,0.8165848030211584,0.981,0.9970367497841551,1.0,147/694,22.04%,MPG;FOXP2;IRF4;EGFR;C1D;POLR2H;WT1;MEOX2;HNRNPA1;HIVEP2;ANG;CTC1;TSHZ2;PBX1;KLF12;TRNP1;SMAD4;NFE2L2;TIPIN;ATF5;RAD51B;SOX10;FOXK2;KLF2;TCF7L2;MAFF;COLEC11;MEIS2;RAD23B;HOXA5;FOXO1;JRKL;NFIB;CREBZF;MND1;CGAS;TARDBP;IGHMBP2;GLI2;AIFM2;MLXIPL;MTF1;TBX6;PHF1;HMCES;FOXL1;MSL3;SPTY2D1;SOX8;NR6A1;VDR;CDK9;FOXC2;SYCP2;DNASE2;RYBP;POLG2;SAMHD1;SMC1A;BCL6;CHD2;ZNF3;MCM3;CSRNP3;CEBPB;MAPT;SLPI;DNA2;ERCC3;LIN9;FAN1;XRCC5;ERCC4;RAD1;CCDC25;QRICH1;POLR2D;KDM5B;GTF3C2;DDB1;POLR2G;TERF1;DDX11;SIX1;RFX5;CR2;ZC3H12A;BRIP1;NME2;SMC6;INO80;EZH1;HDAC4;PLAGL1;FANCG;NBN;DNASE1L2;PLAGL2;HOXA7;CHD8;SMARCA4;POU3F2;FAM111A;SNAI2;NUPR1;NR2C2;E2F3;RPL6;HMGB3;PSIP1;CENPC;RNF138;BCLAF3;CHD3;TFAP4;NUFIP1;ILF2;RAD50;RBM6;ERCC5;CTCF;BLM;POLD1;TINF2;SUPV3L1;PRDM9;SREBF1;RORA;DCLRE1A;GLYR1;TAF6L;ATF6;REPIN1;OGG1;MBD1;FOXO4;RC3H2;THRAP3;KDM2B;KIN;ZEB2;CLSPN;MAP1S;TFCP2;ZMYM3;PMS1;ATF4
prerank,histone acetyltransferase activity (GO:0004402),0.33128849175264735,0.8150663241121738,0.7108721624850657,0.9971482734071306,1.0,12/30,25.29%,NCOA3;MCM3AP;KAT2B;KAT14;SRCAP;USP22;NAA50;ARRB1;KAT6B;BAZ1A;KAT7;KAT5
prerank,organic anion transmembrane transporter activity (GO:0008514),0.290809001387326,0.814969080943327,0.8361981799797775,0.9949627374255046,1.0,18/134,13.12%,SLCO2A1;SLC1A5;SLC25A21;SLC1A7;SLC26A5;SLC4A8;SLC25A25;SLC4A3;SLC6A8;SLC35B1;SLC26A6;SLC2A10;SLC35D1;SFXN1;SLC7A3;ABCC1;SLC23A1;SLC23A2
prerank,ion channel inhibitor activity (GO:0008200),0.3212634011619779,0.8141326968282886,0.7421236872812136,0.9939942788611513,1.0,6/35,12.36%,KCNV1;TNNI3;STX1A;CAMK2D;MCUB;CALM2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.33529172399152796,0.813628182311148,0.7337349397590361,0.9924578256894524,1.0,11/28,30.20%,GABRG3;GRID1;CHRNA7;CHRNA5;GABRG2;GRIK5;GRIK2;GRIK4;GABRA3;GRID2;GABRA1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.3943167828162874,0.8113948984632802,0.7190201729106628,0.9937332868065897,1.0,2/11,18.10%,CHRNA7;CHRNA5
prerank,anion channel activity (GO:0005253),0.3057850526505308,0.8092779755560884,0.7744360902255639,0.9946547289146987,1.0,11/61,19.52%,ANO3;LRRC8D;CLCN5;GABRR3;VDAC2;CLCC1;GABRG3;TTYH3;VDAC1;ANO5;GABRG2
prerank,voltage-gated calcium channel activity (GO:0005245),0.3175318559497396,0.8069750782851001,0.7350620067643743,0.9958537760745347,1.0,7/37,14.16%,CACNA2D2;PKD2;ITGAV;CACNG2;CACHD1;CATSPER3;CACNB1
prerank,lysine N-methyltransferase activity (GO:0016278),0.3500706386554665,0.8066742199415928,0.7101631116687579,0.9939414972130253,1.0,7/20,26.53%,SETD7;SETD2;ANTKMT;EHMT2;EEF2KMT;KMT5A;EEF1AKMT3
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.3013998503516334,-0.8053536242952762,0.7037037037037037,0.8736566157157888,1.0,5/12,19.82%,BCL2L13;CASP8AP2;ATP2A3;NOD1;CTSH
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.340507566713565,0.8012506520070521,0.7419753086419754,1.0,1.0,2/23,4.82%,PLCE1;PLCB4
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.34413651147365004,0.7996585874502621,0.7459926017262639,1.0,1.0,6/22,16.28%,ATP6V0A2;ATP6V1E1;ATP2A2;ATP6V1D;ATP6V0A1;ATP6V1B2
prerank,C2H2 zinc finger domain binding (GO:0070742),0.37903595851464783,0.7988137632335836,0.7449856733524355,0.9989574327589619,1.0,1/11,1.47%,WT1
prerank,cation channel activity (GO:0005261),0.28931148850977423,0.7977008692068598,0.8322981366459627,0.9984214030616256,1.0,11/94,10.53%,KCNK5;PIEZO2;ANXA2;PKD1;TRPV3;TMEM63A;PKD2;PSEN1;MCU;KCNK9;KCNA2
prerank,protein phosphatase regulator activity (GO:0019888),0.30282301712943016,0.7927915298712606,0.7866520787746171,1.0,1.0,14/53,18.91%,PPP1R1B;PPP6R2;RCAN3;B3GAT3;RCAN1;MGAT5;SAG;CALM2;SHOC2;PPP2R1B;PPP1R9B;PPP2R5B;SET;PPP2R2A
prerank,amino acid binding (GO:0016597),0.3224165415397696,0.7907187573312529,0.7650531286894924,1.0,1.0,2/31,5.20%,GCLC;GRIN3A
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.36282234938929964,0.7904043947504578,0.7456953642384105,1.0,1.0,6/16,25.65%,ATP6V0A2;ATP6V1D;ATP6V0A1;ATP6V1B2;ATP6V0B;ATP5F1B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.36282234938929964,0.7904043947504578,0.7456953642384105,1.0,1.0,6/16,25.65%,ATP6V0A2;ATP6V1D;ATP6V0A1;ATP6V1B2;ATP6V0B;ATP5F1B
prerank,cadherin binding (GO:0045296),0.2735452665161103,0.7898807356826222,0.947,0.9987263254062491,1.0,81/315,22.73%,DBN1;CDH26;AHNAK;EGFR;ANXA1;PFKP;PKP3;ANXA2;DIAPH3;HDLBP;STX5;MPP7;SPTAN1;ACVR1;PTPRJ;PPL;FSCN1;SRC;IDH1;SNX1;CAST;ABI1;SLK;USO1;YWHAE;FXYD5;SH3GL1;PSEN1;IQGAP1;PDXDC1;CDH22;TWF1;PAICS;MAPRE1;ZC3HAV1;PDLIM1;TBC1D10A;VASN;JUP;FLNB;LARP1;SFN;SCYL1;CBL;ATXN2L;TNKS1BP1;STK24;CTNND2;ARGLU1;EIF3E;GIPC1;PI4KA;RSL1D1;RPL6;EVPL;PKM;NCK1;SPTBN1;EPS8L2;EEF1G;AHSA1;CKAP5;PUF60;SHTN1;LASP1;STK38;UBFD1;ALDOA;DNAJB1;LDHA;RAB10;FLNA;ATIC;CCS;CTTN;EIF2A;CTNNA3;BAG3;PLEC;YWHAB;SEPTIN9
prerank,glutamate receptor activity (GO:0008066),0.3441218810464903,0.7896944160021373,0.7540983606557377,0.9966945976062391,1.0,9/19,27.98%,GRIN2D;GRIA2;GRID1;GRM1;GRIK5;GRIK2;GRIK4;GRM5;GRID2
prerank,kinase activator activity (GO:0019209),-0.23017467502431999,-0.7896699813442956,0.8205128205128205,0.8923901510528535,1.0,4/30,6.73%,PRKAG2;GPRC5C;RGCC;RPTOR
prerank,secondary active transmembrane transporter activity (GO:0015291),0.30237780876970255,0.7871215015835661,0.7973421926910299,0.9982843456437556,1.0,10/51,16.85%,SLCO2A1;SLC35E3;MCU;SLC25A16;SLC16A10;SLC4A4;SLC35D1;SLC25A3;SLC20A1;SLC35E1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.31302236469649325,0.7860774234189748,0.7879133409350056,0.9974544169516633,1.0,4/38,6.52%,IRS1;AXIN1;SPATA2;SH2B1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.29471042792126156,0.7853971754283284,0.7904451682953312,0.9961816238714205,1.0,13/55,17.59%,ANXA2;PKD1;TRPV3;ATP2B4;PKD2;PSEN1;MCU;ATP2A2;SLC8A2;SEC61A1;TMEM165;CHRNA7;ATP2B1
prerank,exoribonuclease activity (GO:0004532),0.38569237980640914,0.7849425243627178,0.7436582109479306,0.994570265542338,1.0,3/12,13.85%,EXOSC7;EXOSC1;ZC3H12A
prerank,ADP binding (GO:0043531),0.32729143650665377,0.7836097642535341,0.7575392038600723,0.994486455325889,1.0,4/25,10.51%,GCLC;MYO9B;PPP5C;ERN1
prerank,four-way junction DNA binding (GO:0000400),0.35089510976680877,0.7812360221765325,0.7669270833333334,0.9957473087494041,1.0,7/17,27.79%,XRCC3;RAD51B;HMGB3;BLM;RAD51D;MSH6;MEN1
prerank,H4 histone acetyltransferase activity (GO:0010485),0.38686293783940195,0.7807529044859647,0.7586206896551724,0.9941456075322745,1.0,3/10,18.12%,MSL3;USP22;NAA50
prerank,poly-pyrimidine tract binding (GO:0008187),0.3243042675497413,0.7801674344705735,0.7801242236024845,0.9927050175288925,1.0,3/23,10.68%,DIS3L2;RBMS3;HNRNPH1
prerank,retinoic acid receptor binding (GO:0042974),0.3516393468596648,0.7794487046602269,0.776,0.9914600585113559,1.0,7/17,25.84%,PRMT2;VDR;NRIP1;NSD1;ASXL1;NCOA6;RARG
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.3224906353375175,0.7791930480597006,0.7785800240673887,0.9896234000291444,1.0,6/30,12.41%,CARD16;GAS6;CAST;DPEP1;CSTB;CD27
prerank,nuclear export signal receptor activity (GO:0005049),-0.2890954884781712,-0.7788461647837778,0.7251655629139073,0.9012508097366526,1.0,4/11,26.51%,XPO5;NUP214;XPO1;CSE1L
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3840659629201614,0.7788350654928048,0.7763888888888889,0.9879145915485509,1.0,2/11,20.51%,PADI2;DDAH2
prerank,acetylcholine receptor activity (GO:0015464),0.32904162387657876,0.7778976752242807,0.7678132678132679,0.986964970683446,1.0,3/22,18.10%,CHRNA7;CHRFAM7A;CHRNA5
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.33871301788208796,0.7777943900051011,0.7720588235294118,0.9849079852897175,1.0,4/22,10.36%,ZRANB1;ZBTB1;SQSTM1;OTUD7B
prerank,neuropeptide binding (GO:0042923),-0.26167449826603106,-0.7756603461683116,0.7818181818181819,0.8980536599385992,1.0,10/18,40.21%,SORL1;OPRK1;OPRM1;NMUR2;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.34344740133472795,0.775660022442134,0.7730769230769231,0.9857803957980656,1.0,4/17,16.73%,BLVRB;TECR;PTGR1;BDH2
prerank,transaminase activity (GO:0008483),0.37267128200781285,0.7744261487056412,0.7553342816500711,0.9852634105095546,1.0,3/11,20.76%,BCAT1;PSAT1;GOT1
prerank,nucleotidase activity (GO:0008252),0.3516425553070055,0.7735781288686823,0.7430093209054593,0.9842886225056146,1.0,4/15,21.18%,NT5M;BPNT2;ACP3;NT5DC2
prerank,estrogen receptor binding (GO:0030331),0.310143763028747,0.7722761694800016,0.8020833333333334,0.9839083769846808,1.0,10/32,24.28%,ESR1;PRMT2;TRIP4;DCAF13;PADI2;NRIP1;NSD1;LCOR;LATS1;NCOA6
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.3379404407424369,0.7718765494486842,0.756857855361596,0.9823148478331631,1.0,9/19,30.20%,GABRG3;GRID1;GABRG2;GRIK5;GRIK2;GRIK4;GABRA3;GRID2;GABRA1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.28404455651060595,0.7716676984410816,0.8383733055265902,0.9804214422790559,1.0,11/85,20.05%,MGLL;CEL;PLAAT1;LCAT;PON3;APMAP;PLA2G4E;DAGLB;PTRH2;LIPC;GDPD3
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.30099172540075014,-0.7710378951964498,0.7749077490774908,0.8969910020050016,1.0,2/11,10.21%,KCND3;KCNQ1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.33970167212570257,0.7700868349710424,0.7829457364341085,0.9805234352259702,1.0,7/18,24.28%,TGFBR2;ACVR1;AMHR2;TGFBR1;ACVR2A;BMPR1A;ACVR1B
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.31070410626629025,0.7652307217578053,0.7921348314606742,0.9850737003533114,1.0,4/33,12.70%,DIS3L2;ERI3;EXOSC7;REXO2
prerank,NF-kappaB binding (GO:0051059),0.31874985939108896,0.7639122585926672,0.7772277227722773,0.984587781631623,1.0,9/24,31.53%,HDAC3;NPM1;COMMD6;ANXA4;CPNE1;RELA;BCL10;BRMS1;CDK5RAP3
prerank,phosphatidylcholine transporter activity (GO:0008525),0.3437635065863255,0.7593930938144607,0.7803030303030303,0.9884254396726572,1.0,2/17,6.10%,ATP8B1;ABCA1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.31894092314330735,0.7588835879900007,0.7944038929440389,0.9869397521306038,1.0,7/25,20.32%,SESTD1;PLEKHA4;AKT1;PLEKHA1;PLA2G4E;ANXA8;GAB2
prerank,calcium channel activity (GO:0005262),0.274587227136834,0.7566716607770206,0.8695652173913043,0.9877139020621395,1.0,24/84,27.41%,CACNA2D2;ANXA2;PKD1;TRPV3;PKD2;PSEN1;MCU;ITGAV;CACNG2;CACHD1;CATSPER3;CACNB1;SEC61A1;CHRNA7;NCS1;CUL5;CACNA2D1;TRPC1;ANXA6;TRPV2;TMCO1;SLC24A4;SLC24A2;P2RX4
prerank,hexose transmembrane transporter activity (GO:0015149),0.35828088981132733,0.755073236062932,0.7659863945578231,0.9875951549196611,1.0,2/12,14.21%,MFSD4A;SLC2A3
prerank,glutathione transferase activity (GO:0004364),-0.23046000190144134,-0.7533429907295613,0.8638743455497382,0.9147775394893846,1.0,8/23,26.77%,LANCL1;GSTA4;MGST1;GSTA3;MGST3;GSTO1;GSTT2;GSTK1
prerank,adenylate cyclase binding (GO:0008179),-0.29782151925439543,-0.7525804525847911,0.7712177121771218,0.9081224667109844,1.0,3/10,12.14%,ADCY5;CAP2;AKAP6
prerank,phospholipid transfer activity (GO:0120014),0.3191958214249652,0.7524201688135082,0.7849056603773585,0.988929202754129,1.0,6/21,20.52%,TRIAP1;OSBPL2;PRELID3A;GLTP;PRELID1;PITPNM1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3035780195443768,0.751673046225441,0.8161592505854801,0.9877561656615756,1.0,14/34,28.16%,SETD7;SETD2;ANTKMT;EHMT2;EEF2KMT;PRDM9;N6AMT1;EZH2;SETDB1;CAMKMT;KMT5A;EEF1AKMT3;MEN1;SUV39H1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.36647017504610035,0.7470666929169625,0.788515406162465,0.9914310090617954,1.0,2/11,15.22%,SLC25A25;SLC25A17
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.35185026905458483,0.7465440873373409,0.7700680272108843,0.9899920021808749,1.0,3/13,14.64%,SLC7A6;SLC7A3;SLC15A4
prerank,microtubule minus-end binding (GO:0051011),-0.2750170783255202,-0.7459905969090118,0.8201438848920863,0.909072807509979,1.0,3/13,9.55%,TUBGCP4;CEP290;MACF1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3712744944715573,0.7415753041453045,0.7787234042553192,0.9942273462310529,1.0,2/10,8.60%,PIK3C2B;PIK3CA
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2560038806144524,0.7415241248250454,0.986,0.9921685249248661,1.0,121/431,27.72%,TNK1;PFKP;RAB32;RAB6A;IRAK3;ATP1A3;ATP1A1;ACVR1;P2RX3;GTPBP4;RAP1B;ACLY;MVK;ABCE1;ABCA1;ARF4;IGHMBP2;TBCK;SCG5;RIT2;ABCB8;MYO9B;N4BP2;UBA2;HSPA13;DYNC1LI1;GALK1;PPP5C;CLPX;AKT3;RHOJ;ARF1;RHOQ;RAB2A;TWF1;ERN1;TARS1;DYRK2;TUBB6;MAP3K6;AKT1;SARS2;NRAS;KRAS;GTPBP10;PNPLA8;NUDT16;PXK;TUBD1;RRAD;RHOA;RRAGD;STK3;RAB27B;RND3;HSP90AA1;PEX1;CHD8;TUBB4A;ARF6;TUBA4A;GEM;HSPA14;GLUD1;PMVK;HARS1;RAC3;RAB35;PRPS1L1;PRPS1;IDE;NME1;ABCF1;ABCB9;RAB1B;TGFBR1;BLM;STK38;RRAS2;PANK3;ABCD3;PIP4K2B;RALA;RAB10;OXSR1;STK26;BMPR1A;SRPK1;SRR;PI4K2A;ADSS2;TUBG2;MYO1F;KCNJ11;RABL3;LATS1;WNK2;ACVR1B;NOA1;ARL8A;RAC1;MARK2;ANXA6;RHOT2;ATL1;RAB29;RHOBTB2;MAST2;EIF4G1;EIF2B2;RND2;MSH6;TUBB2A;RAP1A;DIRAS2;P2RX4;PEAK1;RHEBL1;TSR1;PRPS2;NDUFA13
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.2867721958338815,0.73912511197101,0.8497237569060774,0.9929140979880123,1.0,15/49,25.66%,ZRANB1;RAD23B;HDAC6;ZBTB1;SQSTM1;OTUD7B;TNIP1;ABRAXAS1;TAB2;FAAP20;TNIP2;PSMD4;UBQLN4;AGAP3;UFD1
prerank,nucleosomal DNA binding (GO:0031492),-0.23913014788276354,-0.7385739943441916,0.9119170984455959,0.9107208357764586,1.0,5/21,14.49%,H3-3A;CHD4;ACTB;SMARCB1;MTA2
prerank,RNA cap binding (GO:0000339),0.3338898535484161,0.7379281892372747,0.7884856070087609,0.9922764140770517,1.0,8/16,28.65%,EIF4A1;AGO2;LARP1;EIF3D;NCBP3;CYFIP1;EIF4E2;LSM1
prerank,histone acetyltransferase binding (GO:0035035),0.31325221761174193,0.7368422657532422,0.8114143920595533,0.9914311854026443,1.0,5/21,16.21%,TRIP4;SIRT2;GLI3;BCAS3;TRIM68
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3104176857847354,0.7366182901833433,0.8118811881188119,0.9895845621945886,1.0,2/24,5.85%,SESTD1;PLEKHF1
prerank,cyclic nucleotide binding (GO:0030551),0.3180328137325475,0.7354560583385253,0.8002466091245376,0.9889914601435668,1.0,5/21,12.04%,PDE11A;PDE10A;CNGB1;PDE5A;PDE4D
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.34559653014883973,0.7325794762300284,0.8086592178770949,0.9901829639144614,1.0,2/12,4.31%,TGFBR2;ACVR1
prerank,voltage-gated sodium channel activity (GO:0005248),0.3138371971863289,0.7282277029078816,0.8172715894868585,0.9932353647538505,1.0,12/22,37.08%,PKD2;HCN4;SCN4B;HCN1;SCN9A;SCN2A;CACNA1H;CACNA1I;SCN1A;CACNA1G;SCN8A;SCN1B
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.2594387176680202,0.7269887182333233,0.9283551967709385,0.9926674571498676,1.0,50/147,27.37%,ARHGEF28;AKAP13;PLCE1;CCDC88C;RASGRF1;PREB;FARP2;RASGEF1A;FARP1;MYCBP2;FRMD7;RGL1;HPS4;ARHGEF10;RGL2;EGF;NGEF;SMCR8;DENND1A;RAPGEF1;EEF1B2;MADD;SOS1;ANKRD27;EPS8L2;RCC1L;DNMBP;MON1A;DENND6A;ARFGEF1;EIF2B1;SERGEF;DOCK4;TIAM1;DENND4B;DENND2A;VAV2;CCDC88A;DOCK11;ALS2;BCR;ITSN1;EIF2B2;RIC8A;ARFGEF2;ARHGEF7;SPATA13;RAP1A;GAPVD1;EEF1D
prerank,single-stranded DNA helicase activity (GO:0017116),0.31212833125817824,0.724905379837499,0.8210659898477157,0.9928077974494187,1.0,3/19,16.08%,HELQ;DNA2;RFC4
prerank,organic cation transmembrane transporter activity (GO:0015101),0.32776715796222017,0.7239447370008032,0.8172185430463577,0.9917915222062078,1.0,4/16,17.43%,SLC18A3;SLC44A1;SLC25A17;SLC44A2
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.3391157195312021,0.723595288050617,0.7955493741307371,0.9901654694365104,1.0,2/12,8.61%,CDK4;CDK9
prerank,potassium channel regulator activity (GO:0015459),0.2768156637124661,0.7206976743380754,0.8601321585903083,0.9915335652540772,1.0,10/49,20.57%,KCNV1;SGK3;SGK2;YWHAE;AKT1;KCNAB3;CHP1;AKAP9;RASA1;FLNA
prerank,Wnt-activated receptor activity (GO:0042813),0.33198889857723135,0.7169135696178112,0.8153638814016172,0.9938244976188422,1.0,4/15,19.40%,PKD1;FZD7;FZD4;ROR1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.32437303269301127,0.7165309628484889,0.8306878306878307,0.9921838022926219,1.0,1/15,4.41%,P2RX3
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.2725071511888612,-0.7150138462494415,0.8352059925093633,0.9322329184628189,1.0,4/13,13.24%,PRKAR1B;KCNQ1;RYR2;PRKAR2B
prerank,voltage-gated chloride channel activity (GO:0005247),0.3565934489802977,0.7130881159912202,0.8268156424581006,0.9939287767589694,1.0,1/10,4.99%,CLCN5
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.32825428345870833,0.71271053701639,0.8225165562913908,0.9922557707111485,1.0,3/14,19.03%,KCNJ2;KCNJ3;KCNH2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.27748655739159916,0.7099460399364866,0.877030162412993,0.9933032611092469,1.0,16/40,32.11%,MEPCE;COMTD1;GAMT;COMT;N6AMT1;ICMT;ASMT;NNMT;SUV39H1;PRMT8;THUMPD3;METTL9;LRTOMT;AS3MT;PRMT7;DNMT3B
prerank,GTPase regulator activity (GO:0030695),0.24864047060009156,0.7084697468165942,0.9699097291875627,0.9929200979257966,1.0,30/212,10.21%,GPSM2;ARHGAP10;SGSM2;ARHGAP44;RABGAP1L;SLIT2;CDC42EP2;ELMOD1;LLGL1;RAP1GAP2;ARHGAP42;PREB;ADAP1;ASAP3;TBCK;FLCN;MYO9B;SEC23A;ARHGAP9;TBC1D2B;GPSM1;ARFGAP3;ARFGAP1;OCRL;ARHGEF10L;IQGAP1;TBC1D17;TAGAP;SIRPA;GDI1
prerank,pseudouridine synthase activity (GO:0009982),0.337647956640582,0.7075720242359161,0.8286479250334672,0.991875604033488,1.0,1/13,4.33%,RPUSD1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.3387725824374527,0.705278443840178,0.8223140495867769,0.9922863273344822,1.0,2/12,15.22%,SLC25A25;SLC25A17
prerank,GTPase activator activity (GO:0005096),0.24512840239850223,0.7015747889883759,0.983983983983984,0.994248646976327,1.0,91/313,24.54%,ARHGEF28;ARHGAP10;SGSM2;ARHGAP44;AKAP13;PLCE1;CCDC88C;RABGAP1L;CDC42EP2;ELMOD1;LLGL1;RAP1GAP2;RASGRF1;ARHGAP42;PREB;FARP2;ADAP1;ASAP3;RASGEF1A;FARP1;TBCK;FLCN;MYO9B;MYCBP2;FRMD7;SEC23A;ARHGAP9;RGL1;TBC1D2B;ARFGAP3;ARFGAP1;HPS4;OCRL;ARHGEF10L;IQGAP1;TBC1D17;ARHGEF10;TAGAP;RGL2;EGF;TBC1D10A;PGAM5;NGEF;SMCR8;DENND1A;RAPGEF1;HACD3;EEF1B2;EVI5;MADD;SOS1;SGSM1;ANKRD27;EVI5L;EPS8L2;TBC1D13;ARAP1;SRGAP2;RCC1L;ADPRH;TBC1D22B;TBC1D15;RP2;DNMBP;MON1A;DENND6A;ARFGEF1;EIF2B1;RASA1;SERGEF;DOCK4;TIAM1;DENND4B;DENND2A;ARRB1;ARHGAP17;NF1;RUNDC1;VAV2;GNB5;JUN;TBC1D8B;CCDC88A;TBC1D12;ARHGAP20;DOCK11;ALS2;BCR;ITSN1;TSC2;STXBP5L
prerank,mRNA 5'-UTR binding (GO:0048027),0.2957380775454924,0.6998131971160966,0.8491017964071856,0.9939657112480916,1.0,4/24,15.34%,MRPS11;IGF2BP1;LARP1;RSL1D1
prerank,metalloexopeptidase activity (GO:0008235),0.2675985414110917,0.6992279897301917,0.886117136659436,0.9925766592840962,1.0,15/51,25.30%,ANPEP;LNPEP;DPEP1;XPNPEP3;NUDT16;NPEPPS;LAP3;MMP16;METAP2;METAP1;METAP1D;CPZ;MMP15;ZMPSTE24;AGBL1
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.2600684210916285,-0.6927693366760149,0.8730769230769231,0.9478290628182016,1.0,11/12,50.16%,ELOVL4;GPR88;GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.330335740013891,0.6909317311693298,0.8463648834019204,0.999095442149565,1.0,2/12,8.60%,PIK3C2B;PIK3CA
prerank,DNA secondary structure binding (GO:0000217),0.27759944206091836,0.6904552140614145,0.8923076923076924,0.9975148109730335,1.0,12/31,28.78%,XRCC3;RAD51B;MAPT;HMGB3;KMT2A;ERCC5;BLM;CLSPN;RAD51D;MSH6;MEN1;LIN54
prerank,exonuclease activity (GO:0004527),0.2677135493946009,0.6869756322458025,0.8853362734288864,0.9990056654834223,1.0,7/46,13.85%,REV3L;EXOSC7;FAN1;RAD1;REXO2;EXOSC1;ZC3H12A
prerank,acetyltransferase activity (GO:0016407),0.278218178800022,0.6863605693366203,0.8790697674418605,0.9976496658140646,1.0,9/31,22.12%,GNPNAT1;LCAT;KAT2B;NAT8;SAT1;NAA15;NAA50;ACAT1;KAT6B
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.31625915274953476,0.6860862893334656,0.8575305291723202,0.9959317684204184,1.0,6/14,20.61%,EXO5;NDUFS1;ACO2;ETFDH;RSAD1;CIAO3
prerank,FMN binding (GO:0010181),-0.2670907888770878,-0.6839352255699995,0.8931297709923665,0.9486888489717193,1.0,4/11,17.90%,NOS3;NOS1;NDOR1;PPCDC
prerank,proton transmembrane transporter activity (GO:0015078),0.26646936248899417,0.6827162645560245,0.8961625282167043,0.9971856750342106,1.0,7/39,21.49%,CLCN5;SLC11A2;SLC9A1;UQCRQ;ATP6V1B2;UQCRH;UQCR10
prerank,DNA replication origin binding (GO:0003688),-0.2120866975940705,-0.680714667525633,0.93,0.9438085912854851,1.0,2/23,3.16%,ORC5;MCM9
prerank,channel activity (GO:0015267),0.2634013361951727,0.6806746143182858,0.8982300884955752,0.9972493801146641,1.0,5/41,17.16%,TRPV3;TMEM266;MCUB;TMEM120A;CHRNA7
prerank,retinoid X receptor binding (GO:0046965),0.3294480095056227,0.6795086037092994,0.8462603878116344,0.9963860458900611,1.0,5/11,25.84%,VDR;NRIP1;NSD1;NCOA6;RARG
prerank,phospholipase C activity (GO:0004629),0.28644031478404697,0.6793169055612331,0.8819951338199513,0.994543797804417,1.0,2/25,4.82%,PLCE1;PLCB4
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.24319629665260584,-0.6770013960763376,0.9074889867841409,0.939708110105302,1.0,1/15,2.40%,CCR9
prerank,adenylyltransferase activity (GO:0070566),0.2914115055650027,0.6760272822751444,0.8764331210191083,0.9956323335260666,1.0,5/21,18.34%,TENT4A;SELENOO;PAPOLB;TENT2;TENT4B
prerank,phospholipase A2 activity (GO:0004623),0.2818569719601677,0.6743499950857814,0.8721351025331725,0.9952310981809346,1.0,3/26,15.10%,PLAAT1;PNPLA8;PLA2G4E
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2706478207856435,0.6742708295629627,0.8831168831168831,0.9933351957185276,1.0,9/33,20.07%,UBA2;SIAH1;TCERG1;RNF14;AUP1;ARIH2;RNF19A;TOLLIP;ARIH1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2612298214534131,0.6740286540447473,0.8929804372842347,0.991562743427259,1.0,19/44,29.30%,CXXC1;SETD7;WDR5;SETD2;EHMT2;SETD5;KMT2A;PRDM9;KMT2C;SETD1B;N6AMT1;NSD1;EZH2;SETDB1;SETDB2;KMT5A;MEN1;SUV39H1;SETD1A
prerank,adenyl ribonucleotide binding (GO:0032559),0.23351612982238032,0.6707674332264321,0.994,0.9926132627137358,1.0,59/291,21.15%,GCLC;TNK1;PFKP;IRAK3;ATP1A3;ATP1A1;ACVR1;P2RX3;ACLY;MVK;ABCE1;ABCA1;IGHMBP2;TBCK;PDE10A;ABCB8;MYO9B;N4BP2;UBA2;HSPA13;GALK1;PPP5C;CLPX;AKT3;TWF1;ERN1;TARS1;DYRK2;MAP3K6;AKT1;SARS2;PNPLA8;PDE4D;PXK;STK3;HSP90AA1;PEX1;CHD8;HSPA14;GLUD1;PMVK;HARS1;PRPS1L1;PRPS1;IDE;NME1;ABCF1;ABCB9;TGFBR1;BLM;STK38;HCN1;PANK3;ABCD3;PIP4K2B;OXSR1;STK26;BMPR1A;SRPK1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.3129674600620148,0.6692676491414556,0.8633288227334236,0.9920176279668872,1.0,5/13,21.52%,PIK3C2B;PIK3CA;PIP4K2C;PIP4K2B;PIK3CG
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.24919837920107762,-0.6692383679503375,0.8784313725490196,0.9390621738913693,1.0,6/12,25.39%,GABRG1;GABRB3;GABRA4;GABRE;GABRB2;GABRA2
prerank,ATP binding (GO:0005524),0.23289976973584312,0.6690507232839923,0.992992992992993,0.9902641220132276,1.0,54/266,21.15%,TNK1;PFKP;IRAK3;ATP1A3;ATP1A1;ACVR1;P2RX3;ACLY;MVK;ABCE1;ABCA1;IGHMBP2;TBCK;ABCB8;MYO9B;N4BP2;UBA2;HSPA13;GALK1;PPP5C;CLPX;AKT3;TWF1;ERN1;TARS1;DYRK2;MAP3K6;AKT1;SARS2;PNPLA8;PXK;STK3;HSP90AA1;PEX1;CHD8;HSPA14;PMVK;HARS1;PRPS1L1;PRPS1;IDE;NME1;ABCF1;ABCB9;TGFBR1;BLM;STK38;PANK3;ABCD3;PIP4K2B;OXSR1;STK26;BMPR1A;SRPK1
prerank,protein kinase C activity (GO:0004697),0.304265642532877,0.6631931151823981,0.8707482993197279,0.9937379828519668,1.0,1/14,1.22%,PRKCA
prerank,inward rectifier potassium channel activity (GO:0005242),0.27816100478298417,0.6628314398576256,0.8819188191881919,0.9921183394807506,1.0,5/24,23.38%,KCNJ2;KCNJ3;KCNH2;ABCC8;KCNJ11
prerank,alpha-actinin binding (GO:0051393),0.2772495558317785,0.6612039295996209,0.8960880195599022,0.9915594147230102,1.0,4/24,12.40%,PDLIM7;PKD2;PDLIM1;PALLD
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.27742684165015125,0.6610424854884802,0.8805970149253731,0.989774020880351,1.0,6/22,27.99%,CLTC;HSPG2;SYT1;AP2M1;HSP90B1;DNAJA1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.3238495384380868,0.6605990334744603,0.8609550561797753,0.9882818567950454,1.0,5/10,33.83%,POLD1;DCLRE1A;MGME1;EXO1;TATDN1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.27158730925472635,0.6603667802181822,0.8820697954271961,0.9865368379987994,1.0,10/27,27.06%,POLR2D;POLR2G;POLR3H;TENT2;POLR1D;POLR1C;POLR3A;POLR1B;POLR2C;MED21
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2624739580506318,0.6539402982285879,0.9179019384264538,0.9900737311229174,1.0,8/35,21.10%,TYW3;FTSJ1;DTWD1;TRPT1;PTRH2;QTRT1;DUS2;QRSL1
prerank,kinase activity (GO:0016301),0.23648768810697784,0.6528508171884677,0.9682051282051282,0.9891530847262149,1.0,26/109,21.52%,PAPSS2;DGKQ;PIK3C2B;MTOR;MVK;GK5;CHKB;PIK3CA;AGK;AKT1;IRAK1;PGM2L1;PSTK;STK39;CERK;PRKD3;PI4KB;PI4KA;PANK1;PMVK;IPPK;DCAKD;PANK3;IP6K1;TRRAP;PIK3CG
prerank,diacylglycerol kinase activity (GO:0004143),0.3122491667973565,0.6458448450355256,0.8765603328710125,0.9931030110047631,1.0,2/11,9.37%,DGKQ;AGK
prerank,NAD binding (GO:0051287),0.2671187323839516,0.6445131477195859,0.9088757396449704,0.9922260376472266,1.0,9/26,21.75%,SIRT2;ZC3HAV1;HSD17B8;CRYZ;GLUD1;NUDT6;BDH2;CTBP1;UXS1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.2656964795643017,0.643948158814632,0.9081145584725537,0.9907598059834332,1.0,15/27,35.94%,POLR2D;POLR2G;POLR3H;POLR1D;POLR1C;POLR3A;POLR1B;POLR2C;MED21;PRIM1;CRCP;POLR2I;POLR2B;POLR2E;POLR2J
prerank,carbohydrate kinase activity (GO:0019200),0.3096163121827844,0.6427899539458677,0.8828451882845189,0.9897247246567518,1.0,3/11,18.39%,NAGK;GALK1;GNE
prerank,chloride channel activity (GO:0005254),0.24369362453841092,0.6416021737144249,0.947481243301179,0.9887431388877989,1.0,8/59,19.52%,ANO3;CLCN5;GABRR3;CLCC1;GABRG3;TTYH3;ANO5;GABRG2
prerank,death receptor binding (GO:0005123),0.2939757015510864,0.6405565207019129,0.8914728682170543,0.9876854898020467,1.0,3/15,16.41%,TMBIM1;EDA;MADD
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2744305077650463,0.6396694850471702,0.9129353233830846,0.9864915071418344,1.0,7/24,20.41%,NME2;PMVK;CMPK2;AK8;NME1;AK9;IP6K1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.1657971454090662,-0.6352022804672511,1.0,0.9585208065106048,1.0,23/57,26.96%,COX4I1;NDUFA9;NDUFA5;NDUFB4;CYB561A3;UQCR11;NDUFA4;NDUFB10;NDUFB8;NDUFC1;NDUFS4;UQCRFS1;NDUFA10;CYBRD1;NDUFA6;NDUFS2;COX5A;NDUFS8;NDUFA12;NDUFA8;NDUFS6;NDUFA4L2;NDUFS7
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.25615661710875737,0.632815251761521,0.9125,0.9899733030599908,1.0,4/34,12.70%,DIS3L2;ERI3;EXOSC7;REXO2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.2916283245744829,0.6312058915822657,0.9042553191489362,0.9892330792460281,1.0,6/14,30.05%,BLVRB;CRYM;PYCR1;DHFR;NOXRED1;PYCR3
prerank,histone demethylase activity (GO:0032452),0.26053440739590894,0.6258395823958303,0.932934131736527,0.9912156705309058,1.0,11/27,28.33%,KDM3B;KDM5C;KDM5B;JMJD1C;FBXL19;KDM2B;KDM4C;KDM3A;JARID2;KDM2A;KDM4B
prerank,phosphoric ester hydrolase activity (GO:0042578),0.2399732221874216,0.6220388545863194,0.9415073115860517,0.9921100653069701,1.0,19/49,30.88%,ACP2;PTPRJ;PPP5C;DUSP11;SAMHD1;PGAM5;PHOSPHO2;PPP1CC;SMPD1;GDPD3;ACP3;LHPP;ACP6;DUSP12;PGP;DUSP8;SBF1;SACM1L;HDHD2
prerank,sequence-specific mRNA binding (GO:1990825),-0.248807431584233,-0.613342813940744,0.9309090909090909,0.9649249190756551,1.0,10/10,75.14%,SSB;SHFL;TYMS;LIN28A;FMR1;DHX9;ETF1;DHFR;RBM24;LARP6
prerank,5'-nucleotidase activity (GO:0008253),0.28691561665882115,0.613251349881002,0.9263301500682128,0.9962538004232091,1.0,3/13,21.18%,NT5M;ACP3;NT5DC2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.29266455534375246,0.6131603239400929,0.9122807017543859,0.9944138448122775,1.0,9/13,37.39%,GABRG3;GABRG2;GABRA3;GLRA3;GABRA1;GLRA2;GABRA5;GLRA1;GLRB
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.30429446683284195,0.6106578344641908,0.9125528913963329,0.994241312093947,1.0,5/10,31.19%,GLCE;GNE;GALM;DSEL;GALE
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.2808120252538129,0.6079762360242407,0.9152086137281292,0.9941665909231021,1.0,4/15,17.36%,HS2ST1;HS3ST6;HS3ST5;NDST2
prerank,voltage-gated ion channel activity (GO:0005244),0.28463406751102865,0.6050706035473083,0.9112903225806451,0.9941723441240952,1.0,4/14,19.31%,PKD2;VDAC2;VDAC1;HCN1
prerank,endodeoxyribonuclease activity (GO:0004520),0.26342534762335357,0.6027294550169856,0.9326683291770573,0.9937908948338762,1.0,5/20,23.30%,DNA2;ERCC4;RAD50;ERCC5;ERCC1
prerank,tRNA methyltransferase activity (GO:0008175),0.2752385534229459,0.6026408186797939,0.9163398692810457,0.9919913999711332,1.0,2/16,8.43%,TYW3;FTSJ1
prerank,neuropeptide receptor binding (GO:0071855),0.27222501255650433,0.5938601719753035,0.9312169312169312,0.995470916490741,1.0,14/14,72.80%,NMU;SHANK1;AGRP;NTS;PPY;QRFP;APELA;UCN3;GHRH;NPPA;UCN2;GAL;APLN;NPY
prerank,NAD+ binding (GO:0070403),0.28126418052387575,0.592490879727404,0.9110512129380054,0.9943765406820062,1.0,4/12,21.75%,SIRT2;ZC3HAV1;GLUD1;UXS1
prerank,cation transmembrane transporter activity (GO:0008324),0.22503914040455672,0.5834455022806949,0.974585635359116,0.9976335454295809,1.0,11/48,25.94%,SLC1A5;SFXN1;SLC7A3;SLC15A4;SLC38A1;SLC25A15;SLC8B1;SLC38A9;SLC25A2;SLC36A4;SFXN2
prerank,ankyrin binding (GO:0030506),0.2520971753809863,0.5748855957757459,0.9602564102564103,1.0,1.0,6/19,25.93%,SPTBN1;KCTD6;SPTBN4;PLEC;KCNJ11;NRCAM
prerank,pyridoxal phosphate binding (GO:0030170),0.25113976101128743,0.5694317615926894,0.9542566709021602,1.0,1.0,8/20,30.69%,ACCS;PSAT1;GLDC;PYGB;SRR;CTH;PNPO;PLPBP
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.273815930311869,0.5582147187730435,0.9539106145251397,1.0,1.0,1/11,7.95%,HMCES
prerank,GABA receptor binding (GO:0050811),0.2718959783664306,0.5579291030459766,0.9559228650137741,1.0,1.0,1/11,6.85%,TRAK2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.271932802745271,0.5553452588010299,0.9469914040114613,1.0,1.0,4/11,26.73%,STUB1;AMFR;UBE2K;PRPF19
prerank,5'-3' exonuclease activity (GO:0008409),0.26005653622740693,0.554852570993619,0.9479166666666666,1.0,1.0,6/14,32.89%,FAN1;DCLRE1A;TRIR;CPSF3;EXO1;XRN2
prerank,symporter activity (GO:0015293),0.2733210049520354,0.5508550303631783,0.95,1.0,1.0,1/10,11.41%,SLC4A4
prerank,protein phosphatase activator activity (GO:0072542),0.25130169800580243,0.5417825112475658,0.9623655913978495,1.0,1.0,3/13,17.38%,B3GAT3;CALM2;PPP2R5B
prerank,vitamin D receptor binding (GO:0042809),0.25191277064479806,0.5370051843955107,0.960328317373461,1.0,1.0,3/14,21.29%,MED24;MED13;THRAP3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.2549063431124884,0.5346077057762116,0.9512534818941504,1.0,1.0,4/12,23.51%,TRAF3;TRAF4;TRAF5;TRAP1
prerank,Notch binding (GO:0005112),0.2247512938478573,0.533050210684078,0.9779951100244498,1.0,1.0,3/22,12.53%,JAG1;CUL3;NCOR2
prerank,kinesin binding (GO:0019894),0.21553142645801718,0.5251404601558479,0.9759903961584634,1.0,1.0,11/27,32.45%,TOR1A;ARHGEF10;ATCAY;CROCC;RAB29;KIFAP3;SPAG9;MAPK8IP3;PLEKHM2;KLC2;KIF1B
prerank,GABA-A receptor activity (GO:0004890),0.2306545178883836,0.5121392532336762,0.9778051787916153,1.0,1.0,3/18,19.52%,GABRR3;GABRG3;GABRG2
prerank,neuropeptide receptor activity (GO:0008188),-0.14497926403390732,-0.5080302606427297,0.9865771812080537,0.9980790605646657,1.0,17/29,41.73%,TACR1;TACR3;OPRM1;GALR1;NPY5R;NMUR2;GRPR;KISS1R;SSTR2;NPY1R;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL
prerank,histone methyltransferase binding (GO:1990226),0.24563468196815727,0.49873116710388954,0.9685792349726776,1.0,1.0,5/11,34.78%,PHF1;LCOR;NOP56;WIZ;HSP90AB1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.17389619820479074,-0.48972377148919466,0.9877551020408163,0.9935180202250621,1.0,7/16,33.06%,CD38;TDG;NEIL1;NEIL3;NTHL1;NEIL2;BST1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.1951817784346963,0.4847888167333138,0.9942922374429224,1.0,1.0,5/34,14.57%,NDUFS5;NDUFS1;NDUFB7;NDUFA2;NDUFV2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.1951817784346963,0.4847888167333138,0.9942922374429224,1.0,1.0,5/34,14.57%,NDUFS5;NDUFS1;NDUFB7;NDUFA2;NDUFV2
prerank,ligand-gated anion channel activity (GO:0099095),0.2173602295451116,0.48355020275500277,0.9786432160804021,1.0,1.0,9/17,35.10%,GABRG3;GABRG2;GABRA3;GLRA3;CFTR;GABRA1;GLRA2;GABRA5;GLRA1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.24101069262019245,0.4814542729266039,0.9680998613037448,1.0,1.0,5/10,33.61%,GABRG3;GABRG2;GABRA3;GABRA1;GABRA5
prerank,endopeptidase activator activity (GO:0061133),0.23327364062434347,0.4701244034090768,0.9817415730337079,1.0,1.0,1/10,8.69%,ADRM1
prerank,MHC class I protein binding (GO:0042288),0.21081006234998345,0.44799265411835776,0.9893048128342246,1.0,1.0,4/13,28.67%,ABCB9;DERL1;ATP5F1B;ATP5F1A
prerank,GABA receptor activity (GO:0016917),0.18917898346281103,0.432106691629005,0.9963680387409201,1.0,1.0,3/21,19.52%,GABRR3;GABRG3;GABRG2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.18402712375211905,0.3996903475696998,0.9973368841544608,1.0,1.0,15/15,81.61%,PLA2G4E;PLA2G12A;PLA2G1B;PLA2G4D;PLA2G2E;PLA2G2F;PLA2G10;PLA2G2D;PLA2G2C;PLA2G3;PLA2G5;PLA2G4B;PLA2G4A;PLA2G4F;PLA2G4C
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.16423464509457208,0.3809288008192125,0.9987864077669902,0.9989161537225884,1.0,3/22,22.91%,HTR1F;HTR2C;HTR2A
prerank,serotonin receptor activity (GO:0099589),0.16423464509457208,0.3809288008192125,0.9987864077669902,0.9989161537225884,1.0,3/22,22.91%,HTR1F;HTR2C;HTR2A
prerank,G protein-coupled amine receptor activity (GO:0008227),0.16423464509457208,0.3809288008192125,0.9987864077669902,0.9989161537225884,1.0,3/22,22.91%,HTR1F;HTR2C;HTR2A
